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extracting the discharge and billing data from the hospital information system.
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processed and reprocessed the many versions of the manuscript with a remarkable patience,
Brcnda Swaak who has edited the text into proper English, Wilma Vcrhcydcn-Pustjcns who
has designed the book cover and Hetty Crccmcrs who took care of the lay-out.
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A very special place in all of this is for Sjeng. His positive attitude, his understanding and
his music have meant a lot to me.
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Introduction.
A hospital can be compared with a multi-product organization, in which a variety of outputs
-in the sense of 'medical care products' provided to patients- is produced. Health care
providers and hospital managers arc responsible for the effectiveness and efficiency of the
medical care provided. Today, cost control is an important issue in health care policy.
Information on the quality of hospital processes and the outcomes of these processes in
relation to the money spent has become a necessity for modern hospital managers.
Furthermore, information on factors influencing hospital costs is essential for controlling
hospital costs. Hornbrook (1982) has lucidly described the relationship between hospital
costs, health care policy, hospital management and patient care: 'The definition and
measurement of the output of the hospital is a complex, persistent and pervasive problem. It
is a central concern to health policy makers, who must determine ways of improving the
reimbursement mechanisms to provide greater incentives for cost-effective operations of
hospitals; to hospital administrators, who must develop ever more accurate forecasts of
staffing and budget needs in an era of increased cost-consciousness; and to health services
researchers, who must develop better measures of hospital output to advance our
understanding of the determinants of hospital productivity and costliness. To achieve these
goals of predicting, explaining and controlling hospital performance, it is necessary to define
what the hospital produces and to specify appropriate measures. However, quick resolution
of the measurement problem is precluded by the complex, multidimensional nature of
hospital activities, and the multiple objectives of the physicians and patients who use the
hospital'.
Variables to opcrationalize the hospital output have been proposed in a variety of research
settings. Variables representing hospital facilities and services like number of beds, high care
facilities, ambulatory services, mix of medical specialties etc. have frequently been used in
studies to explore cost differences among hospitals (Berry 1970, Berry 1973, Ruchlin 1974,
Van Aert 1977, Van Montfort 1980). However, using these variables places more emphasis
on the characteristics of a hospital organization than on the complexity of the hospital
patient population. Therefore, this approach can be regarded as an easily available surrogate
for measuring hospital output. Other studies have shown that variables reflecting the hospital
case-mix, like number of patients in specific diagnostic groups, surgical groups and age/sex
categories, describe hospital output in a different way. Consequently, case-mix variables will
offer a more precise explanation for differences in costs of medical care (Evans 1971, Lave
1971, Feldstcin 1977, Watts 1980, Klastorin 1980).
Many researchers have dealt with the problem of finding factors that explain cost differences
between and within hospitals. Although they have come to the conclusion that case-mix
variables, like diagnoses and surgical procedures, are more successful in explaining cost
differences than indirect variables describing hospital characteristics such as patient days,
number of beds, hospital facilities etc., they have at the same time reported important
difficulties in measuring the hospital case-mix in an adequate way. First of all, a hospital
population must be defined in terms of patient categories which on the one hand makes
sense to physicians and on the other contains economic relevancy for hospital managers.
Medically relevant patient categories must be homogeneous with respect to costs: patients
who have similar costs patterns must be defined within the same category. Only then, can
the hospital output be defined and measured in an adequate way.
In the past decade several studies have concentrated on the development of patient
classification systems that aim to explain differences in costs between and within hospitals
(sec chapter 2). Such patient classification systems may be applied to several areas within
health care (Groot 1978, Fetter 1980, Ncdcrstigt 1981, Wood 1981, Hornbrook 1982,
Grimaldi 1983 , Fetter 1986, Lichting 1986).
Reimbursement of hospital services.
A very well-known patient classification is the Diagnosis Related Group (DRG)-system
which is used as a prospective reimbursement system for hospitals in the US health care
system. To finance patient care within hospitals, specific reimbursement rates have been
established for each DRG separately. Dcsharnais (1987), and Rosko (1987) have come to the
conclusion that this type of prospective payment system reduces hospital utilization without
resulting in a deterioration in the quality of care. Prince (1987) and Wyszcwianski e.a.
(1987) conclude that an advantage of this form of payment is that it provides an incentive
for belter hospital management ('Managed Care'). On the other hand, adverse consequences
for the US health care system may be that this type of system provides incentives to choose
surgical over medical treatment, or that it leads to selective admission practices or to an
increase in rc-admissions (Omcnn c.a. 1984, Hunt 1988, Slcin 1985, Torf 1989). Roger e.a.
(1990) found that mortality following hospitalization has been unaffected, and improvements in
hospital processes of care that began prior to the prospective payment system have
continued after its introduction, but that the likelihood that a patient will be discharged
in an unstable condition, has increased. Furthermore, the appropriateness of the DRG-
classification as a reimbursement system is questioned: limited information is used in
assigning patients to a DRG; the severity of illness and socio-economic characteristics of
patients are not considered, and the possibilities for data-manipulation arc alarming (Stern
1985, Williams 1984, Simborg 1981. Torf 1989).
In Dutch health care there is no experience with the application of patient classifications
systems to finance hospital care. But at the moment political discussions arc going on to
reorganize the Dutch hospital financing system ('Stelselwijziging Gezondheidszorg'). In the
near future, health insurance companies have to come to an agreement with health care
institutions about the type, amount and costs of the health care that is provided. Application
of a patient classification system may be useful in discussions between health insurance
companies and health care providers.
Hospital applications.
Wuhm a hospital, a patient classification system may have important implications for four
types of application.
Patient classification systems may be helpful in predicting budget requirements, in budget
monitoring and in analyzing differences between budget and actual expenditures. Each type
of patient requires specific medical care. Determination of the expected costs of medical
care for the various types of patients may form a basis for budget allocation for medical
departments and subsequently for ancillary departments. A patient classification may be
especially helpful in budget analysis. Deviations from the budget may by traced to specific
causes such as (a) changes in the number of patients, (b) changes in types of patients (c)
changes in resources used within a patient group or (d) changes in costs of the services
provided to a patient group.
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Historical information about the patient population can help hospitals to develop long-term
plans. Expected changes in the patient population may require specific health care facilities.
Anticipating changes in patient populations with the help of empirical data may contribute to
a timely prediction of the consequences for the hospital.
Patient classification systems can be used to examine resource utilization patterns among
clinically similar groups of patients and to identify patterns that arc atypical. These atypical
patterns can then be further evaluated by means of detailed case analysis.
* mom'/oring //i<» fua/iiy o/care.
Physician performance cannot be assessed appropriately without reference to the types of
diseases treated. If quality criteria arc established for clinically similar groups of patients,
deviations from the standard or norm may be observed and singled out for further inquiry.
Research applications.
Patient classification systems concerning resource use and costs provide detailed data on the
types and amounts of health care services used. Such information may be valuable for
scientific research in health care in addressing such questions as: What procedures arc being
performed in various settings, and how often? What types of patients tend to make more use
of a particular service? What arc the relative costs and outcomes of treating patients in
different settings such as teaching versus non-teaching hospitals? Arc new services replacing
old ones, answering unfulfilled needs, or just duplicating existing services and adding
unnecessary costs? (Lichting 1986).
Another application of such patient classification systems may lie in medical technology
assessment studies. Classifying patients into clinically relevant categories which arc
homogeneous with respect to costs may be seen as a precondition for performing these
evaluation studies. After grouping, costs and effects of medical care may be determined and
compared for each group of patients. Also the effect of changes in medical care (i.e. the
introduction of a new technology) may be evaluated in terms of the direct or long-term
consequences for the total treatment.
Patient classification systems may thus become a powerful instrument applicable in various
areas of health care. During the past decade several researchers have developed
methodologies to classify patients and have established applications for these patient
classification systems within health care.
The study described in this thesis must be placed in the context of the ongoing process to
find ways to classify patients into clinically relevant categories which arc homogeneous with
respect to costs. This study concentrates on the development of a method to classify patients
according to their severity of illness.
In this thesis the following subjects will be described. First, a theoretical view on patient
classification will be given. General criteria for assessing a patient classification system will
be listed (§ 2.1). Well known patient classification systems aimed at predicting or explaining
costs of medical care in hospital settings will be described (§ 2.2). A comparison will be
made between characteristics of these systems reported in literature (§ 2.3). One of the most
well known and widely applied patient classification systems at the moment is the Diagnosis
Related Group (DRG)-systcm. In the Netherlands, and in most other European countries as
well as in the US, studies arc going on to test the feasibility of this system for various
applications within health care. These studies have shown that the DRG-mcthodology fails
76
to incorporate the patient's severity of illness even though severity of illness can be expected
to be the most important factor causing differences in costs of medical care.
Subsequently, the research objective of this study will be described. The objective of this
study is to investigate the contribution of the patient's severity of illness to explain cost
differences between patients in the same diagnosis group (§ 3.1 and § 3.2). Two models will
be proposed: one for explaining costs of medical care closely related to the severity
condition of a patient during a specific time period in hospital, and another to determine the
effect of changes in severity of illness on the cost of medical care during the entire hospital
slay (§ 3.3). These models will be applied to one specific patient population (§ 3.4). The
research population has been restricted to DRG's comprising patients with Acute Myocardial
Infarction (AMI).
Next, the patient population and the data collection performed for this study will be
described in chapter 4. The study involves 464 AMI patients admitted to the University
Hospital of Maastricht (the Netherlands) between January 1987 and April 1988.
In chapter 5 a methodology will be proposed to define and operationalize the two most
important research concepts. Attention will be paid to the measurement of costs of medical
care in hospitals: a methodology will be proposed to allocate costs of ancillary departments
to medical care services. Furthermore, a methodology will be proposed to measure the
severity of illness of AMI patients.
Subsequently, in chapter 6, the methodologies proposed will be applied for the research
population. Costs of various types of medical care will be determined and described.
Furthermore, the measurement of the severity of illness will be described. The severity of
several cardiac and cardiovascular deficiencies (coronary stenosis, myocardia] ischemia/
necrosis, rhythm and conduction disorders, heart failure and specific complications) will be
measured by means of specific clinical indicators. A description will also be given of how
severity weights derived from a panel of cardiologists will be used to operationalize severity
of illness into various severity indices.
In the next chapter the empirical relationship between severity of illness-indicators and costs
of medical care will be investigated. The effects of the severity indicators on specific costs
will be investigated using regression analysis techniques. The data analysis will be
performed separately for: costs of thrombolytic therapy ( § 7.2.1), costs of (acute) heart
ealhctcri/alion (§ 7.2.2), costs of (acute) PTC A (§ 7.2.3), length of hospital stay (§ 7.3.1),
costs of coronary care unit (§ 7.3.2), and other costs of medical care (drugs, laboratory
services, electrocardiograms, cchocardiography and exercise tests, § 7.3.3).
The results of the data analysis will be employed to propose a severity of illness
classification for AMI patients which on the one hand contains clinically recognizable
palicnl categories that, on the other hand, arc homogeneous in an economic sense.
Furthermore, an analysis of variance will be made to which degree the new classification
system and the DRG-systcm offer explanations for cost differences (chapter 8). Finally, the
conclusions from this study will be presented in chapter 9.
2. Patient classification systems: a review.
In this chapter general criteria for developing a patient classification system will be listed (§
2.1). Currently used patient classification systems aimed at explaining costs of medical care
in hospital settings will be described (§2.2). A comparison will be made between
characteristics of these systems as reported in the literature (§ 2.3).
2.1. Theoretical background of patient classification
systems.
Each hospitalized patient may be seen as an unique case. Each patient is expected to be
treated on an individual basis depending on his/her specific illness condition. However,
interpretation of the diagnostic procedures physicians use will eventually result in the
definition of the patient's case: the diagnosis labels each patient in a medical sense. The
purpose of a patient classification system is not to classify a patient by this label. It aims to
classify patients on a more aggregated level by clustering them into patient categories based
on similarities between their illness characteristics. Categorizing patients on an aggregated
level may produce information which cannot be detected by examining individual cases or
labels. Patient classification systems must therefore not be regarded as a tool for describing
individual patients but as a tool for describing a hospital population. This enables managers
or researchers to understand and analyze medical care processes given to specific types of
patients.
Although patient classification systems have been applied in various health care studies no
comprehensive theory is available indicating how to measure illness characteristics of a patient
population. Hornbrook (1982) and Wood (1981) have proposed a methodology to evaluate
patient classification systems by specifying general criteria. Each author distinguishes a
number of evaluation criteria, of which some arc partly overlapping (table 2.1.).
Table 2.1 General criteria for patient classification systems.
* /?f/;<j/;/7iry
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The most important criteria mentioned by both authors are the medical mcaningfulncss and
the economic meaningfulness of a patient classification system.
ion mfr/ru;
Medical Meaningfulness/Content Validity.
Both authors explicitly mention that a patient classification system must contain medically
relevant patient categories. Medical mcaningfulncss is defined by Wood as 'the extent to
which knowledge of a patient's case type alone - without other information about the
individual patient - conveys clinical expectations and enables clinicians to exchange
information about those expectations. For a group of clinicians, a medically meaningful
classification stimulates expectations as to the natural history of the disease, the appropriate
ways to manage the case, the prognosis, the likelihood of complications and the risk of
death'. Hornbrook describes this requirement more generally as the content validity of a
system and defines it as 'the representativeness and comprehensiveness of the content of the
measuring instrument. For patient classification systems it refers to the breadth of coverage
of the various case types and the dimensions of the patient population relevant for the
purpose'.
Economic Meaningfulness/Predictive Validity.
The other important requirement for patient classification systems aimed at analyzing costs
of medical care is the economic mcaningfulncss of the patient categories. Wood says that 'a
classification is economically meaningful if, within its case types, the vectors of amounts of
the various goods and services needed for the patient's clinical management are
homogeneous. This means that the patients in any case type use about the same array of
goods and services and that the required amount of any particular good or service is fairly
constant from patient to patient'. Hornbrook describes this as predictive validity which he
defines as 'the ability of the measure to predict some outcome or event that is hypothesized
to be related to the fundamental concepts. Thus, a valid resource-intensity case-mix measure
will predict total hospital costs; a valid length of stay case-mix measure will predict overall
length of stay; and a valid mortality case-mix measure will predict overall death rates.'
Other criteria mentioned by both authors arc the sensitivity and reliability of a classification
system. Sensitivity, as described by Hornbrook refers to 'the ability of a case-mix measure
to discriminate adequately among hospitals with respect to the relevant dimension(s) of their
outputs. How small a difference in the case mix can the index detect?' Reliability as
described by Hornbrook refers to 'the dependability, stability, consistency, predictability and
accuracy of the measurement system. If a measure is reliable, repeated applications of the
measure to the same set of hospitals provide the same or similar results'. According to
Wood, a classification is reliable 'if any patient is placed in the same case type no matter
who or what mechanism is entrusted with the assignment. Two qualities influence
classification reliability: manipulation (of data or by management) and precision (data
quality)'.
Other requirements as described by the authors emphasize more pragmatic issues.
According to Wood a classification must be administratively meaningful if it is to be used
in hospital planning or administration. Wood points out the possibility of using the
classification for internal hospital management. The measure has to correspond with the way
the hospital is organized and has to fit in with other already existing procedures in
measurement. Hornbrook emphasizes this by using the term aeceptability; the users must
believe in the usefulness of the measurement system for policy or administrative purposes.
Wood ulso suggests that a patient classification must be versatile. He suggests that 'its
categories can be put together in different ways to form different uses, specifically
classifications for review of medical care, for administrative control, and for prospective
reimbursement.' Hornbrook describes this as the flexibility of a system, referring to the
property of a measure to be used for multiple purposes.
Hornbook also mentions the cost-effectiveness of a patient classification system. This
criterium relates to 'selecting the least cost method of measurement, without adversely
affecting any of (he other properties of the measure". Wood refers to this as practicality.
Both emphasize the conscious decision a hospital has to make in this matter with respect to
investments and expected benefits in the long run.
The criteria as discussed by both authors can be seen as general guidelines according lo
which a classification system can be evaluated. However, from these general criteria no
fundamental and comprehensive theory for patient classification systems can be derived.
According to Wood a complete theory should suggest various weighting structures and
techniques for mathematically combining cases. Both authors do not make clear how to
distinguish or prioritize their general criteria. It is clear that all criteria can not be fulfilled in
an optimal way within one and the same classification system. Nor do they present ways of
opcrationalizing the criteria. The medical meaningfulncss (or content validity) is, for
example, an issue which is from a methodological point difficult to attain. Clinical
rccognizability may vary from one physician to another. In addition, (he principles of
economic and medical criteria can be counteractive to each other: a patient classification that
is relevant to clinicians need not be economically homogeneous, or a patient grouping used
by economists may be an unrecognizable amalgamation to physicians. Furthermore, the
relative importance of each criterion depends on the specific purpose of a classification
system. A system developed to predict death rates will tend to be less relevant to predict
hospital costs.
In spite of the lack of a complete theory about patient classification systems one may
conclude that at least these general criteria have to be fulfilled as much as possible, Further
conceptualisation in this field is certainly necessary and may contribute to the development
of theories on patient classification systems.
In recent years attempts have been made to develop patient classification systems that may
be useful in analyzing medical care processes; these systems will be described in the next
paragraph.
2.2. Review of patient classification systems.
In this paragraph a number of patient classification systems that have been developed during
the past decade will be reviewed. Only those systems have been selected that are frequently
used in analyzing costs of medical care, or that arc likely to become widely used systems.
Furthermore, only those systems arc described which classify the greater part of the clinical
hospital population. The systems under review arc listed in table 2.2. The systems will be
briefly described in terms of conceptualization, classification method and classifying
variables. For each classification system the criteria used to classify patients with Acute
Myocardial Infarction will be given. In § 2.3. their medical mcaningfulncss/contcnt validity
and their economic mcaningfulncss/prcdictivc validity will be reviewed and evaluated.
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Table 2.2. Review of Patient Classification Systems during last decade.
is /fa/ated* Groups (D/JO /•>»<>/; freeman.
GonW/a
Computerized* SpveWry »ƒ///n«5 f CSA) Worn
/4CM/*" /Viyj/o/offy rWC/iron/'c //<•a/f/i Wagner,
A/«/if«/ ////i<\s.v Group/flfl System
2.2.1. Diagnosis Related Groups.
The DRG-mcthodology was developed by Fetlcr e.a. (1980) at Yale University. Originally,
the Diagnosis Related Groups (DRG)-system was developed for utilization review, but since
19X2 it has been used as a prospective financing system for Medicare patients in the U.S.A..
One of the most important criteria used when developing the DRG-systcm was that each
patient category had to he medically intcrprctablc. The researchers did make use of the
Delphi method with panels of physicians. The panels reached consensus on categories
expected to be medically recognizable. Another important criterion was that (given the
content validity of the categories) each group was expected to have a statistically narrow
range in the distribution of length of stay and costs. Analysis of variance was applied to test
the predictive validity of the length of stay by the system.
In addition some pragmatic criteria were applied: there must be a manageable number of
groups which arc mutually exclusive, the definitions of the group must be exhaustive and the
groups must have sufficient numbers of patients. Furthermore, classes of patients are defined
in terms of variables normally collected and available in hospital medical abstract records,
i.e. computerized discharge data including amongst others diagnoses and surgical procedures
as defined by the International Classification of Diseases. 9-th revision (the ICD-9-cm
coding scheme).
The researchers ended up. in 1981, with a patient classification system containing 467
categories. The classification process is briefly explained by Avcrill e.a. (1986) in the DRG-
Dcfinition Manual: 'The process of forming the DRG's was begun by dividing all possible
principal diagnoses into 23 Major Diagnostic Categories (MDC's). The 23 MDC's were
formed by panels of physicians as the first step toward ensuring that the DRG would be
clinically coherent. The diagnoses for each MDC correspond to a single organ system or
etiology, and are in general associated with a particular medical specialty. Once the MDC's
were defined each MDC was evaluated to identify those additional patient characteristics
which would have a consistent effect on the consumption of hospital resources. Since the
presence of a surgical procedure which required the use of the operating room would have a
significant effect on the type of hospital resources used by a patient, most MDC's were
initially divided into medical and surgical groups. Then, in general, the surgical patients
were further defined based on the precise surgical procedure performed while the medical
patients were further defined based on the precise principal diagnosis for which they were
admitted to (he hospital. Since a patient can have multiple procedures related to their
principal diagnosis during a particular hospital stay, and a patient can be assigned to only
one surgical class, the surgical classes in each MDC were defined in a hierarchical order.
Patients with multiple procedures would be assigned to the surgical class highest in the
hierarchy.
Once the medical and surgical classes for an MDC were formed, each class of patients was
evaluated to determine if complications, co-morbidities or the patient's age would
consistently affect the consumption of hospital resources. The final variable used in the
definition of the DRG's was the patient discharge status. The actual process of forming the
DRG's was highly reiterative, involving a combination of statistics results from test duta
with clinical judgment'.
An example of the classification process for non-surgical patients with Acute Myocardial
Infarction is outlined in figure 2.3. The DRG-system distinguishes three DRG's for these
patients. A list containing specific cardiovascular diagnoses is used to separate complicated
from non-complicated patients. Furthermore, patients who die during hospital stay arc
grouped into a separate DRG.
Figure 2J. DRG-Classification of patients with Acute Myocardial Infarction.
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During a period of more than 10 years (1977 -1991) the DRG-systcm was subjected to
modifications (Me Guire 199(), Health Information Systems 1991). Recently the researchers
have proposed the 'Refined DRG-system' in which the severity of illness is more
specifically included. Surgical and diagnostic categories (Adjacent DRG's) have been
subdivided by sets of specific complications and comorbiditics (Health Systems
Management Group, 1990).
Because of the expected differences in the organization of American and Dutch health care,
a feasibility study for applying DRG's in Dutch health care was carried out (Ncdcrstigt,
1985). Nederstigt recommends that only the American DRG method must be applied, but
that specific Dutch DRG-dcfinitions need to be developed. In that way one will get a patient
classification system that is expected to have more medical relevancy to Dutch clinicians.
The feasibility study took place at three general hospitals in the Netherlands. Most of the
criteria and guidelines used by Fetter e.a. were not changed, except that in the Dutch DRG-
classification a hierarchy in diagnostic categories has also been applied. The variance
explained by the Dutch DRG-system concerning the length of stay turned oul to be similar
to that of the American DRG-systcm. Per MDC the variance explained varied between 5 %
and 70 %. The variance explained in length of stay for surgical DRG's was higher than for
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non-surgical categories. Differences in types of treatment within ambulatory care and
clinical care did account for some improvements in medical mcaningfulness: the same type
of treatment performed as clinical care in the Netherlands may have been performed as
ambulatory care in the U.S. In addition, differences in the definition of pediatrie care caused
some changes. Instead of using the criterion 'age 18 years and older', the Dutch DRG
version, reduced the age criterion to ' 15 years and older'. Some changes occurred as a result
of differences in medical definitions. Particularly in surgical categories changes such as
creating specific new surgical categories or re-allocating operating room procedures within
the existing categories have taken place. In addition, changes were made in the hierarchy of
the surgical categories. In the diagnostic categories specific secondary diagnoses were used
to define the ultimate DRG's (Fetter c.a. also refined the DRG-systcm on the basis of
specific secondary diagnoses). Although the clinical relevance did increase, much
heterogeneity in length of stay within the Dutch diagnostic DRG's still existed. Ncderstigt
(19X5) presumes that this is because the DRG-systcm docs not specifically take into account
the patient's severity of illness.
2.2.2. Patient Management Categories.
Patient Management Categories (PMC's) is a patient classification system developed by W.
Young c.a. at Blue Cross of Western Pennsylvania. PMC's were designed to identify
clinically specific patient types, each requiring a distinct diagnostic and treatment strategy.
The original development of PMC's (Young, 1982) was not only based on medical discharge
data, but also on the reasons for hospital admission. According to Young the principal
discharge diagnosis alone, even if it is accurately identified, cannot reflect what happened
during the patient's hospital stay. Adding other data, such as secondary or multiple
diagnoses and procedures, will not solve the problem. Patient categorization in terms of all
these variables at discharge may result in some sort of clinical similarity at discharge but
dissimilarity with respect to the medical care during hospital stay.
Integrating the admission condition into a classification scheme is, according to Young,
necessary to define groups of patients with similar medical care patterns. For each type of
patient, the typical diagnostic and treatment strategics applied and the resources generally
used within each hospital slay can then be identified.
In summary:
1. the PMC's were developed using admission state and discharge diagnosis;
2. the PMC's were first defined by physicians and then applied in data analysis;
3. for every PMC, Patient Management Paths arc developed which consist of diagnostic and
treatment services for effective care for the typical patient in each PMC.
However, rcccnl developments in the PMC-system have caused some important changes in
the methodology. Because the reason for admission is not always computerized and
commonly available in hospitals, the recently computerized PMC-version only uses
discharge data (The Pittsburgh Research Institute. 1988). It distinguishes about 800 different
categories of which approximately 300 PMC's classify approximately 80 * of a hospital
population.
The PMC-assignment process (Young, 1986) is based on principal and secondary diagnoses
and surgical procedures as coded according to the lCD-9-cm code at the patient's discharge
from hospital. The PMC methodology takes into account the fact that several interrelated
diagnoses often represent one manifestation of a single disease, and do not necessarily
reflect disease complications or co-morbidities. For this reason, combinations of diagnoses
are used to assign a patient to a PMC. The sequence of diagnoses listed on the discharge
abstract is disregarded. A patient may be assigned to more than one PMC if unrelated co-
morbid conditions arc present. Eventually, only a single P M C will be assigned. In order to
determine which P M C should be selected, an order of relative severity and/or difficulty of
management was developed. This allows the assignment of a patient to a single PMC with
the highest severity ranking.
As an example the P M C classification for surgical and non-surgical patients with acute
myocardial infarction is presented in table 2.4. This system dist inguishes eight different
categories of AMI patients while using specific secondary diagnoses, diagnostic tests and
surgical procedures in the classification process.
Table 2.4. Patient Management Categories for patients with acute myocardial infarction.
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2.2.3. Disease Staging.
Disease Staging was developed by Gonclla c.a. (1984) for measuring disease severity.
Severity is defined by Gonclla as the likelihood of death or residual impairment as the result
of a disease, without consideration of treatment. The idea behind 'Staging' is borrowed from
clinical oncology, in which various stages in the course of diseases can be defined. Gonclla
applied this concept to other medical and surgical problems in order to classify all
hospitalized patients. The development of staging criteria was limited to the major diseases
in each etiology-body system class.
According to Gonclla (1984) diseases should be distinguished from health care problems
and conditions. Classifying patients on the basis of conditions and health problems without
considering the underlying causes is not justified. Approximately 420 diseases arc identified
in the Staging process. The diseases arc characterized by four primary categories of
increasing levels of severity:
stage 1: conditions with no complications or problems of minimal severity;
stage 2: problems limited to an organ or system, with a significantly increased risk of
complications over stage 1;
stage 3: multiple site involvement, generalized systemic involvement, poor prognosis;
stage 4: death.
Panels of medical consultants specified the medical staging criteria for the primary stages
and. if necessary, the substages within every primary stage category. Disease Staging
pertains to two related approaches for measuring severity:
(1) Clinical Staging, a method based on a manual review of clinical measurements
documented in the medical record. For each of the 4(X) disease categories clinical
criteria have been developed indicating values (laboratory, radiographic findings, vital
signs, etc.) which characterize the stages and which represent the severity levels within
the disease.
(2) Coded Staging, an automated method based on the coded diagnostic data contained in
the discharge abstract. Each of the criteria defined in the clinical staging method were
converted into 1CD-9-CM codes. Because of the lack of computerized data in most
discharge abstracts such as laboratory findings, changes have been made in the
medical criteria of the Coded Staging System.
The staging concept emphasizes the medical relevancy of the criteria. In patients with
mulliplc non-related diseases the overall severity is captured by the highest stage level of
only one disease. One important condition for applying the Disease Staging method is that
the abstract data must be complete; when one or more secondary diagnoses arc missing the
severity can be underestimated. In the development of the Disease Staging mechanism no
statistical or economic analysis was applied. However, using this classification system to
analyze resource data has demonstrated that there is a relationship between Staging
categories and costs (Conklin 1984, Garg 1978, Louis 1984).
The criteria for clinical and coded Disease Staging of patients with Acute Myocardial
Infarction arc presented in table 2.5. Four primary stages including 10 substages of the
course of the illness of AMI patients have been distinguished.
Table 2.5. Staging criteria in Clinical and Coded Disease Staging for patients with Acute
Myocardial Infarction.
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2,2.4. Computerized Severity of Illness.
The Computerized Severity of Illness-system was developed by Horn e.a, {1986} to measure
{he hospital case mix in relation to the patient's total burden of illness. The Computerized
Severity of Illness <CS1) is determined by clinical criteria such as results from physical
examination and various diagnostic findings. The CSI-system, modeled after the Original
Severity of illness (Horn, 1983,1985), was developed in order to facilitate widespread
collection of severity of illness data.
The CSI classification uses objective signs and symptoms, laboratory values, radiology
findings etc., commonly available in the medical record, to assign a patient into one of four
severity levels. The severity indicators are derived from discussions with medical
consultants, in which morbidity and likelihood of death are used as guiding criteria.
For every ICD-9-cm code, specific sets of clinical criteria have been developed and put into
a matrix, representing a gradation in severity. Several ICD-9-cm diagnostic codes can refer
to one severity matrix. Altogether, more than 7(M) separate criteria sets, corresponding to
over i0.000 ICD-9-cm codes, have been developed. The CSI score can be expressed by an
Admission-score (based on diagnostic findings on admission) and a Maximum-score
(throughout the entire hospital stay). An example of a severity matrix for patients with the
diagnosis Acute Myocartlial infarction is presented in table 2.6. If at least two criteria within
a severity level {column) arc present the patient will get the score belonging to this column.
If one or more diseases are present during the hospital stay, the severity score is established
for each separate disease. A computer algorithm with weighting rules, taking into account
the interactive effects of the conditions, can he applied to produce an overall Computerized
Severity of Illness Index. During the development of the CSI no economic analysis was
performed", the severity criteria and their corresponding severity level were derived from
lengthy sessions with physicians. Use of this classification system to analyze resource data
has demonstrated that there is a relationship between the CSI-scorc(s) and costs (Horn 1086,
Horn 1991).
2.2.5. Acute Physiology And Chronic Health Evaluation.
According to its developers (Wagner e.a., 1984) APACHE II (Acute Physiology and Chronic
Health Evaluation, second version) is a severity of illness classification that employs basic
physiologic measures to stratify patients according to risk of death, independent of the
diagnostic category assigned by physicians. Their original goal was to describe and evaluate
intensive care unit (ICU)-paticnts. Because the system is nol diagnosis-specific they claimed
it could be also be used for other patient populations. APACHE II classifies patients into
severity categories based on diagnostic data, collected early in the course of each hospital
stay (within 24 hours of ICU admission), rather than during or after hospital discharge. The
researchers assume that the patient's severity on admission will reflect the burden of illness
while in hospital, in the most valid way.
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Table 2.6. Computerized severity of illness criteria for patients with Acute Myocardial
Infarction.
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Clinical criteria include: heart rate, blood pressure, temperature, respiratory rate, the
Glasgow Coma Score, five variables obtained from routine blood samples and two variables
obtained from arterial blood tests. The criteria were selected by physicians with regard to
validity and specificity of measures, breadth of vital organ system coverage, objectivity,
reliability and frequency of measurement. The scores on the 12 physiologic variables are
added to form an Acute Physiology Score (APS), described in table 2.7. The full APACHE
11 score for 1CU patients consists of the sum of points for APS. plus weights assigned for
age category and for severely disabling chrome diseases. A patient can maximally be
assigned to a total score of seventy-one points; relatively high scores indicate a high
severity. APACHE II was developed as a means of predicting death or survival during
hospital stay, but data analysis has also shown a relationship between the scores of APACHE
II, total costs of intensive care episodes and total length of hospital slay (Wagner, 1984).
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Table 2.7. Criteria for grouping patients, severity of illness according to APACHE I I .
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2.2.6. The Medical Illness Severity Grouping System.
The Medical Illness Severity Grouping System (MEDISGRPS) is also an admission oriented
severity grouping system developed by Brewstcr c.a. (1985). MEDISGRPS classifies
hospital patients into one of five admission severity groups. It measures changes in severity
over the course of the inpatient stay and monitors the results of the care provided and the
resources consumed. Assignment depends on the reason for admission and the patient's Key
Clinical Findings (KCF's), which arc assumed to be objective indicators of an abnormal
condition. KCF's include laboratory, radiology, pathology and physical examination results.
Approximately 500 KCF's are distinguished in this system. The KCF's were derived by
screening the illness information transfer between the residents at morning call and the
residents coming on duty. It is assumed that during this process, information exchange is
focused on relevant key clinical findings in newly admitted patients. Each KCF is assigned
to a severity level based on the clinical perception of the potential degree of organ failure.
The most severe KCF determines the patient's severity category. If two or more KCF's occur
at the same severity level, the patient is placed into the next highest severity category,
because the outcome and resource use of these patients is assumed to be the same as that of
patients at the higher severity level.
A patient may be categorized into one of five severity categories:
Severity group 0: patients with no KCF's;
Severity group 1: patients with 'minimal findings' indicating a low potential for organ
failure;
Severity group 2: patients with cither acute findings connoting a short time course, with an
unclear potential for organ failure, or severe findings with potential for
future organ failure;
Severity group 3: patients with both acute and severe findings indicating a high potential
for imminent organ failure
Severity group 4: patients with critical findings indicating the presence of organ failure.
Severity group 5: death.
An example of the MEDISGRPS classification for patients with acute myocardial infarction
is presented in table 2.8. Like APACHE II, MEDISGRPS is constructed independently of
the clinical diagnosis of physicians. According to Brcwsicr the KCF's arc the functional
manifestation of the illness and therefore data collection and severity classification are
independent of the final discharge diagnosis. MEDISGRPS therefore provides an indication
of how ill a patient is relative to all other patients, irrespective of the patient's diagnosis.
Table 2.8. Medisgrps criteria for patients with acute myocardial infarction.
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2.3. Evaluative comparison of patient classification
systems.
The patient classification systems presented in the previous paragraphs show a variety of
ways to measure characteristics of a hospital population. The systems differ in goal,
conceptualization, classification variables, classification method, moment of measurement
during stay, number of patient categories, etc.. Because of these differences in goals and
conceptual differences, results and applications may also be expected to be different. All
authors have in common that they want to provide an instrument to measure hospital
population characteristics by means of disease-related variables or indicators in order to
analyze complex hospital care processes. A summary of goals and characteristics of the
patient classification systems under review is presented in table 2.9. In this paragraph an
attempt will be made to compare the medical meaningfulness (the content validity), the
economic meaningfulness (the predictive validity), the reliability and the practicality of
these systems.
Table 2.9. Summarized characterization of six patient classification systems.
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* the number Is higher in recent releases of the DRCi-grouper.
Medical Meaningfulness/Content Validity.
The requirement for patient classification systems to be medically meaningful is an
important one. The medical meaningfulness of a classification can be defined as the degree
in which a representative panel of physicians from a specific medical specialism may reach
consensus on collapsing a number of similar or adjacent cases into a smaller number of
aggregated patient groups, in such a way that these groups are still recognizable by other
physicians not in the panel. The content validity refers to the degree in which the
JO Pa/irnr cfaxsi/ïcarion systems:
classification covers the range of all relevant medical case types.
However, the purpose of this collapsing procedure is not a medical one: the goals are set by
economists who for instance want to explain costs of medical care, by epidemiologists who
for instance want to explain survival or death of patients, by researchers who for instance
want to compare the efficacy of alternative treatment types or who are interested in the
effects of quality of care on the patient's state of body or mind. The resulting classification
of patients will be different for each goal. It is very important that the classification of
patients is validated by a panel of physicians, so the independence of measurement of the
system in relation to its function is guaranteed.
It can be concluded that all patient classification systems have used clinical expertise to
develop criteria to classify patients. However, it is not always clear which specific rules have
been used by physicians in order to judge the clinical recognizability. It is likely that clinical
recognizability will differ depending on the type of variables used to develop a patient
classification system. More basic clinical indicators such as those used by CSI, APACHE II
and MEDISGRPS may result in other ways of 'recognizing' patient types than the discharge
diagnosis and surgical procedures that arc used by DRG, PMC and Disease Staging.
Regarding the complexity of the matter, very few studies have been performed to judge the
medical mcaningfulncss of a system. In a study conducted at the University of Michigan
(Thomas c.a. 19X6), a panel of physicians did evaluate the clinical mcaningfulncss by
comparing the content validity of PMC, MEDISGRPS, APACHE and Disease Staging. The
panel of physicians rated the clinical credibility of both APACHE II and Clinical Staging as
high. However APACHE II was thought to be more valid as a severity measure for intensive
care palienl.s lhan for general hospital puiicnt.s. The panel expressed reservations about the
credibility of severity systems, such as Coded Disease Staging and PMC's, based on ICD-9-
cm codes. Thomas c.a. (19X9) has evaluated also the construct validity of Apache II, Disease
Staging (Clinical and Coded), MEDISGRPS and PMC's. Severity scores assigned to
characteristics of individual patients by a panel of physicians were compared with the scores
derived from each of the severity systems. MEDISGRPS compared most favorably with the
ratings of the panel, suggesting that its scorc(s) will approximate the information used by
experienced clinicians in evaluating patient's severity. Ranking behind MEDISGRPS in
descending order of construct validity were PMC, Clinical Staging and Apache II. The
construct validity results for Coded Disease Staging were lower than for the other severity
systems. In another study performed by Charbonncau c.a. (1988) it was found that
physicians did not feel comfortable with the concepts of DRG's, particularly with regard to
patients with multiple illnesses. Disease Staging was thought to fit in relatively easily in the
process of evaluating the patient's condition because of its familiarity with oncology. The
idea of PMC's was thought to be more difficult to understand because it docs not explicitly
take the designated principal diagnosis into account in the categorization of patients. On the
other hand. PMC's were found to be more consistent with standard medical nomenclature.
Economic Mraningfulncss/Predictive Validity.
Another important requirement of patient classification systems is the degree in which it is
able to explain medical care costs. A statistical technique which is often applied to measure
the predictive validity is analysis of variance. The degree in which a system is able to
explain variations in the dependent variable (such as length of stay or medical care costs)
can be expressed by the R' or Eta'; the higher these proportions the better the predictive
validity. Results from the studies as described in this paragraph must be interpreted with
care: R' values arc not comparable across studies because they may be influenced by
differences in populations, in opcrationali/ation and measurement and in lime. Results from
u study in which the different classification systems have been applied to the same data set
of AMI patients will be described in table 8.7. (paragraph 8.3).
Various studies (Mitchell e.a.,1984. Mitchell c.a. 1985. West e.a.,1985. Coffcy, 1985. Frank
and Lave. 1985) showed that in general DRG's will explain 16 to 18 percent of the variation
in length of stay or costs in unirimmed data sets (outliers included). Between 26 to 33
percent of the variation in costs will generally be explained in trimmed data sets (outliers
excluded). Within the DRG classification the surgical DRG's will provide most of the
explanatory power. In trimmed data sets surgical DRG's will explain from 48 to 57 percent,
while the nonsurgical DRG's tend to explain only from 7 to 16 percent of the variation in
costs.
The predictive validity of the Computerized Severity of Illness has been tested by Horn
(1987) in patients with 30 common disease conditions in 6 hospitals across the United
States. Analysis of these data showed that five CS1 levels explain 30 % of the variance in
length of stay. When CSI was determined wilhin a group of patients undergoing a specific
operating room procedure the predictive value increased lo 67 percent. In another study
(Horn, 1991) performed in five teaching hospitals using a sample of 2378 patients classified
into 27 high-volume DRG's, it was found that the DRG's explained 27 % of the variance in
length of stay, while DRG's adjusted for admission-CSI-scores explained 38 9(. DRG's
adjusted for maximum-CSI-scores throughout the hospital stay explained 54 % of the
variance.
Comparing Disease Staging with PMC's and DRG's, Calorc (1985) has found thai neither
PMC's nor Disease Staging explain costs better than DRG's. If one distinguishes non-
surgical patients from surgical ones, both PMC's and Disease Staging perform equally well
as DRG's. Coffcy (1985) found similar results and suggests lhat the failure of Disease
Staging to improve on DRG's may be caused by the fact that both rely on the same medical
information. According to Coffcy co-morbidilics and disease-specific seventy indicators
based on ICD-9-cm codes arc insufficient to predict differences in hospital costs. Similar
results were found by Calorc and Ic/./.oni (1987). After controlling for DRG's, both Disease
Staging as well as PMC's add little lo the predictive value regarding costs for cilher
pneumonia or prostatic disease. The authors conclude thai application of cilher system as a
DRG-modificr will not improve on the results of DRG's, but may identify patients wilhin
DRG's that clearly do not belong to that group. Also Charbonncau (1988) concluded thai the
Disease Staging system and the PMC system did not increase statistical homogeneity in
length of stay within some specific DRG's (in this case acute myocardial infarction and
respiratory problems).
Wagner (1984) has studied the relationship between the APACHE-scorc on admission and
the total costs of treatment over the entire course of the ICU stay in 12 hospitals. The APS-
score alone accounted for 38.6 percent of variance explained, and diagnostic variables and
hospital identifiers together accounted for 24 percent of the variance explained regarding
ICU costs. Data analysis for three diagnostic categories (drug overdose, peripheral vascular
surgery and diabetes) has shown that a consistent and substantial increase in costs was
significantly correlated to an increase in APS scores for each of the three diagnostic
categories.
Brcwsler e.a. (1985) have studied the relation between the admission Mcdisgrps-scorc and
costs for abdominal pain and chest pain; the mean total costs for both patient groups increase
significantly for each successive severity group. The same results were found using the
Mcdisgrps-score after 10 days; an increase in severity from admission to the second review
had a significant effect on costs. The researchers also tested the capability of Mcdisgrps to
refine DRG's. The additional variance explained was 44 <# for DRG 140 'angina pectoris'
and 40 * for DRG 243 'medical back problems'. Brcwster indicates that besides the
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admission severity, the increase in severity is an important factor causing cost differences
within DRG's. Iczzoni e.a. (1988) found different results; the admission Medisgrps score
alone explained only 3 % of costs using trimmed data. Addition of Medisgrps score to
DRG's modestly improved the explanatory power for both costs and length of stay. Using
unlrimmcd data the explanatory power was higher. Iezonni suggests that the relatively better
performance among untrimmed cases might result from the ability of admission Medisgrps
score to predict the costs of severely ill outliers. Within individual DRG's the Mcdisgrps-
classificalion on admission explained the variance in costs ranging from 0 to 21 9f>. Iezonni
did not use a second review score in this study. This may account for the differences
between her results and the results found by Brcwstcr.
Thomas c.a. (1986) have compared the predictive validity of four severity measurement
methods: Apache II, Disease Staging (Clinical and Coded), Medisgrps and PMC's. The
study focuses on the explanation of cost variations within a limited number of DRG's. To
obtain a broad representation of cases, adjacent DRG's (ADRG's: diagnosis or surgical
categories not subdivided into DRG's using age or complication and co-morbidity criteria)
rather than single DRG's were chosen. The authors conclude that in almost all ADRG's at
least one of the severity measures (and usually several of the measures) provides higher R*
values than those obtained with DRG's. The increase in variance explained, however, will
vary per severity measure and per ADRG. In a recent study performed by the same author
(Thomas, 1991) APACHE II, Medisgrps, CSI, Disease Staging and PMC's were compared
in terms of how well they arc able to explain variations in observed costs among patients.
All severity systems were found to improve on DRG's for some types of cases, but to offer
little or no improvement in others. Indicators of maximum severity, especially maximum
CSI, did explain greater proportions of cost variation than measures of admission severity
and measures based on discharge abstracts.
Reliability and practicality.
In two articles by Thomas c.a. (1986,1989) the inter-rater reliability of four severity
measures (Apache II, Disease Staging (Clinical and Coded). Medisgrps and PMC's) as well
as the potential for measurement error have been examined. The highest observed reliability
was achieved by Apache II and Medisgrps. Clinical Disease Staging was found to be more
reliable than Coded Disease Staging and PMC. Remarkable is that the latter two systems
which were found to be relatively more unreliable, arc the ones which use medical discharge
data exclusively.
Results of the comparison for the potential for measurement error showed that Apache II
and Clinical Staging were viewed as relatively less erroneous. Measurement error in
patients' discharge records by listing additional diagnoses and/or procedures, in cither
Coded Disease Staging or PMC's is likely to be no larger than that in DRG's.
The same authors have also compared the more practical issue of the costs of
implementation and operation of patient classification systems. Their conclusions arc that
neither Coded Disease Staging nor PMC's have any additional time requirement over that
required for the discharge abstract. Apache II requires about 11 minutes and Clinical Staging
required about 12. The admission review with Medisgrps required on average 16 minutes
per record. Computer processing costs of PMC's and Coded Disease Staging arc negligible
and no additional data entry is required. Medisgrps, Apache II and Clinical Staging do
require computer processing time for data entry but costs arc supposed to be relatively low.
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Conclusions.
Examining and evaluating the patient classification systems described in literature one may
conclude that each system has advantages and disadvantages. Generally speaking a major
distinction can be made between (1) illness-specific classification systems that classify
patients by discharge data; their original purpose is prediction of length of stay and/or costs
of medical care and (2) severity of illness classifications based on specific clinical
indicators, originally developed to predict mortality; these systems are used for quality
assurance programs.
Patient classification systems relatively easy to apply because of their use of computerized
discharge variables (DRG's, PMC's and Coded Disease Staging) will predict variations in
hospital cost to some extent. The predictive power turns out to be much higher for surgical
patients than for diagnostic (non-surgical) patients. Severity measures using clinical
indicators (such as CS1, Medisgrps and Apache II) may sometimes improve cost prediction,
although these systems were originally not developed for this purpose. Measurement of
changes in a patient's severity of illness during hospital stay may contribute even more to
the explanation of costs than one unique, period-bound score intended to represent a
patient's severity of illness during his or her whole hospital stay. Assuming (hat the severity
of illness is useful in explaining variations in cost amongst patients it is reasonable to expect
that its value will be greatest when examining patients with similar medical conditions. It
may be assumed that the addition of a severity measure based on (he results of clinical
findings will improve the explanatory power of patient classification systems, which are
based on medical discharge data.
The various severity criteria used in severity systems arc mainly derived from sessions with
panels of physicians in order to predict mortality. Studies in which sets of severity indicators
themselves are also empirically tested to explain costs of medical care arc rare. It is likely
that within a similar diagnosis group, mortality or quality of care will be explained by other
severity indicators than those explaining costs of medical care. As can be seen from the
examples of classifying patients with acute myocardial infarction, these systems each use
different severity criteria to categorize patients into a group. It may be concluded that
severity of illness is not an absolute or universal notion and much is still unclear about how
to define and opcrationalizc this rather complex concept.
The measurement of severity of illness in relation to costs of medical care must be seen as
an ongoing process which will cost years of study and analysis by many researchers. In the
forthcoming chapters an attempt will be made to measure this concept for patients with
Acute Myocardial Infarction (AMI). The severity of illness will be defined and opcralionalizcd
independently of already existing systems. We feel that systems that arc not originally
developed for cost explanation arc less suitable in the context of this study. So we have made a
fresh start at defining and measuring severity of illness. In the forthcoming chapters relations
between the severity of illness and cost of medical care will be investigated and finally a
Severity of Illness classification specifically developed to explain cost of medical care in AMI
patients will be proposed.
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3. Explanation of medical care costs.
3.1. Study objective and definition of problem.
A precondition for setting up models for medical management is having insight into the
factors that will cause cost differences in medical care. These factors will be manifold.
It is very plausible that illness characteristics of a patient arc the most important factors
causing costs differences between clinical patients. Next to this, factors not related to the
patient's illness may produce cost differences. Characteristics of internal hospital processes
or the way in which hospital and medical departments arc organized may also be responsible
for cost differences. In addition, there may be external factors responsible for cost
differences. The medical care given in hospital is only part of the overall care given to a
patient. Other types of care arc provided by health care facilities like home care, general
practitioners, ambulatory care and long term facilities. The extent to which health care was
provided by other health care facilities outside the hospital will influence the medical care
that patients receive in hospital (Van de Ven c.a., 1980).
The main interest of this study is to explain differences in costs of medical care caused by
illness characteristics of clinical patients. Classification of patients in terms of their illness
may be seen as an important step toward reaching this goal. Literature (sec chapter 2)
reveals that patient classification systems using discharge diagnosis and surgical procedures
do not quite succeed in achieving a high level of homogeneity in medical care costs within
defined patient categories. Economic homogeneity is generally considered to be an
important goal for evaluating the accomplishments of a classification system. Literature also
indicates that once a patient group has been delineated, more sophisticated instruments
which aim to measure a patient's severity of illness may increase the homogeneity of costs.
It is plausible that the typical medical deficiencies of a patient play a central role in the
explanation of cost differences within patient groups defined by diagnosis. Thus, a patient
classification system should place the characteristics of a patient regarding his/her typical
medical deficiencies in a more prominent position. However, a person's illness condition
may change during hospitalization as a result of 'natural' autonomous processes or in
response to medical treatment. A prior illness condition will, for example, be followed by
certain medical care (and medical care costs). This medical care will generally ameliorate
the condition of a patient in a next phase. The cyclic character of the causal relations
between severity of illness and (costs of) medical care is presented in diagram 3.1.
The dynamics of change in the severity of illness may follow certain patterns in specific groups
of patients. For instance, patients may be severely ill on admission but may not develop
complications during hospitalization. Other patients may initially have a moderately severe
condition, but may develop severe complications. Consequently, a different process of
diagnostics and treatment will be part of the patient's hospital stay. The illness condition of a
patient and the changes therein during hospitalization may be seen as the most important factor
for differences in costs. Therefore, a longitudinal, dynamic model describing the patient's stay
will be appropriate in order to study the severity of illness in relation to medical care costs.
Although some of the severity systems described earlier may have found ways to incorporate
changes in severity of illness during hospital stay, they generally fail to do this in a reliable and
valid fashion. In these systems patients arc assigned to severity levels based on a set of global
physiological indicators. Severity of illness is usually measured by a unidimcnsional index
using the patient 's most deviating scores on certain severity indicators. The mutual
relationships between the severity indicators are not medically validated; the individual
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effects of specific severity indicators on specific costs are also not empirically analyzed or
tested.
Diagram 3.1. Dynamic causal model or relations between severity of illness and costs of
medical care during hospital stay for pre-determined diagnosis groups.
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It is assumed that measurement models which, first of all, specify the interrelations between
medically defined indicators of severity of illness offer a better approach to explaining cost
differences. Subsequently, these measurement models should be condensed and trimmed by
economists to be used in the explanation of costs during hospital stay. This latter process
should be done without impairing the medical meaning of the indicators and should result in
a more refined and flexible classification of patients.
The objective of this study is to investigate the factors which may explain the differences in
costs between clinical patients with similar discharge diagnoses. Applying a longitudinal
mullivuriulc model of explanation is assumed to be effective in reducing the heterogeneity of
costs within patients with similar discharge diagnoses. The DRG-system will be used to
categorize patients into discharge diagnosis groups. For a selected number of DRG's the
effects of severity of illness on differences in costs of medical care during hospitalization
will be investigated. In a dynamic model, relations arc hypothesized between, on the one
hand the different indicators describing the severity of illness of a patient, and on the other
hand costs of medical care in hospital. By using a flexible and dynamic definition of
Severity of Illness, a new patient classification system will result, aimed at explaining
differences in costs in a more detailed and clinically valid way.
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3.2. Factors which explain differences in medical care
costs.
In general, medical care costs for clinical patients can he divided into three major cost
categories: treatment costs, diagnostic costs and nursing costs. The classification using (1)
severity of illness may have different effects on each of these costs categories. But next to
this, (2) background characteristics (3) contra-indications for treatment, (4) research
protocols and (S) admission and discharge characteristics of patients are also assumed to
play an important role in explaining differences in costs.
1. Severity of Illness.
At present, diagnosis groups are specified after discharge according to the international
Classification of Diseases, 9th revision, clinical modification, (ICD-9-cm) coding scheme.
These codes are used to categorize patients according to the DRG classification. However,
the retrospectively given codes obviously fail to measure a patient's total burden of illness
during hospital slay in an adequate and valid way. Diagnosis codes do not take into account
the periodical changes in a patient's health state during hospital stay. The classification
process places the patient into a category, which crudely summarizes the severity of illness.
The patient's complications or co-morbidities (secondary diagnoses) arc not sufficient to
describe the severity of illness. A better approach to defining a patient's total burden of
illness during hospital stay would be provided by a severity of illness classification defined
in terms of a time-dynamic set of scores that deviate from 'normal' on a complex of
clinically interrelated medical deficiencies. The deviations from 'normality' may be
weighted by a panel of physicians. A high score on a weighted index will correspond with a
more severe illness condition. It stands to reason that in comparison with relatively mild
cases, more severe cases are medically complex (have higher scores for many deficiencies)
and have a relatively bad prognosis. Consequently, patients with more severe conditions
may need more intensive medical care, and may have a longer hospital stay. In both
instances, this will produce higher costs of care.
Most costs in medical care are generated by the diagnostic or treatment policy of the
physicians. It may be assumed that the physicians' decisions in these matters arc eventually
caused by and based on severity characteristics of patients. In other words: a severity of
illness classification will explain the differences in costs of medical care between patients
more successfully than the DRG-classification.
2. Background characteristics of patients.
Clinical patients will differ in their prc-hospital medical history or in individual characteristics. From a
clinical point of view, a patient's medical history before hospital admission (including
former hospital stay) may require the physician to pay special medical attention to that
patient. For example: in comparison to other patients, patients with chronic deficiencies like
diabetes mcllitus will need special care when they arc admitted to hospital. In addition to
this, individual patient characteristics may influence a physician's decision policy in
providing care. Differences may exist between costs for young patients and old patients with
the same medical problem. Ultimately, a thorough understanding of the severity of illness
during hospital stay can only be acquired if one takes into account the complex interplay
between decision making policy (protocol) and these patient characteristics. Thus, the
conclusions from above may be stated as follows: specific background characteristics of
patients may also be responsible for differences in medical care costs, given their severity of
illness.
3. Contra-indications for medical treatment.
Specific patient characteristics, such as high-risk indications, may restrict a physician's
decision to provide certain care. These restrictions from specific medical care will be
applied if a patient has one or more so-called contra-indications. Contra-indications may be
connected to specific individual patient characteristics or events in the individual medical
history. Consequently, it may be concluded that contra-indications for diagnostic or
therapeutic services will constrain or preclude specific care to be given to a patient. In such
instances, cost of medical care may be relatively low, in spite of the patient's severity of
illness.
4. Research protocols.
In many university hospitals clinical trials arc held in combination with (or next to) patient
care. If patients participate in such research projects, a specific research protocol has to be
followed. Consequently, for these patients the costs of diagnostic tests and medical treatment
may differ, in type and amount, from treatment or tests given to patients not in the research
project. In other words: costs of medical care may vary between patients with similar
diagnosis depending on the patients' involvement in and compliance to a specific research
protocol. Enrollment of patients in a research project may partly be responsible for
differences in costs of medical care, regardless of the patient's severity of illness.
5. .Admission and discharge characteristics of patients.
The way patients enter and leave the hospital will differ from one patient to another. If
patients arc transferred from other hospitals, they will generally have lower costs than
patients who arc admitted regularly or who come in by ambulance. Patients will show
differences in discharge too: if patients arc transferred to other departments of the same
hospital their costs at the admission department will generally be lower than patients who
have a 'regular' discharge. Also individual decision making of physicians to discharge a
patient may vary from patient to patient.
When patients die during hospital stay, they will generally have lower costs than non-
deceased patients. The purpose of this study is, among others, to develop a severity of illness
classification which explains costs of medical care. Such a classification is not intended or
fit to explain a non-regular admission or discharge (like mortality). Thus, characteristics of
moment of admission to and discharge from the hospital may be seen as additional factors in
costs explanation.
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3.3. Models for explaining differences in medical care
costs.
Il may be clear from the above that many factors relevant for explanation must be included
in the analysis of the problem; usually this is done in multivariatc models. In the
development of such cost-explanation models several methodological issues have to be
considered. A patient's condition, measured in terms of his/her severity of illness, will be
subject to changes during hospital stay as a result of autonomous processes or medical
treatment. The objective of this study is to develop a model which will explain medical care
costs in terms of the possible changes in severity of illness. The steps in a physician's
decision-making process as well as the patient's changing condition will have to be
translated into the model's concepts. To realize this objective the model should be
representative for the illness condition of the patients in all relevant time periods during
hospital stay. With these considerations in mind, two different models aimed ut explaining
differences in costs of medical care arc proposed. Firstly a period-specific model will be
presented which can be seen as a specification of the model in Diagram 3.1, and secondly u
dynamic model for the whole stay will be given. Both models will be used to analy/.c
differences in medical care costs for patients with acute myocardial infarction (sec chapter
7).
(1) A model explaining differences in period-specific costs of medical care using a
period-specific Severity of Illness definition.
The first model (diagram 3.2) explains differences in period-specific costs of medical care
by a patient's period-specific severity of illness. In this model the hospital stay has been
divided into several time periods (0-2). The number of time periods will strongly depend on
the type of illness within a patient population (for instance chronic versus acute illness). For
each time period costs of medical care arc distinguished into diagnostic costs and treatment
costs. It is assumed that the costs for the first diagnostic investigations will depend only on
the direct cause of admission. The provision (and costs) of medical treatment on admission
may be directly dependent on the patient's severity of illness on admission and on specific
indications or contra-indications. Costs for further diagnostic investigations will be
influenced by the severity of illness at admission and the given medical treatment. Contra-
indications are assumed to affect costs of treatment in every period, regardless of the
patient's severity of illness. Costs for additional medical treatment in a next phase of
hospital stay may be explained on the same basis. It is also expected that former medical
treatment and the period-specific severity condition of a patient will form the basis upon
which a physician makes decisions. If patients are admitted to a research project in which a
specific research protocol has to be followed, this will constrain the physician's freedom of
choice in diagnostics or treatment.
Diagram 3.2. Period-specific model explaining differences in costs of medical care during
hospital stay for pre-determined diagnosis group(s).
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This model concentrates on period-specific analyses of costs; costs made within a certain
time-period during a hospital stay arc explained on the basis of a period-specific severity of
illness. This approach is relevant if medical care costs can be ascribed to a specific lime
period within the hospital stay. However, if costs of medical care pertain to the entire
hospital stay, this model will be too laborious. Consequently, an aggregated model for the
total hospital stay is also proposed.
(2) A model explaining differences in costs of medical care during total hospital stay
using a dynamic Severity of Illness definition.
The second model (diagram 3.3) explains differences in total costs of medical care by a
dynamic definition of severity of illness. The illness condition of a patient and the changes
therein during hospital stay may be seen as the most important causal factor for differences
in costs of medical care accumulated over all periods of hospital stay. Patients, with a similar
diagnosis may show different courses of illness during their hospital slay. If the severity of
the illness is measured repeatedly over several time periods, a severity pattern may be
established for each patient. Patients with similar severity patterns may be grouped into the
same severity category. This severity category then will summarize the degree of severity
plus the (possible) changes herein during hospital stay. In this case we will speak of a
dynamic Severity of Illness grouping. These severity categories may explain differences in
the accumulated total costs of diagnostic procedures, medical treatment and nursing care
during hospital stay. Possible influences of background characteristics, local research
protocols, contra-indicalions and type of admission and discharge are taken into account in
the same way as in the first model.
£ip/asui/ion o/m^JiraV ca/r coi f5
Diagram 3.3. Model explaining differences in summarized costs of medical care during total
hospital stay for pre-determined diagnosis gn>up(s).
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3.4. Adaptation of the models to patients with Acute
Myocardial Infarction (AMI).
Hospital Time periods.
To assess the effects of severity of illness in relation to hospital costs it is proposed to divide
the patients' hospital stay in specific hospital time periods. The way the time periods will be
distinguished may be very crucial for period-specific costs analysis and the establishment of
a dynamic severity of illness classification.
This study concentrates on patients with acute myocardial infarction who have not
undergone cardiac surgery during hospital stay. For a full description of the patient
population sec chapter 4. Establishing the length of the lime periods is strongly dependent
on the type of patients under investigation. The patient population in question is
characterized by an acute and sometimes life-threatening situation. From sessions with
cardiologists it was concluded that the hospitali/.ation period of these patients can be
distinguished into four different phases:
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When a patient with suspected myocardial infarction is admitted to hospital, the first hours
of symptom appearance are very crucial. Diagnostic tests are performed to ascertain the
patient's type of diagnosis and severity of illness. Next, medical intervention will be
performed. One of the most important interventions is the administration of thrombolytic
drugs which may have a dramatic impact on the course of the illness. This intervention is
only effective, if applied within the first six hours of symptom appearance. There may be a
delay between the acute symptom appearance and the moment of admission in hospital, but
this is very difficult, if not impossible, to measure. For reasons of practicality the first six
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hours after admission to the hospital will be defined as the acute phase of the infarction. If
patients arc already hospitali/.cd the first six hours after typical ischemic pain will be
relevant.
The evaluation phase is defined as the period starting from six hours and ending three days
after the moment of hospital admission (or ischemic pain during hospital stay). During this
period the severity of myocardial infarction is expected to become clinically manifest.
Patients will normally stay monitored intensively in a coronary care unit during this period.
Further specific diagnostics may be applied to assess the magnitude and impact of the
infarction.
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The first follow-up phase starts after three days and ends ten days after the patient's moment
of hospital admission (or ischemic pain). During this period patients are generally placed in
medium or low care wards. Specific tests may be applied to exclude any risks of post-
infarction complications. In case of a minor infarction, and if there appear to be no further
complications, patients arc normally discharged from hospital within this period.
The second follow-up phase theoretically starts ten days after the moment of hospital
admission (or ischemic pain) and ends when the patient is discharged from hospital or is
transferred to another medical department in the same hospital (sec 4.2). It is assumed that
these patients will develop complications during their hospital stay.
Thus, hospital stay for Acute Myocardial Infarction-patients is divided into four hospital
time periods: the acute phase of infarction (henceforth TO), the evaluation phase (henceforth
Tl) the first follow-up phase (henceforth T2), and the second follow-up phase (henceforth
T3). These four hospital time periods will be incorporated into the general models
explaining hospital costs (figure 3.2 and 3.3).
Medical care costs.
The major objective of this study is to investigate the relation between severity of illness
indicators in patients with myocardial infarction and costs of medical care. Patients with
myocardial infarction will generally receive various types of medical care. Diagnostic
procedures mainly consist of laboratory tests, elcctrocardiographic tests (ECG's), heart
cathctcrization, cchocardiography and exercise tests. Major medical interventions such as
administration of drugs (amongst others thrombolytic therapy) and performance of
Percutaneous Transluminal Coronary Angioplasty (PTCA or dottcring) may take place. The
length of the patient's stay in hospital may be seen as an indicator for nursing care costs.
Nursing care costs may be extra high, if patients stay at the Coronary Care Unit (CCU). The
measurement of medical care costs for the patient population at hand is described
extensively in chapter 6.
The relation between the individual patient's background characteristics, contra-indications,
enrollment in medical trials, type of admission and discharge and the patient's severity of
illness for AMI patients will be empirically analyzed for different types of costs. In chapter 5
and 6 the models discussed in the previous paragraph (figures 3.2 and 3.3) will be further
specified and operationalizcd for patients with acute myocardial infarction. In chapter 7, the
relations as described in this chapter will be investigated and analyzed.
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4. Patient population and data collection.
4.1. Patient population.
The survey population consists of patients admitted to and discharged from the Department
of Cardiology of the University Hospital Maastricht between the first of January 1987, and
the 30-th of April 1988. Patients were retrospectively selected from the Diagnosis Related
Groups System, categorized in the DRG's 'Acute Myocardial Infarction" (DRG 121. 122
and 123). These three DRG's arc defined as hospital admissions of patients with a primary
or secondary diagnosis of acute myocardial infarction, in which no cardiac surgery was
performed during hospital stay'. Patients with cardiovascular complications (like heart
failure, rhythm and conduction disorders) arc calcgori/cd as DRG 121 'Complicated AMI';
patients having no other cardiovascular problems are categorized in DRG 122 'Non-
complicatcd AMI'. Patients, who died during hospital stay arc grouped under DRG 123
'AMI deceased'.
In total 557 hospital admissions were categorized into these three DRG's. For patients with
multiple hospital stays during the investigated period only the last hospital stay was taken
into account (n=10, 1.8 9f-). This was done because the unit of observation and analysis of
this study is the patient and not the admission (period). The aim is to investigate differences
between patients rather than differences between hospital admissions. During the clinical
data collection (see § 4.3) it appeared that a total of 49 patients (8.8 9f) had incomplete or
missing medical records; they had to be excluded from further study. There were 6 patients
(1.1 %) who were admitted and discharged by departments other than cardiology; they were
aAso excluded. For ihe remaining patient population close observation of the medical record
revealed that 28 patients (5.0 %) were misclassificd as DRG's 121, 122 or 123, because of
coding errors or inappropriate diagnosis. The most frequently found errors were:
patients with unstable angina pectoris were coded as having acute myocardial
infarction (n= 17);
patients with an old myocardial infarction were coded as having acute myocardial
infarction (n=7);
patients with suspected acute myocardial infarction as recorded in medical record
abstracts, but whose diagnosis was not confirmed in the patient's medical record (n=4).
In total 464 patients (83.3 %) of the original patient population as defined by the DRG's
were investigated. About 30 % of them were women with a mean average age of 68.1 years
and 70 % were men with a mean age of 60.5 years. The patients had a mean length of stay of
11.5 days with large variations between patients (std.dcv. 9.6). A large group of 310 patients
(66.8 %) was classified as DRG 122 'Non-complicated AMI' with a mean length of stay of
10.1 days (std.dev =4.7). The second largest group of 102 patients (22.0 9f) was classified as
DRG 121 'Complicated AMI' with a mean length of stay of 18.1 days (std.dev.= 16.1). The
smallest group of 52 patients (11.2 %) died during hospital stay and were grouped under
DRG 123 'AMI deceased' with a mean length of stay of 6.4 days (std.dcv=7.7).
4.2. Hospitalization characteristics of the patient
population.
The way patients enter and leave the cardiology department may differ from one patient to
the next. Hospitalization flow characteristics for the patient population at hand are presented
in figure 4.1. The hospital stay at the cardiology department is divided into four time periods
' Patients with cardiac surgery are placed in other DRG's. Costs of these patients must be analyzed separately
from patients who had not have surgery.
Pa/ienf popu/afion
(TO to T3) as defined in our model of explanation. The first period (TO) concerns the first six
hours of stay during acute myocardial infarction. Almost all patients in the population
(n=447) were admitted to the hospital during this period. A sub-group of them, namely 14
patients, was already staying in hospital. During the first six hours of the infarction 10 of the
447 patients died. In the second time period (Tl) 6 'new' patients entered the cardiology
department. The latter group of patients came from other hospitals: they were admitted after
the acute phase of the infarction. In total 28 patients 'left' the department in this period: 19
patients died, 3 patients were transferred to other departments, and 6 patients were
discharged from hospital. Between 3 days and 10 days after the infarction (period T2)
another 8 patients were admitted to the cardiology department. In this same period a large
group of patients (n=238) was regularly discharged from hospital, 14 patients died and 4
patients were transferred to other departments. 167 patients stayed longer than 10 days
(period T3), while 3 patients were admitted from other hospitals at a later stage in the
infarction. The majority of these patients (n=162) were discharged from hospital; in this
period 7 patients died and only 1 patient was transferred to another department.
Figure 4.1. llospltull/.atlon flow characteristics of patient population.
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AMI patients arc usually admitted to the hospital in the regular way: they enter the hospital
directly arriving from non-hospital environment (home, work, etc.)- Some patients may get
the infarction while already in hospital. Patients may also enter the hospital via other
hospitals during various stages of their illness. For the patient population, the type of
admission was specified as: 'from home', 'already in hospital* and 'admitted via another
hospital*. If patients already were in hospital when they began to show symptoms of an
acute infarction this was indicated with a special variable (ADINT0; internal admission in
TO). Furthermore, if patients were admitted via another hospital, the stage in the infarction
upon entering the hospital was important. A distinction was made between patients entering
the hospital during the evaluation phase of the infarction (Tl), the first follow-up phase (T2)
and the second follow up phase (T3). For the patients entering the hospital in this irregular
way, separate variables were constructed (ADEXTl: admission external in Tl, ADEXT2:
admission external in T2 and ADEXT3: admission external in T3)
ftjn>nf /jopu/a/ton and dala f o//<rft<wi
The majority of the patients were discharged from the cardiology department in the regular
way (during T2). Patients with a non-regular discharge were characterized respectively by
variables HOME1 (discharged to home within three days) and H0ME3 (discharged to home
after 10 days). Due to the severity of AMI it was assumed that no patient would be
discharged during the acute phase (TO). Patients might also have been transferred to another
medical department in the same hospital. In this case, the moment of transfer was
characterized by the following variables: TRANS 1: transferred during Tl , TRANS2:
transferred during T2 and TRANS3: transferred during T3. For deceased patients also
separate variables were constructed namely: DEATHO; deceased during TO. DEATH 1:
deceased during Tl. DEATH2: deceased during T2 and DEATH3; deceased during T3.
4.3. Data collection.
Two basic sources were used to obtain the necessary data in this study: computerized data
from the hospital administration departments and non-computerized data from medical
records of patients.
The computerized data collection comprises partly medical discharge vuriablcs and partly
billing variables.
Medical discharge variables have been collected in Dutch hospitals during the past decades
and are used for general and specific hospital purposes. In the majority of Dutch hospitals
these data are registered and coded according to national guidelines from the 'Landelijke
Medische Registratie' (LMR registration). For every hospital admission there is a medical
abstract record which contains information on general and specific patient characteristics
(e.g.: age and sex), clinical characteristics (e.g.: diagnosis and surgical procedures), medical
specialty (e.g.: admission and discharge specialty) and hospital stay (e.g.: length of stay).
These data are collected by trained medical record personnel from the physician's discharge
letter and from information in the patient's medical record. Some of this information is used
for categorizing patients into DRG's according to the 1985 version of the Yale DRG-
groupcr. Finally, the patient abstract record is extended with specific DRG variables like the
MDC code (Major Diagnostic Category) and the DRG-codc (Diagnosis Related Group).
The computerized billing variables measure the type and amount of resources consumed
during an episode of patient care. The hospital billing administration office normally sends
out bills or submits claims for payment to insurance companies. All hospital activities that
can be charged arc collected, coded and entered into the billing system. For this survey, the
billing records arc converted into individual patient-resource records to obtain information
on the resource use per patient. Subsequently the number and type of services arc calculated
for each patient.
The repository of clinical information in a hospital is the patient's medical record. While a
patient is in hospital, physicians and nurses enter clinical and other information into the
patient's record. Transfers among hospital departments, laboratory test results, operating
room notes, medication orders, standardized anamnesis forms and all other relevant clinical
information of a patient are gathered in the medical record. The patient's medical record is a
handwritten and/or typed documentation file in which several papers, documents and reports
regarding to the patient's hospital stay are compiled. The content may differ from one
medical department to another. After discharge the records arc kept in the central archive of
/*a/tf«/ popu/afion anrf data co/tec/ion
the medical administration department.
In this study medical records were the main source of clinical information. The data required
for this study were registered using a specially designed registration form containing more
than MX) items (sec appendix 1). Each registration form consisted of a title page on which
patient number, name, admission and discharge date were noted. Next, items concerning the
medical background, physical examination, results of diagnostic tests, medication and
therapeutic interventions were collected and coded according to a previously constructed
code book. In this registration form the patient's cardiovascular and cardiac history and risk
factors were collected. If patients were participating in a research program during the
hospital stay this was also recorded. Next, items concerning the current hospital stay,
repeated for every defined hospital period (TÜ-T3), were collected. These items are collected
from (1) the medical history, like the duration of ischemic pain and Angina Pcctoris Class
and from (2) the physical examination, like rales, edema and blood pressure. Furthermore,
(3) liCG data, like the location of Q-wavcs and ST-changcs, but also the type and frequency
of several rhythm and conduction disorders were included. Next, (4) coronary stenosis
measured by coronary angiography, (5) different enzyme rates and the duration of an
cn/.ymc peak were collected. Also, (6) wall motion abnormalities and heart failure measured
by cehocardiography, (7) administrated drugs, (8) treatment such as thrombolytic therapy
and P'l'C'A and (')) specific relevant complications, such as CVA, mitralis insufficiency etc.
were included. F'inally, (10) results from exercise tests, according to the Bruce protocol and
thallium lest were recorded. As general guideline, the most deviating score in each observed
time period has been taken as the definite score. In case of missing, unknown or illegible
information special codes were used , . . , , ,
t.oiiecuons ol errors in data gathering were made alter the registration lorm was completed.
Still missing data were traced as much as possible and incorrect codes were rectified.
Subsequently, the coded data were entered into a database. Due to the medical complexity of
interpretation and registration, this part of data collection was performed by specially
instructed medical personnel. The time spent transcribing scores from an average medical
record took approximately an hour and a half per patient.
4.4. Quality of data.
A study on (he quality of medical abstract records in The Netherlands has been performed
by the "Stichting Informatievoorziening voor de Gezondheidszorg' (Gcmcrt, 1986). In
administrative variables, like age, insurance, acuicncss indication at admission, the
percentages of misclassifications were lying between 0.5 - 1.5 * . Unfortunately the
percentage for 'misclassificd diagnosis' was much higher: sequencing errors occurred in 3-4
% of the cases, a 'vague' principal diagnosis occurred in 4-6 % of the cases and a similar
percentage of the cases showed an inconsistent relation between diagnosis and surgical
procedures. With respect to the surgical procedures only 1-2.5 % appeared to be incorrect. In
our research population we found comparable results. These results corroborate the results
from other studies outside the Netherlands (Conncll 1984. Corn 1980, Dorcmus 1983,
Johnson 1984, Lloyd 1985. Young 1986).
and data co/fc crion
Expectations are that billing data are more reliable than medical discharge data, since billing
data are carefully processed by both the hospital and the insurance companies. There
appears to be no adequate literature on the quality of billing data in Dutch hospitals. In the
hospital under observation the percentage of misclassified billing data lies approximately
between 1 aid 1.5 %, as estimated by experienced administrative staff members from the
billing department.
* C/m/ca/£afa
The data colection has been performed by two physicians. For the interpretation of ECG
data they were instructed by a cardiologist. But in case of doubt, scoring difficulties or if
contradictor) results were observed by the physicians comparing their interpretation and the
results as described in the medical record, an experienced cardiologist was always consulted
for a second opinion. In the latter case the opinion of the cardiologist was always followed.
Some of the information, like the results of echoeardiograms and heart cathetcri/ations, was
obtained fron the reports of the cardiologist(s). The inira-ratcr or intcr-raler agreement in the
interpretation of these tests had not been investigated. So the data reliability may be
influenced b» the accuracy of the interpretation made by these cardiologists.
To measure the accuracy of data collection (interpretation and transcription), an asclcclly
drawn subsanple of 17 patients was independently rc-scorcd by one physician.
Data scoring on the patient's background characteristics was found to be consistent in 96.5
% of the items; deviations occurred in the scoring of prc-stay angina pectoris, prc-stay
coronary insjfficicncy and prc-stay hypertension.
In the demarcation of time periods TO to T3 one case was not consistent: one patient was
scored by tie first rating as having 'missing' values in time periods TO and Tl , while
according tc the second rating this patient did in fact have scores in TO and Tl . Closer
examination revealed that this patient had a subacute infarction and as a result of this it was
unclear how to demarcate the correct time periods. Consequently, there was a systematic
misclassification in all items for this case. So it had to be excluded when determining the
reliability of the data.
The agreement in the scoring of items related to physical examination (ischemic pain,
palpitations, dyspnea, blood pressure etc.) was lowest in the first six hours of hospital
admission, but improved in the other time periods (percentage of agreement in TO: 92.2 %;
in Tl: 94.8 %; in T2: 95.8 %; in T3: 97.1%). Disagreement of scores mostly occurred for the
duration of ischemic pain before hospital admission and the presence or absence of ischemic
pain during stay.
The reliability of ECG-intcrprctation from the medical records of patients differed according
to variables type. Agreement in the scoring of myocardial necrosis in the wall segments (by
location of Q-waves) was 96.2. % in TO, 93.7 % in Tl , 92.5 % in T2 and 100 % in T3.
Agreement in scoring of myocardial ischemia (by location of ST-segmcnt changes) was
somewhat lower (92.7 % in TO, 91.7 % in Tl , 87.5 % in T2 and 98.0 % in T3). Deviations
occurred in the exact location of myocardial necrosis and ischemia in each wall segment.
Agreement in the scoring of rhythm disorders was 93.0 % in TO, 95.8 % in Tl, 97.9 % in T2
and 99.3 % in T3. Differences appeared to exist in the presence or absence of
sinustachycardia and ventricular escape rhythm. The agreement in scoring of conduction
disorders proved to be higher than that of rhythm disorders; 98.8 % in TO, 96.6 % in Tl ;
99.4 % in T2 and 98.9 % in T3.
Agreement in scores of coronary stenosis measured by heart catheterization was 96.9 % in
TO, 93.7 % in Tl . 100 % in T2 and 94.2 % in T3. Differences occurred in the scoring of
stenosis before and after PTCA and in one patient the time of catheterization was
inconsistent: in one case caihctcri/.ation took place in period TO and in the other case in
period Tl .
Agreement in the scoring of the cchocardiography data was almost total. The only difference
was that in one case the cchocardiogram data belonging to one patient was reported to be
missing, while in the other case these data were not missing. This difference may be due to
the fact that in one case the data of the cchocardiogram were not found in the patient's
medical record, but in records from the heart function department where echocardiography
normally takes place. Strictly speaking, misclassification appeared to occur in about 7 % of
the cases.
Agreement in the scoring of enzyme values and the time it takes to reach an enzyme peak
was 93.7 % in TO, Tl and T2 , and 96.1 % in T3.
Differences did occur in the registration of the highest enzyme peak within a time period and
in some cases the number of hours after which a peak was reached was different. Sometimes
these problems were caused by differences in demarcating the hospital time periods.
Agreement in the scoring of variables of the exercise ECG according to the Bruce protocol
was KX)*inTI ,90.6%inT2and 1<X)<# inT3.
Differences in T2 existed because the data of one patient were reported to be missing in one
case, while in the other case these were present. The same explanation can be given as for
the scoring of cchocardiography variables.
Agreement in the scoring of the thallium test could not be investigated. For all patients who
had a thallium test, an independent scoring of results was performed by a single cardiologist
specialized in interpreting thallium tests results. These scores were used in the data analysis.
The agreement in the scoring of medical interventions (i.e. thrombolytic therapy, PTCA etc.)
that were performed during the various hospital time periods was 97.9 % in TO, 98.9 % in
Tl, 100% inT2 and 1(X) % in T3.
The agreement in (he scoring of types and amount of drugs administered during each time
period was 96.2 % in TO, 95.6 % in Tl . 95.0 <* in T2 and 99.4 % in T3. Differences in
scoring did exist concerning the exact number of daily doses given within a time period.
The reliability of our data was the lowest for the interpretation of ECG data. Other
inaccuracies in scoring were related to the demarcation of the hospital time periods and
might be caused by differences in rounding off days of stay when defining the hospital time
periods.
Taking into consideration the retrospective character of the data collection and assuming that
the intra-rater and intcr-ratcr agreement is high when test results were interpreted by
cardiologists, it is expected that the reliability of the data -as far as it could be established-
will be sufficient for the purpose of this study.
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5. Medical care costs and severity of illness:
definitions and operationalization.
In this chapter the methodology of defining and opcralionali/.ing the research concepts will
be described. Attention will be paid to the measurement of costs of medical care in hospitals
(S.I.) and on the measurement of the severity of illness of patients with myocardial
infarction (5.2).
5.1. Costs of medical care in hospitals.
Costs of medical care are assessed, monitored and reported by means of specific accounting
systems used in the financial-administrative departments of hospitals. Economists generally
distinguish between costs made at ancillary departments (laboratories, operating rooms etc.).
costs made in nursing departments or medical departments (for instance cardiology,
gynaecology, internal medicine), and costs made by overhead departments (management,
financial administration etc.). The costs of each hospital department (labor, materials,
equipment) will be calculated and (if defined) output measures are determined (number and
type of services, number of patient days, etc.). However, most accounting systems do nol
provide adequate information about the actual costs of the total of medical care delivered to
a patient during his or her stay at the hospital.
Fetter and Freeman (1986) follow a more generalized approach to this problem by stating
that a hospital produces specific goods and services for its patients. These include, for
example. X-rays, drugs, and laboratory tests ordered by physicians, as well as nursing care,
operating room facilities and certain hotel and social services. However, since the real
business of the hospital is to treat individual patients, these arc only 'intermediate products'.
The specific set of 'intermediate products' provided for each patient results in the 'final
product' of the hospital (see figure 5.1).
Figure 5.1. Defining (he hospital product.
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Assessing the costs of the intermediate products is an essential step in measuring the costs of
the final hospital product (the total of medical care delivered to a patient). The costs per
service multiplied by the number of services, added up for all services are supposed to give
the most reliable estimation of the real costs made during a patient's hospital stay. However,
because of the complexity of calculation methods and the enormous variety in different
services which a hospital may offer, the real costs for each hospital service are generally not
available. For example, in a university hospital more than 6000 different services can be
distinguished. Assessing the real costs of all individual services may prove to be a goal
which is difficult to attain. As a substitute for the real costs per service, charges (tariffs) or
specific costs weights may be used. However, this may affect the reliability of the
determination of costs. For instance, the charges may not cover the real sum of money spent
by the hospital to perform a service. In Dutch Health Care the charges per service are
established at a national level by a uniform tariff system. Charges may not be exactly
representative of the real costs which may vary from hospital to hospital.
So, to determine the hospital costs per patient it is obvious that the real costs per service
need to be assessed. These efforts towards an approximative calculation of the costs of
medical services arc being made at the University Hospital Maastricht.
The real costs per service have been estimated through extensive cost allocation studies
carried out at the ancillary department level. Cost allocation studies have been performed at
the clinical chemistry department (Limpcns, 1986), bacteriology, virology and immunology
department (Limpcns, 1988; Roberts, 1989), haematology department (v.d. Kar, 1989), the
heart function laboratory (Limpcns. 1989), the lung function laboratory (Limpcns, 1989),
radiology department (Jcttcn, 1987), nuclear medicine (Wcncmoscr, 1988), operating room
inclusive sterilization and recovery (Roberts, Kamm, 1990), clinical pharmacy department
(Brouwers. 1988; Huppcrichs, 1988), physical therapy department (Steenbakkers, 1988),
pathology department (Macs, 1987), gastro-cntcrology department (Schelling, 1988),
hemodynamic laboratory (Coclcn, 1988), department for tissue characterization (Roberts,
1989), blood transfusion department (Kamm, 1989) and the department of ncurophysiology
(Slabbers, 1987).
The cost allocation process is restricted to those hospital departments delivering services
directly related to patient care. Indirect costs like general administration, maintenance,
education and research cither cannot be allocated to patient care or can only be allocated
using arbitrary allocation-keys. These costs arc therefore excluded from the cost allocation
process.
In cost allocation studies the depart mental costs (the inputs) are allocated to the various
services performed by the department (the intermediate products). For each service cost
prices are assessed. The methodology used in this allocation process will be further outlined
in paragraph 5.1.1.
The set of given services may differ by type and amount for each individual patient. The use
of hospital resources can be determined for each patient from information in the bill abstract.
It is assumed that cost prices per service combined with the information derived from the
bill abstract add up to a reliable measure of the real costs of medical care per patient. Results
from an application of this method for the patient population in question are described in
paragraph 6.1.
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5.1.1. Cost allocation of departmental costs to medical
care services.
In the cost allocation process the following definitions can be made (Limpcns, 1986):
* /nd/Vecf an*/ dïnecf serv/Cfs/or paftV
Indirect services do not have any direct relation to patients but they do support patient care
departments and the hospital in its totality in performing the care process adequately (for
instance cleaning personnel or the goods and services of technical equipment suppliers).
Direct services are those services which can be directly ascribed to the process of patient
care (laboratory tests. X-ray's, surgical procedures, etc.). These arc defined as the products
of the ancillary departments.
* P/wJuc/ re/a/eJ a/ia*
Costs of direct services can be specified into product and non-product related costs. If there
is a direct relation between the departmental costs and a part of the production, these are
called product related costs or specific costs. If the direct relation is not present we will
speak of non-product related costs or general costs.
In the cost allocation process four different components can be distinguished:
1. overhead costs: costs of management, administration and inventory;
2. capital related costs: costs of machines and instruments;
3. material costs: costs of materials and means;
4. personnel costs: costs of manpower.
* Faea" ana* Var/aWe
During a period of time fixed costs can be regarded as independent of the size of production
while variable cost may be changing with the level of production in the same period.
Figure 5.2. General process of cost allocation of departmental costs to medical care services.
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The main objective of the cost allocation process is to estimate a reliable cost price for each
service, keeping in mind the operating costs of the department in charge.
The mix of services will vary per department; some departments only perform a restricted
number of different services, while others offer a large diversity of services. In addition,
high and low frequency services occur in both situations. Consequently, establishing a
reliable cost price for all individual services is a goal difficult to attain, especially if cost
prices need to be revised or kept up to date.
In the development of the cost allocation system for hospital services at the University
Hospital Maastricht some general principles have been applied (Limpcns, Roberts 1988).
Cost-allocation and the establishment of a cost-price per service arc made on an annual
basis. Cost allocation includes personnel, material, capital (depreciation, interest and
maintenance) and overhead costs. A distinction is made between product related and non-
product related costs. Costs per service arc calculated in such a way that number of services
times the costs per service equals the operating costs. For ancillary departments with a
widespread mix of services, a distinction is made between (1) routine services for which cost
prices arc calculated separately for each service, and (2) non-routine services for which cost
prices arc derived from costs of routine services. Although the cost prices of non-routine
services may be somewhat less reliable, it is assumed that the overall effect may be
neglected, since routine services (20 9f of the service mix) generate the majority of costs (80
'# of the department costs). No distinction is made between urgent and non-urgent services.
In addition, no distinction is made between services produced within or outside regular
working hours. Thirdly, no distinction is made between services for patient care, research or
education.
1. Product related personnel costs.
Allocation of product related personnel costs to the various services and the establishment of
a cost price per service will be illustrated by a ficiivc example (table 5.3). A distinction will
be made between routine and non-routine services. For routine services the average time in
minutes spent by each category of personnel (analysts, assistants, technicians, physicians) is
established through empirical studies. The average lime (AT) of a service comprises the
duration of all activities necessary to complete the service. For non-routine services the
average time per service is assumed to be equal to the average time calculated over all
routine services. It is supposed to be equal for all types of non-routine services (see example
table 5.3); AT (non-routine services) = {(10*6) + (20*3) + (30*6) + (40*3)) / (10 + 20 + 30
+ 40) = 4.2.
Multiplication of the total Number of services (Ns) from both routine and non-routine
services by the Average Time per service will give the Total Time (TT) spent by a member
of (he personnel to perform certain services.
The Workload Proportion (WP) is defined as the relative weight in personnel costs of a
service; this comprises the total time needed by a person to perform that type of service
divided by the performer related 'total' time for all services (483 minutes in the example).
For instance, the Workload Proportion for service 'a' can be represented as:
10*6
483
= 0.12
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The service related Salary Costs (SC) arc defined as the Workload Proportion (WP)
multiplied by the Total Salary Costs (TS) of the performer (for the example set on fl. 1 .(XX),-
for 483 lime units).
The service related Salary Costs for service 'a' may be written as:
= 124.22
483
The Cost Price of Personnel Costs (CPP) for each service may be calculated as service
related Salary Costs (CS) divided by the number of services (Ns) a performer produces and
can be seen as the estimated personnel costs of the service. So, the cost price of personnel
costs for service 'a' may be written as:
/47a *rS
"
6,1000
483
= 12.42
Table 53. Fictive example of cost allocation of product related personnel costs for routine and
non-routine services in Dutch Guilders.
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2. Product related material costs.
Allocation of production-related material costs and calculation of a cost price per service
will also be presented by a fictivc example (sec table 5.4.). The material costs per service
arc the average material costs to perform a service given the machinery setup. These
include all types of material necessary to complete a service. The average material costs
of routine services have been estimated using specific expertise of performing personnel
and by independent observers. Costs of product related materials, which can not directly
be allocated to a type of service, arc equally divided over routine care services. The
average material costs of non-routine services are derived from the average costs of
routine services (sec example table 5.4). Calculation of a cost price for material costs per
service is made following the same rules as for personnel costs.
Table 5.4. Relive example of costs allocation of product related material costs for routine
and non-routine services in Dutch Guilders.
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3. Product related capital cost
Capital costs refer to the equipment (machinery and hardware) used to perform a service.
Allocation of product related capital costs to the various services and the calculation of a
cost price per service is made by applying the same rules used for determining personnel
and material costs. Routine and non-routine services arc calculated in different ways. For
routine services the average use. in minutes, of the equipment per type of service is
determined by independent observers. The estimated use of equipment for non-routine
services is derived from the average use of routine services. Costs of equipment which
can not be allocated to a specific type of service are equally divided over routine services.
If more than one type of machinery is used to perform a service, a cost-price is calculated
for each type of machinery and subsequently added for all machinery to obtain an overall
cost-price per service.
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4. Overhead costs
Overhead costs include all costs which arc not allocated to the production related personnel,
material and capital costs. These consist of:
- personnel costs: management, secretarial offices and administration offices of departments;
- material costs: office materials, office machinery and equipment and furniture,
travelling expenses, xerox use, literature etc.
- capital costs: computers for administrative purposes.
The total overhead costs are equally divided over routine and non-routine services.
Therefore the overhead costs consist of a uniform fixed amount for each type of service.
5.2. Severity of Illness.
Severity of illness is a familiar and often used term in patient care. Yet, little has been done
to define, operationalize and measure this difficult and complex concept in u reliable and
valid way. Studies in this research field have not yet succeeded in overcoming the luck of
'golden' standards in the measurement of a patient's severity of illness. Severity of illness is
a concept which cannot be measured entirely on its own; medically speaking it will always
be associated with a patient's type of medical deficiencies and, in a more general way, wilh
the type of diagnosis. Nonetheless, a more formal definition is necessary to delineate it.
The severity of illness of a patient within a clinically homogeneous diagnosis category is
defined as the degree of pathologic deviation from the 'normal ' state of health
measured by structural and functional medical deficiencies which belong to this
diagnosis category. A diagnosis category is defined as a set (or syndrome) of medical
deficiencies or complications that intrinsically belong to each other.
The structural and functional medical deficiencies may include clinical and non-clinical
concepts (indisposition, malfunctioning in daily life or quality of life). In this study we will
restrict ourselves to clinical concepts of severity of illness.
In the coming paragraphs an attempt will be made to opcrationalizc the concept for patients
with Acute Myocardial Infarction (AMI). A general and formal terminology will be
developed and be used in chapter 6 to operationalize and measure severity of illness in AMI
patients. In this chapter, some preliminary concepts and assumptions in defining Severity of
Illness will be given. The difference between structural and functional deficiencies will be
outlined. In addition, the difference between units of observation and characteristics of units
of observation will be given. The assumptions and terminology will be then specified for
AMI patients (5.2.1.). Next, a short overview of the relations that exist between the medical
deficiencies will be presented using a causal model. In doing so a distinction will be made
between:
* the severity of deficiencies causing AMI;
* the severity of the AMI deficiencies themselves;
* the severity of deficiencies caused by AMI.
Some methodologie considerations on the use of techniques of observation (ECG,
cchocardiograms, etc.) pertaining to unidimensional and multidimensional severity scales
will be presented (5.2.2.). A measurement approach is proposed consisting of three
interrelated elementary scales of Severity: the Intensity Scale, the Extent Scale and the
Location Scale (5.2.3.). In the next paragraph it will be described how the principles above
are used to determine the severity of illness (and changes therein) in AMI patients during
their hospital stay. Some rules for categorizing patients into dynamic Severity Illness
Categories will be given (5.2.4). Finally a summary will conclude this chapter (5.2.5).
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5.2.1 Assumptions and terminology regarding severity of
illness in AMI patients.
* 5/r«t7wfü/ versus
A distinction can be made between medical deficiencies of a more 'structural' and a more
'functional' nature. 'Structural' medical deficiencies can be ascribed to organic subunits of
the human body like the heart muscle or coronary artery system. 'Functional' medical
deficiencies can be ascribed to the heart and specific organic processes taking place within
and between organic subunits. These processes fulfill certain vital needs of the organism,
like the coronary oxygen supply to the heart by the coronary vessels or the cardiac output
capacity of the cardiac ventricle; survival of the whole organism (and its organic subunits) is
at stake, if these processes (slowly) degenerate or come to a stop.
From the definitions above, some general methodologie rules can be derived. A distinction
can be made between (I) units of observation and (2) characteristics of units of observation.
The principal unit of observation in our study is the patient with Acute Myocardial
Infarction. Structural units and functional processes within the heart first will be specified.
The structural units of observation of the heart relevant for the purpose of measuring
Severity of Illness arc listed in scheme 5.5. The heart can be clinically subdivided into four
main parts (units): (a) the left ventricle (b) the coronary artery system (c) the conduction
system and (d) the cardiac pacemaker. As the second row of the scheme illustrates, the four
structural units of the heart arc built up of smaller subunits: the left ventricle consists of wall
segments, the coronary artery system of arteries, the conduction system of conduction fibers
and the cardiac pacemaker of automatic fibers. The pathological characteristics of these
subunits relevant for defining severity of illness arc named the structural cardiovascular and
cardiac deficiencies. These arc mentioned in the third row of the scheme. Wall segments of
the left ventricle may show myocardial ischemia or myocardial necrosis. Within the arteries,
arteriosclerosis or coronary stenosis might be present. Structural medical deficiencies within
conduction or automatic fibers arc considered to be less relevant in AMI patients, but may
be important in other diagnostic groups.
The functional processes within the heart can also be seen as units of observation. Five types
of functional processes may be discerned within the heart, relevant for AMI patients. Left
ventricle contraction, coronary artery pcrfusion, conduction as a process, rhythm behavior
and cardiac function arc the relevant processes which may show pathological characteristics.
These pathological characteristics are entered in the last row of the scheme. The functional
deficiencies arc called respectively: abnormal wall motion, hypopcrfusion of the coronary
arteries (combined or not combined with insufficiency of the collateral circulation), cardiac
conduction disturbances, cardiac arrhythmia and heart failure.
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Scheme S.S. Structural units of observation and functional processes within the heart and their
medical deficiencies.
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5.2.2. Severity of Acute Myocardial Infarction: a causal
model.
Subsequently, the relationships between the medical deficiencies observed in patients with
Acute Myocardial Infarction must be considered. By defining causes and consequences of
the characteristics mentioned above one can hypothesize a causal model. This model can
explain changes in dependent deficiencies, given particular changes in other deficiencies.
The general idea behind the causal model is that structural deficiencies will influence
functional deficiencies, and not the other way around. The relations between structural
deficiencies can be regarded as a causal chain model (see diagram 5.6.): coronary
arteriosclerosis (sometimes combined with coronary spasm) may lead to coronary stenosis.
Coronary stenosis in turn may lead to myocardial ischemia. When this process of
myocardial ischemia becomes irreversible this may lead to myocardial necrosis. Diagram
5.6. also visualizes the relations between myocardial ischemia and necrosis and the
functional cardiac deficiencies; all direct relations between coronary stenosis and the
functional deficiencies are supposed to 'pass' through the processes of myocardial ischemia
and myocardial necrosis. Myocardial ischemia and necrosis can cause functional
deficiencies of the heart (abnormal wall motion and -indirectly- heart failure). At the same
time it can directly lead to specific functional complications (rhythm and conduction
disorders). In their turn these complications may also lead to heart failure. Heart failure may
cause several body deficiencies in other organs than the heart (lungs, kidney, liver, etc.).
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Diagram 5.6. Causal Model specifying relations between deficiencies in patients with Acute
Myocardial Infarction.
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If one wishes to use the causal model presented in diagram 5.6. as a guideline for
multivariatc analysis in empirical research, its concepts must certainly be further specified
into indicators. For example. 'Myocardial Necrosis' may be measured by means of three
indicators, namely by the appearance of significant Q-waves in ECG leads, by certain
biochemical changes in the blood scrum, and by certain radiotopic changes observed in the
myocard, when a so-called thallium test is performed. Patients who show significant Q-
wuves in ECG, who have these characteristic changes in their blood serum, and who show
these thallium-negative areas in their myocard will be labeled as: 'having an Acute
Infarction'. Patients who have no significant Q-wavcs, and no changes in blood scrum, and
no thallium-negative areas in the myocard will be labelled as 'Normal'. Patients with
contradictory symptoms (Q-wavcs in ECG, but no blood scrum changes, or: no Q-waves in
ECG, but significant thallium changes) will be placed into 'in between' categories ( i.e.
'suspected AMI').
5.2.3. Defining Severity of Illness: an operationalization.
The patient's overall severity of illness may be determined by a combination of scores on
medical deficiencies. The measurement of the severity of a deficiency can be very
elemental: the dichotomous scale is a widely used method of assigning scores to a patient. If
no deficiency is present the score is '0', if a deficiency is found the score is ' 1 ' . However,
when medical professionals talk about the severity of an illness or deficiency, as a 'real life'-
concept, they think in terms of gradation. Therefore, the use of an ordinal measurement scale
with more than two scores is a more realistic approach to defining and measuring the
severity of a deficiency. The degree to which the severity will vary can be operationalized
into rank scores, and patients with the same rank score can be categorized as belonging to
the same group. Of course, one of the aims of social-medical research must be to investigate
if severity scales approach interval measurement, where the length of the distances between
the (rank) scores can be ascertained. Until this goal will be reached, let us assume that a
polytomous ordinal rank scale can be applied to the concept of severity of a medical
deficiency. For instance, one could assume that for a certain deficiency four stages or rank
scores exist, and that the resulting scale would describe the deficiency in a valid and reliable
way. The minimum rank score ('no deficiencies') could be set at '0', the category 'low level
of deficiency' could be set at rank score ' 1 ' . the category 'moderate' could be set at '2' . and
the maximum rank score ('3') could be given to the category 'life threatening deficiency'.
However, a single deficiency can be measured with the help of multiple indicators which are
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the outcome of various medical techniques. As we have seen in 5.2.2.. 'myocardiul necrosis'
can be measured by certain ECG-abnormalitics, by certain changes indicated by u thallium
test and by certain biochemical changes in the blood scrum of patients. In principle,
"myocardial necrosis' seems to be a multi-attribute concept, which can be measured as a
multidimensional scale. Furthermore, a unit of observation in medical science can be
analyzed into several subunits, and in many instances sub-subunits can be distinguished.
Techniques of observation are being used that can screen certain deficiencies within an
organ at a sometimes microscopical level. Later on in the causal process deficiencies in one
subunit may cause other types of deficiencies in other subunits of the same organ (sec
diagram 5.6.). Thus, in the first place we must state which deficiency at what level of
observation we arc interested in (as we have done in scheme 5.5). When several subunits can
be discerned that arc relevant for a more precise (and medically valid) measurement of the
deficiency, the concept of severity becomes necessarily a complex, multidimensional one.
Naturally, this will often generate a situation, where more than one indicator must be used
for one specific deficiency.
Indicators for specific medical deficiencies may imply several dimensions of severity of
illness. Three independently defined, but related dimensions may be discerned:
(1) the intensity of a deficiency
(2) the extent of a deficiency and
(3) the location of a deficiency.
When an indicator measuring the deficiency for a unit is used, the Intensity of a Deficiency
can be defined as the total of observed deviations times the specific weights of the degree of
the deficiency, which its subunits get ascribed. For instance, when we measure the intensity
of abnormal wall motion in the left ventricle (sec § 6.2.6), we can give certain weighted
scores to every cardiac wall segment, while at the same time the technique of e.g.
echocardiography will indicate that certain cardiac wall motion abnormalities arc or arc not
present. The deficiency to be measured (the process of abnormal wall motion) in the higher
unit (the left ventricle) is measured by a single indicator (contraction behavior) at the
observational level of a subunit (left ventricular wall segment). Each wall segment is given a
numerical weight ranging from '0' (in this case Normokinctic Function) to '3 ' (in this case
Dyskinctic Function): these weights arc multiplied with the observed deviations to a score
for each subunit and eventually all scores can be aggregated or added up a total score for the
unit. The example above is a one concept-one indicator case. When the concept to be
measured is indicated by several indicators (e.g. myocardial necrosis), a more complicated
situation exists.
When an indicator measuring the deficiency is used for a unit the Extent of the Deficiency
can be defined as the spread of the observed deviations scores of this indicator over the
subunits, irrespective of any weight given to the degree of the deficiency. Using the same
example as before, we can measure the extent of abnormal wall motion in the left ventricle
by giving a score of ' 1 ' to every wall segment that shows signs of abnormal contraction. A
score of '0' is given to every wall segment that shows no abnormalities at all. These '()'- and
' 1 ' - scores of all wall segments are then totaled for the entire left ventricle. One can interpret
this aggregated total value as the spread of any abnormal wall motion over the left ventricle:
the resulting absolute number can be seen as the extent of abnormal wall motion in the left
ventricle of a patient.
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When an indicator measuring the deficiency is used for a unit, the Location of a Deficiency
can be defined as the total of observed deviations times the specific weights, expressing the
relative vulnerability of its subunits. In the above example one can measure the location of
abnormal wall motion of the left ventricle by giving a weight to specific vulnerable cardiac
wall segments. These weights for vulnerable sites in the left ventricle can be given
independently of the intensity weights. For the chosen example, it means that abnormal wall
motion in the anteroseptal segment can be considered more severe than in the other
segments.
Together, the Intensity, Extent and Location scales can be interpreted as a three-dimensional
measure of the concept of severity of a medical deficiency. Each dimension is independently
defined with regard to the other two.
In empirical research, situations may arise in which one or even two of the three dimensions
of the measure collapse into a much simpler concept of severity of illness. For instance,
when the deficiency indicator can only be measured by a dichotomous scale (0 - 1), the
intensity dimension disappears and a two-dimensional concept of severity of illness remains.
This often happens, when the degree of measurement in research is rather crude. A further
degeneration of the three dimensional measure may occur, if the unit and subunit of
observation arc one and the same: in this case the extent and location dimensions collapse
into a single unidimcnsional scale. This applies for instance, for the measurement of cardiac
conduction disorders: only a gradation measuring the type of conduction disorder can be
del mod and given weights for these disorders only the intensity scale remains. The most
extreme degree of this degeneration in measurement occurs when the above restrictions are
combined. In this case only a crude unidimcnsional score remains which can be used to
register the absence of presence of the deficiency.
5.2.4 Severity of AMI patients during hospital stay; changes
in severity and rules to obtain dynamic Severity of
Illness Categories.
As we have seen in previous paragraphs, severity of illness for AMI patients may be
ascertained by various cardiovascular and cardiac deficiencies. Each deficiency can in turn
be measured by one or more indicators and each indicator can be expressed in terms of one
or more severity dimensions. The patient's severity of illness must be seen as a dynamic
concept. In general the severity of illness will change while a patient is in hospital.
To measure changes in severity of illness, the condition of a patient needs to be measured at
various moments during hospital stay. For AMI patients, who generally experience a life-
thrcalcning situation, these measurements should focus on the first part of their hospital stay,
in which indices may show extreme variations. The later stay period can generally be
described as an after-crisis situation. Based on these considerations, four lime periods have
been distinguished (sec § 3.3). When severity of illness is measured repeatedly within these
four periods certain changes in severity may be observed: patients may stabilize soon after
crisis or at a later point, they may develop complications, or they may deviate consistently in
some way (table 5.7).
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5.7 Some patterns of changes in severity of illness.
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The various severity patterns which occur during a hospital stay may he measured for each
medical deficiency belonging to the AMI diagnosis. For instance the severity of myocardiul
ischemia may be measured repeatedly by daily ECG. Severity patterns of myocardial
ischemia during hospital stay which appear to be similar in a medical way may then be
grouped into one severity category. Severity patterns may be seen as dynamic severity
categories. Subsequently, the dynamic severity categories may be placed in a rank order of
increasing severity. For instance, the severity pattern 1 in table 5.7. may be grouped into one
dynamic severity category A. Severity patterns 2 and 3 into category B and 4 and 5 into two
categories C and D. A rank order in severity may be given in which it is assumed that
category A is less severe than category B and category C is more severe than B, etc. In this
process of categorizing and subsequent ranking medical specialists need to be consulted
regularly.
The process of grouping severity patterns into dynamic severity categories and ranking the
categories according to their severity may involve methodological problems. Consequently,
some additional rules need to be specified.
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Evidently, severity indicators must be repeatedly measured during the patient's hospital stay
in order to determine changes in severity. Therefore the clinical observation technique by
which the indicators is being measured must be applied several times during a patient's
hospital stay (and preferably once during each of the four time periods). Examples of such
severity indicators are those which arc based on results of ECG (which provides information
about myocardial ischemia and necrosis plus rhythm and conduction disorders). If during a
period more than one ECG is made for a patient, the one with the most deviating results
from the 'normal' situation will be selected for classification.
However, some cardiac deficiencies are only measured once during the whole hospital stay.
Examples of such deficiencies are cardiac wall motion and heart failure which arc estimated
by cchocardiography. If an observation technique is applied only once, it will be impossible
to categorize patients according to the changes in severity of this particular deficiency. Thus,
next to the more 'dynamic' severity classification of patients, a more 'static' classification
must be used which characterizes their illness condition during the whole stay. In chapter 6,
severity of illness for both the dynamic and static classification will be dealt with.
^ ^ ƒ /
In the above line of thought it has been assumed that the grouped patterns of a deficiency
can be placed into a rank order of increasing severity. This ordinal scale construction will be
used in the forthcoming data-analysis to explain differences in costs. However, there are
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situations in which severity patterns of a deficiency can not be placed into a single
unidimcnsional rank order. For instance, cardiac rhythm disorders may be so diverse and
may or may not be important at different moments during hospital stay, that forcing them
into a unidimcnsional scale seems impossible at this time of research. We did not feel
confident enough to hypothesize which underlying dimensions can be found within all these
types of rhythm disorders. Furthermore, this problem should better be solved in a more
medical (cardiological) research setting. For the time being our solution is a simple one: all
paticnis arc categorized into one uniquely defined nominal group and this nominal category
will be used as a factor in the analysis of medical care costs.
( , vv/7/i
A typical medical deficiency may not always be measured in all patients. For instance, the
severity of coronary stenosis can only be measured for those patients who have had at least
one heart calhctcrization during their hospital stay. For patients who have not undergone
cathctcrization during their stay or for those patients whose results of catheterization are
lost, illegible or otherwise unknown, no information about the severity of coronary stenosis
can be transcribed. In this case, the grouping of patients into severity categories may be
limited to lower numbers of patients.
Missing data in indicators of severity of illness may of course also result when patients are
discharged early, arc transferred to another medical department or if they die during hospital
stay. This problem also arises when patients arc admitted from another hospital during a
later phase of their illness period (sec § 4.2) In the eventual cost analysis some correction
has to be made for patients who have these types of missing values for indicators. To
overcome these difficulties, which may seriously narrow down the number of patients in
data analysis, we will regard 'missing values' as a separate subcategory of patients in each
analysis. Sometimes extra (dummy) variables arc constructed for the sole purpose of
supplementing the numbers of patients in the categories of severity of illness. In § 7.1. a
precise description of the solution for this typical 'missing values' problem will be given.
5.2.5 Summary.
To measure a patient's severity of illness within a homogeneously defined diagnosis group a
conceptual distinction must be made between (1) structural and functional medical
deficiencies and (2) units of observation and characteristics of units of observation.
Relations between the medical deficiencies may be hypothesized in a causal model. The
severity of a medical deficiency may be measured with single or multiple indicators. It is
assumed that three interrelated severity dimensions can be discerned: the intensity, the extent
and the location of a deficiency. Sometimes all three dimensions can be distinguished in
measuring severity of illness, sometimes they may collapse into one or two dimensions. The
severity of a medical deficiency may be measured cither per time period or summarized for
the whole hospital stay. In the latter case it will be condensed into dynamic severity
categories. These may be obtained by defining various patterns of severity of illness.
Patients having similar severity of illness patterns can be categorized within the same
severity group.
The proposed methodology for measuring dynamic severity categories will be applied for
the AMI patient population. Measurement of the severity of illness per time period and the
determination of dynamic severity categories for each deficiency as outlined in the causal
model of patients having acute myocardial infarction (diagram 5.6.) will be more
extensively described in paragraph 6.2.
6. Measurement of research concepts.
The methodology proposed in chapter 5 will be applied to operationally*: and measure the
research concepts outlined in the models of explanation (chapter 3.2.). The
opcrationalization and measurement process is described tor the patient population at hand:
464 patients with acute myocardial infarction.
This chapter will concentrate on operationalizing the three major research concepts:
- Cost of medical care (6.1)
- Severity of illness (6.2)
- Background characteristics (6.3)
6.1. Costs of medical care.
The costs of medical care for the patient population at hand arc measured by (1) the type of
service, (2) the number of services and (3) the cost-price of each service (sec 5.1.1). For
each patient, resource data have been collected from our hospital billing administration.
Resource data consist of the number and type of services given to a particular patient during
his or her hospital stay. In order to measure the exact costs of a hospitalized patient,
ambulatory care services and services requested by physicians other than cardiologists are
excluded. Results from cost price studies of medical care services have been used lo
measure the financial impact of the medical care delivered. Medical costs arc calculated by
multiplying the scrvice-spccific-cost-pricc by the amount of services performed. In our
research strategy the scrvicc-specific-cosl-price includes (I) product-related personnel costs'
and (2) product-related material costs. Product-related capital costs and overhead costs arc
nol taken into account because of their fixed character. Costs arc limited to variable costs
which arc assumed to be dependent on characteristics of the patient population. Overhead
and capital costs in hospital care arc assumed to show less variations due to illness or palicnt
characteristics. Patient characteristics may only influence these costs on a long term basis.
For example, severely ill patients may require more laboratory tests. This will mainly affect
costs of materials needed and time of the laboratory personnel, but in general this will have
no direct impact on the costs of the machinery or the departmental administration. Our
research strategy concentrates on explaining medical care cost differences on the basis of
specific illness and patient characteristics. Obviously only variable costs which arc strongly
related to illness and patient characteristics will be taken into account.
The only exception to the procedure described above is the calculation of the costs of drugs
which are not recorded in the billing system; the types and amounts of drugs arc derived
from the patient's medical record and cost-prices arc estimated on the basis of daily doses.
Costs of medical care per patient will be divided over the four hospital time periods defined
in our model of explanation (chapter 3.3). For some specified categories of services, costs
made in time period TO (first six hours of hospital admission) had to be included in Tl
because they are recorded per twenty-four hours.
Various hospital costs will be described in the following sections: costs of diagnostic
services (6.1.1); costs of medical interventions (6.1.2); costs of nursing care (6.1.3) and
other costs, like physical therapy (6.1.4). Within these four major groups of medical care
more detailed costs categories will be defined on the basis of their medical relevancy lo the
hospital care process.
Physician salary costs have been exluded from the personnel cost-price because they do not represent cost» of
ancillary departments.
6.1.1 Costs of diagnostic services.
* Costs of Laboratory Services.
Laboratory services can be distinguished into routine and specific tests. Routine laboratory
tests arc tests that are normally performed irrespective of the specific illness of a patient.
These services provide an overall impression of the patient's physiologic health condition.
These include: general hcmatology tests (like hemoglobin, hematocrit, counts of leukocytes,
crythrocytcs, thrombocytcs), general blood chemistry tests (like glucose, urea, crcatinine,
sodium, potassium) and general urine chemistry tests (like protein, glucose, urobilin).
Specific laboratory tests include all extra tests considered necessary given the patient's
health condition and/or disease. For the patient population at hand these include specific
blood chemistry tests (like Crcatinc Phospho-Kinasc (CPK), Serum Glutamic Oxalacctic
Transaminasc (SCOT, also known as ASAT), Scrum Lactic Dchydrogcnase (LDH), Scrum
Glutumic Pyruvatic Transaminasc (SGPT, also known as ALAT), repetitive determination of
daily glucose and urine acid levels), specific hcmatology tests (like rcticulocytc, cosinophile
count, blood gases and hcmatologic coagulation) and other blood tests (like hormone tests
and tests from microbiology and immunology). Costs of all (routine and specific) laboratory
services for the palicnt population at hand are presented in appendix 2. Per patient a mean
number of XO.2 laboratory tests arc made during (he total hospital stay (mean costs: fl.
2IX.34). The greater part (75 '#) of these tests lakes place during the acute phases of the
hospital slay (in time periods TO and Tl).
* Costs of Routine Diagnostic Services.
Routine diagnostic services arc normally performed for each AMI patient. These involve
ECG-rcgislrations (appendix 3) and radiology tests (X-thorax) (appendix 4). When patients
arc admitted to the Coronary Care Unit, ECG tests arc performed on a very regular basis and
urc included in the costs of intensive care. For the patient population at hand, most patients
spend their first days of stay in the intensive care ward. This may explain why the costs of
ECG tests are relatively low during the first days of the hospital admission. On average, 7.5
ECG's arc made per patient (mean costs: fl. 47.86) and 2.1 radiology tests arc performed per
patient (mean costs: t l 46.11).
* Costs of Specific Diagnostic Services.
Specific diagnostic services lor AMI patients include all additional non-laboratory tests
considered necessary given the patient's specific health condition and/or disease. Because of
large differences in technique, in what is measured and number, these costs are distinguished
into five categories.
/.
During a heart cathcterization several activities may take place. Normally a session consists
of left catheteri/ation with (1) pressure measurement and Oi-saturation measurement, (2) left
ventriculography and (3) coronary arteriography. Next to these activities, less regular
activities may occur, like right heart pressure measurement with Swan-Ganz catheters. Costs
are calculated for every separate activity. For the costs of cathcterization (appendix 5) the
unit of measurement is the calhctcrization activity. A cathcterization is generally done
during the acute phase of the slay: in 54.5 <* of the patient population the cathetcrization
occurs at the very beginning of the hospital admission in T-0 and 29.3 9F- in T-l. Relatively
few cathctcrizations arc performed in the following two periods.
2. Wo/fer f/ec/rocan/i'ojjra/n or 24 /ir>«rs ECG.
This test is normally performed on some patients to detect (severe) rhythm and/or
conduction disorders. The total costs for our patient population arc relatively low (sec
appendix 7). This lest is only performed 72 times in total (distributed equally over all lime
periods) which amounts to a mean of .16 tests per patient (mean costs: fl. 8.43).
In some cases echocardiography is performed in combination with a Dopplcr lest to estimate
cardiac valve function during the same session and using the same machinery. Costs of
Doppler tests arc also included under the heading 'costs for echocardiography' (sec
appendix 8). Echocardiography for AMI patients is normally performed three days after
admission. In total 417 times a test is made (total costs: II. 20,201.05), which amounts (o u
mean of .90 tests per patient (mean costs: fl. 43.54).
4. Ererci» Wecfrocan/io/?ram u.«'n# f/ie Bruce
An exercise ECG is usually performed to detect post-myocardial infarction angina and is
normally planned just before patients leave the hospital. Therefore, costs due to this lest only
occur in time periods T2 and T3. Costs of this test (appendix 6) arc generally made between
three and ten days after the admission. For the patient population at hand in total 206 Bruce
protocols are applied which amounts to a mean of .44 tests per patient (mean costs fl. 17.20).
5. Nuc/ear Car<//7>gra/>/iy.
This category consists for the greater part of the so-called thallium test. During this lest two
conditions are (simultaneously) investigated normally: (1) thallium uptake at rest and (2)
thallium uptake during exercise. In appendix 9 costs of nuclear cardiography are given. The
number of services is based on the number of (research) activities during a session. Like the
Bruce protocol, a thallium test is performed normally to measure posl-myocardial infarction
angina or to ascertain the magnitude of myocardial necrosis. In general this test is planned a
few days before patients check out the hospital. This explains why costs of this lest only
occur in time period T2 and T3. In total 235 activities arc performed which amounts to a
mean of .51 per patient (mean costs: fl. 37.07).
6.1.2. Costs of medical interventions.
Medical interventions in myocardial infarction may be distinguished into three major types.
* Drugs.
Thrombolytic therapy is a relatively new and very effective treatment in cardiology.
Administration of thrombolytic drugs within the first hours of the (suspected) infarction
leads to reperfusion of totally occluded or severely stcnotic coronary arteries. Because of
their impact on the patient's survival, severity of illness and the ensuing medical care costs,
the costs of thrombolytic therapy arc distinguished from costs of other cardiovascular
medical drugs.
V.
During the time period under study several thrombolytic drugs were administered. However,
the most common and most frequently used thrombolytic drug was 'strcplokina.se'. Other
thrombolytic drugs such as 'APSAC', 'urokinasc', 'pro-urokinasc', and 'rt-PA' were applied
less frequently. These other thrombolytic drugs may generally be considered a consequence
of specific research protocols. Alternative drugs might also have been used in case of contra-
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indications to the use of strcptokinasc. Although the costs of the different types of
thrombolytic drugs are varying considerably (strcptokinasc: fl. 557.55 and urokinase: fl.
1813.98 per dose), the costs of strcptokinasc are thought to be relevant for setting a cost-
price for thrombolylic therapy. This decision is made because streplokinase was the most
frequently used drug. Because thrombolytic therapy is only successful if administered within
about the first six hours of the infarction, almost all costs for thrombolytic therapy are made
in T-0 (appendix 10). In total 150 thrombolylic therapies arc given (almost one third of the
patients).
2.
Other drugs include Sympathoplcgic Drugs, Nitrates, Calcium Antagonists, Diuretics,
Glycosidcs, Anti-Arrhythmic Drugs, Sympathomimctic Drugs, Vasodilator Drugs, Drug
treatment of hypertension, Anti-Coagulants and Acctylsalicylic Acid. The calculation of
(hese costs is based on the cost price of daily doses for each type of drug therapy. The
accumulated costs of these drugs arc presented in appendix 11. On average 38.2 daily doses
of these drugs arc administered per patient, amounting to a mean cost of fl. 71.60 per
patient.
* Percutaneous Transluminal Coronary Angioplasty (PTCA).
ITCA is performed during the heart cathctcri/ation session. Costs of PTCA arc calculated
us extra-costs made on (op of the costs of a heart cathctcri/ation. As illustrated in appendix
12, PTCA is performed most frequently during the acute phase of the myocardial infarction;
that's why 60.9 '# of all PTCA applications arc performed in TO. The cost-price of PTCA is
II. 3677.24 and the mean costs per patient arc fl. 649.86.
• Other Medical Interventions.
Other medical interventions relevant to this study include resuscitation, a temporary
(external) pacing system and the use of an intra-aortic balloon pump. These types of
interventions in patients arc extremely rare and the cost price per intervention type tends to
vary considerably. We have decided to regard the 'other medical interventions' as a rest
category and have combined the costs (appendix 13).
6.1.3 Costs of nursing care.
Costs of nursing care arc indicated by the patient's length of stay. The mean length of stay
per patient amounts to 11.45 days (std.dcv.: 9.60). Costs of nursing care at the Coronary
Care Unit (CCH) are calculated separately. These costs arc calculated on the basis of the
total material and personnel costs of this department over the year 1988 divided by the total
number of CCU days in that year. This results in the average costs per CCU-day. It is
assumed that the average daily costs per type of patient do not differ significantly, because in
most cases standard procedures will be applied in patients with AMI. For each patient the
actual number of CCU-days is multiplied with the average costs. The costs of this intensive
nursing care arc described in appendix 14. The total number of days for the whole patient
population can be divided into 45 '*• of days at the coronary care unit and 559f of days at the
medium care unit or the 'normal' care unit. The mean costs of CCU per patient amount to fl.
1392.02 (std.dcv. 1577.40).
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6.1.4. Other Costs.
Other costs besides those of diagnostic tests, medical interventions and nursing care are
costs for physical therapy. Costs of physical therapy arc described in appendix 15. This type
of care concerns the physical rehabilitation of patients. In total fl. 11,176.93 is spent, which
amounts to a mean of fl. 24.09 per patient.
There may be other types of costs made during a patient's hospital stay that arc not
mentioned in one of the categories above. These are excluded from this study for lack of any
direct relation to AMI. These costs are sometimes related to specific and less frequent
problems involving consultation of other medical specialists, kidney dialysis etc. These
services amount to less than one percent of the total amount of services. Another important
cost category concerns physician salaries. These will however not be investigated in this
study because at the time of investigation no adequate workload measures had been
available and no allocation of time spent by physicians to patient care for the 464 AMI
patients could be made. Although the total costs of a patient's hospital stay might be
somewhat higher because some costs have been excluded, it is expected that the cost
calculation and measurement is fairly representative for the patient population ut hand.
Summary.
The costs of the patient population concerning the total hospital slay arc summarized per
category in table 6.1. As can be seen from this table costs may vary considerably per type of
medical care. The mean costs per patient arc relatively high for heart cathctcri/ation and
PTCA. Costs of laboratory services and thrombolytic therapy arc moderately high.
Extremely high costs arc made as a result of CCU-stay. In almost all categories a large
variation in costs is observed. Explanations for these differences in costs of medical care and
length of (CCU) stay will be given in chapter 7.
Table 6.1 Cost of medical care in patients having Acute Myocardial Infarction (n=464).
VariaWe
CL48
CECG
CKAD/O
CG477/
CECtfO
Cflflt/CE
CHML
crw/?OA/
C/Jflt/GS
OTCA
CO77/E/?
CPWKS
ccct/
LOS
Dpsenpf/on
Coirs 0/"/«00r«/0ry ifrv'icei
CO575 0 / £ C G Ï
CO.J/5 o/ ra<//0/o^v
Coj/i 0//ifflrr car/if rrr/zafion
COJ« 0//10/ffr ECG /MAS
C05/5 0/fc/wcflrdw^rrt/jyiy
Co5fi 0/Brucf ECG ffstó
C05/5 o/f/w//;um /f.yfi
Coi/s 0///irom/w/vf/c //if/Yj/jy
Co5/s 0/rfrugi
C0W5 o/P7"C4
C05M 0/0f/i<T iVi/frvpnf/flaj
C05/5 o/p/iyj/ca/ f/ierapy
C05/5 0 / coTOmjry cnrp
Z^njff/i 0/jfay O'/i drtyjj
A/wm/xr
5WIC«
J7274
J492
962
«57
72
4/7
206
2J5
750
77709
«2
95
///«
222S
5J/7
0/ 70fa/
CO5U
/0/.J/0J4
22,209./2
2/.J96.40
269,6/2.54
j,9»r>9.^
20,20/. 05
7,9«2.5O
/ 7,200.68
«i,6J2.5O
JJ.22J.40
J0/.5JJ.68
/4.6J/.44
//./76.9J
645,897.20
A/ra/i c0.vf.'
ptr/wi/iV/il
2/8.J4
47.86
46.//
58/. 06
».4J
4J.54
/7.2O
J7.O7
/80.24
7/.6O
649.86
J/5J
24.09
/J92.02
//.45
/«J./6
42.6^>
4 6 . / 7
750/7
25. J4
J2.76
20.58
7/./»
280.88
79./4
7424.79
257.26
J0.J2
/ 5 77.40
9.60
6<S M«uurem«/if o/nwea/r/i concepts
6.2. Severity of Illness of patients having AMI.
The patient's severity of illness was measured by observing the cardiovascular and cardiac
deficiencies as outlined in the causal model for patients with Acute Myocardial infarction
(see chapter 5.2.1). In defining the research concepts, background information was obtained
and distracted from several standard works on cardiology (Fustcr 1975, Gensini 1975,
Plotnick 1982, Braunwald 1984, Willcms 1985, Factor 1986, Gorlin 1986, Hurst 1986).
Furthermore the definitions and terminology used in this paragraph are derived from
sessions with the panel of cardiologists. The different concepts that will be operationalized
in the next paragraphs arc:
Severity of coronary stenosis (6.2.1)
Severity of myocardial ischemia (6.2.2)
Severity of myocardial necrosis (6.2.3)
Severity of ischemic pain (6.2.4)
Severity of cardiac wall motion abnormalities (6.2.5)
Severity of cardiac rhythm disorders (6.2.6)
Severity of cardiac conduction disorders (6.2.7)
Severity of heart failure (6.2.8)
Severity of physical deficiencies and specific cardiac complications (6.2.9)
We will summarize the main points of paragraphs 5.2.1. to 5.2.4. The severity of these
cardiovascular and cardiac deficiencies is opcrationali/.cd and measured by means of
specific indicators. For each indicator a severity rank order was constructed. Sometimes a
typical deficiency can be measured by a set of distinct indicators. For example, 'myocardial
necrosis' can be measured by three indicators, namely: the appearance of significant Q-
waves at the liCCJ, certain biochemical changes in the blood scrum and certain changes of
(he uptake of nuclidcs in the myocardium at nuclear cardiograph;/. In other situations a
typical cardiac deficiency can be measured by one only indicator. For example 'cardiac wall
motion abnormalities' will be assessed using cchocardiography. For deficiencies which can
be measured by multiple indicators, a separate scale, comprising a severity rank order, was
constructed and described for each indicator.
Severity of a cardiovascular or cardiac deficiency can be seen as a property or characteristic
of the heart as a whole, but it can also concern a part or a process within the heart (see
chapter 5.2.1.). Thus, the unit of observation may be differentiated into several subunits. For
example, the left ventricular wall (unit) consists of several wall segments (subunits). If
several subunits can be discerned a more precise measurement of the deficiency can be
made using the characteristics of all (relevant) subunits. Data collection of medical
deficiencies was always performed on the lowest level of measurement.
For each indicator measuring a certain cardiovascular or cardiac deficiency severity of
illness is opcrationali/.cd by three independently defined dimensions (see chapter 5.2.2.),
namely:
* the intensity of the deficiency
* the extent of the deficiency
* the location of the deficiency
The dimensions in severity of an indicator arc operationalized by attaching weights to the
scores of cardiovascular or cardiac deficiencies. The weights form a rank order of increasing
severity. The severity weights that were used were derived from professional judgements of
three cardiologists; two from the University Hospital Maastricht and one from the Catharina
Hospital Eindhoven. Independently from each other, all three cardiologists judged the
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severity of each deficiency. In case of discordance over the severity weights, each
cardiologist was confronted with the weights of the other two. The severity weights were
applied after consensus was reached between the three cardiologists.
For the patient population at hand severity-indices are constructed for each defined time
period. However, during hospital stay a patient's severity of illness is subject to changes.
Therefore, specific severity categories are established which will reflect alterations in
severity during hospital stay. The severity categories are based on the results measured by
the time specific severity indicators (TO to T3). If severity indices are measured repeatedly
during the patient's hospital stay (like ischemia measured by ECG) severity categories arc
determined representing the severity trend with respect to the patient's total hospital stay. In
case there was a large number of different severity categories, these will be categorized into
smaller numbers. If severity indices arc measured only once during the hospital slay (like
wall motion abnormalities measured by the cchocardiogram) no changes in severity can be
measured. In this case the index measured is thought to be representative for the condition of
the patient during whole hospital stay (sec § 5.2.4.).
6.2.1 Severity of coronary stenosis.
A stenosis in the coronary arteries is measured by means of coronary angiography. This is a
diagnostic method involving injection of a X-ray sensitive dye into the blood. X-rays taken
during and after the injection show the inner dimensions of the primary arteries and their
branches, outlined by the contrast medium. This test visualizes and delineates coronary
artery stenosis in terms of location, extent and degree of stenosis.
The severity of coronary stenosis depends amongst other things on the specific location of
the stenoses in a coronary artery. Cardiologists usually restrict themselves to detect stenosis
in specific parts of the artery and its branches. In the context of this study only stenoses in
the three primary arteries are thought to be relevant. The three primary coronary arteries arc:
(1) the circumflex branch (RCX) which provides normally blood to the antcrobasal, lateral,
inferior and posterior wall of the left ventricle of the heart and in some cases to the AV-nodc.
The RCX can be subdivided into five arterial segments: proximal, marginal branch, mid and
distal, posterior lateral branch and posterior dcsccndcns branch.
(2) the left anterior descending branch (LAD) which is supplying normally blood to the
septum and the antcrobasal, anterior and apical wall of the left ventricle of the heart. The
LAD can be subdivided into five arterial segments: proximal, mid, distal, first diagonal
branch and second diagonal branch.
(3) the right coronary artery (RCA) which supplies generally blood to the sinus and AV-
nodc, the right ventricular wall and a part of the inferior, posterior and apical wall of the left
ventricle of the heart. The RCA can be divided into four arterial segments: proximal, mid,
distal and posterior descendens branch.
The degree of stenosis for every arterial segment is recorded as a percentage of narrowing or
obstruction varying from 50 9F stenosis to 100 ^ stenosis (occlusion).
In acute situations, haemodynamically significant stenoses in the coronary system can be
treated by thrombolytic drug therapy or Pcrcutanous Transluminal Coronary Angioplasty
(PTCA). These treatments are performed to reduce the degree of stenosis or to remove a
specific occlusion in a coronary artery so that arterial blood flow will not be hindered
anymore. Usually these interventions will reduce considerably the severity of stenosis.
If drug therapy was applied the last scores of coronary stenosis during the heart
catheterization were taken. In case PTCA was performed two different scores were
recorded: stenosis before and after PTCA. If no intervention (drug therapy or PTCA) has
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taken place, the last score of coronary stenosis during heart cathctcrization was recorded. If
a stenosis was measured in (he Left Main Coronary Artery the severity of this type of
stenosis was recorded for both proximal LAD and proximal RCX.
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First, the weights of the degree of the stenosis were determined separately for each arterial
segment. Next, the degree of the stenosis with respect to each coronary artery and
subsequently to the coronary artery system was calculated.
If there was not a significant degree of stenosis (< 70 # ) a severity weight of '0' was given.
Patients got severity weight ' 1 ' when the degree of stenosis varied between 70 and 99 %.
The highest severity weight of '2 ' was given in case of 100 % stenosis (occlusion).
These weights were applied to measure the 'intensity of the stenosis' for each coronary
arterial segment of RCA, LAD and RCX. Empirical combinations in weighted scores over
arterial segments revealed that for every coronary artery the severity score of the stenosis
did range from 0 'no significant stenosis' to 3 'combination of occlusion in one arterial
segment and significant stenosis in another arterial segment'. The scores of the 'intensity of
stenosis' per artery (0-3) were again aggregated into one overall severity score by adding the
individual stenosis /.-scores of the three primary arteries (ranging from -1.00 thru 3.00).
Stenosis /.-scores were used because the number of arterial segments varies per primary
artery. The sum of the /.-scores represents the degree of stenosis with respect to the coronary
artery system.
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The severity categories were based on scores after PTCA was performed. Because PTCA is
performed during the same cathetcri/ation session the score after PTCA was assumed to be
relevant for measuring the severity of coronary stenosis. From the patient population at hand
only 182 patients were calhctcri/cd (119 patients only once and 63 patients twice). Thus a
actual changes in severity of the degree of coronary stenosis could only be measured for the
63 patients. For the remaining group of patients the single 'intensity' score was used. It is
presumed that the degree of the stenosis measured by this single indicator was representative
for the stenosis condition during the whole hospital stay.
Six severity categories based on the degree of coronary stenosis were distinguished (table
6.2.). In total 39 patients had 'no' (n=23) or 'decreasing to no significant coronary stenosis'
(n=16). The majority of the patients had significant stenosis varying from low degree of
stenosis (n=20) to moderate stenosis (n=37) and highly severe stenosis (n=57). For 29
patients the degree of stenosis did increase during hospital stay.
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Table 6.2 Severity categories
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Extent measures the spread of stenosis within the coronary artery system. The extent of
stenosis comprises the number of coronary arteries with any kind of stenosis, regardless the
degree and the specific location. If no significant stenosis (< 70 9f) is present in any of the
three arteries, patients received severity weight '0' . If a significant stenosis is present in only
one artery patients get severity weight ' 1 ' . If there were two arteries present with a
significant stenosis patients get severity weight '2 ' . The highest severity weight of '3 ' is
given to patients who had a significant stenosis in all three primary arteries.
The same rules are applied that arc used for the severity trends concerning the intensity of
stenosis. The extent is distinguished into 5 severity categories (table 6.3.). Most patients
(n=82) had significant stenosis in only one artery, in 42 patients stenosis was present in two
arteries and in a small group of 20 patients three arteries showed stenosis.
Table 6 J Severity categories describing the extent of coronary stenosis.
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It is generally assumed that the location of stenosis (or occlusion) in a coronary artery is
important, when one is interested in measuring the severity of this deficiency. It stands to
reason that a stenosis in the beginning (proximal segment) of an artery will reduce or
obstruct the blood supply over a larger area than when a stenosis occurs at the end (distal
segment) of an artery. Therefore each arterial segment is given a severity weight. The
severity weights were determined with the help of the panel of cardiologists, who used
mortality risk as one of the principal criteria. The severity weights for the location of
stenosis arc given in table 6.4.
Table 6.4 Severity weight* for the location of coronary stenosis.
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First, the severity for each coronary artery is calculated by taking the highest severity weight
occurring within the artery. Il is expected that the highest severity weight within the
segments of an artery is sufficient lo indicate the severity of the stenosis of (hat artery. Next,
the location based severity score with respect to the stenosis concerning the overall coronary
artery system is obtained by taking the sum of ihc individual segments scores. Theoretically
this lotal score may vary between 1.5 - 19 for each patient. The total score for a patient will
give the overall severity based on the location of the coronary artery stenosis.
The scores of ihc location of coronary stenosis were recoded into six categories (table 6.5.).
The largest category of patients has stenosis in minor (n=50) or moderately severe locations
(n=43). About 30 patients show significant stenosis in severe locations and 21 patients have
stenosis in highly severe locations.
Table 6.5 Severity categories describing the location of coronary stenosis.
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6.2.2. Severity of myocardial ischemia.
The etiology underlying myocardial ischemia can be regarded as the discrepancy between
the myocardial need for oxygen and the amount of oxygen in the blood delivered to the
myocardium via the coronary arteries. Different indicators to measure the severity of
myocardial ischemia are presented in the model below.
severity of myocardial ischemia
severity based
on electrocardiographic
st-changes at rest
severity based
on electrocardiographic
st-changes
during exercise
severity based
on reversible
thallium changes
6.2.2.1. Severity based on electrocardiographic ST-changes at rest.
When myocardial ischemia is present this can be detected by elevation or depression of the
ST-scgmcnt (henceforth ST-changc) in several leads of the ECG. ST-changcs in distinct
leads arc an indication for the location and the cxlcni of the ischemic segments of the
myocardium. ST-changcs arc recorded separately for the following left ventricle wall
segments: anterior, septa], lateral, posterior and inferior . The wall segments scores arc
distinguished into: (0) no ST-scgmcnt changes and (I) significant ST-scgmcnt changes (a ST
elevation or depression with a sum of at least 3 mm.) indicating myocardial ischemia.
Because of this rather crude dichotomy the intensity of ihc ischemia in the Icfl ventricle
cannot be calculated.
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The number of ischemic wall segments according to ST-changcs arc used to construct a
severity index. When ischemic wall segments or no ST-changcs arc present patients arc
given severity weight '0 ' . If ST-changcs correspond with only one wall segment or two
adjacent wall segments, it is likely that myocardial ischemia is occuring in a rather small
area, so a severity weight of ' 1 ' is given. If patients have three wall segments according to
significant ST-changes, they get severity weight '2 ' . The highest severity weight of '3 ' is
given to patients with ST-changcs corresponding with four or five ischemic Icfl ventricular
wall segments.
significant ST-segment changes are defined as ST elevation or depression wiih a sum of at least 3 mm.:
Sejxal: ST-changes in leads VI-V2
Anterior: ST-changes in leads V2-VS
Lateral: ST-changes in leads 1, AVL. V6
Posterior : ST-changes in leads VI, V2 and T-wave changes in leads VI, V2
Inferior: ST-changes in leads II, III, AVF.
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Ten different severity patterns could bc discerned (table 6.6.; a to j). Only a few patients had
no ST-changcs at all, or their ST-changcs on admission (TO) disappeared subsequently (n=
25); these severity patterns arc combined in one category with weight '0' . A large group of
patients (n=187) had consistent ST-changcs corresponding with one or two wall segments;
they form one category with weight ' 1 ' . Patients with consistent ST-changes corresponding
with three or more wall segments (n=210) were put together in the category with weight '2 ' .
The three different patterns of increasing ST-changes concerning 40 patients are combined
into the category with weight ' 3 ' . This category also includes a small heterogeneous group
of five patients with increasing as well as decreasing ST-changcs. Eventually four different
severity categories can be distinguished on the basis of the extent of ST-changes measured
by the ECG at rest.
Table 6.6 (Combined) Severity patterns and categories describing the extent of ST-changes
during the total hospital stay measured by ECG at rest.
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A distinction must be made between ST-changcs in the anteroseptal wall segments and those
in other wall segments in the left ventricle. ST-changcs in the anteroseptal wall segments are
assumed to be more severe. Therefore patients with ST-changcs in leads VI - V2 will get a
severity weight '2' in comparison to patients with ST-changcs in other leads, who get M'. If
no ST-changcs were present patients receive a severity weight of '0*.
75
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There appear to be seven different patterns in the location of ST-changes during hospital stay
(table 6.7.; a to g). Patients with no ST-changcs at all or disappearing ST-changcs during
hospital stay (n=23) are combined in one category with weight '0' . Patients with consistent
or increasing ST-changcs in non-antcroscptal leads (n=28O) arc put together in the category
with weight ' 1 ' . Patients with consistent antcroscptal ST-changcs (n=150) all remain in one
category with weight '2 ' . Patients with increasing ST-changcs from non-antcroscptal to
antcroseptal during hospital stay (n=9) were put into a higher severity category (3).
Eventually four different severity categories arc distinguished based on the location of ST-
changes measured by the ECG at rest.
Table 6.7 (Combined) Severity patterns and categories describing the location of ST-vhange.s
during the total hospital stay measured by FXG at rest.
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6.2.2.2. Severity based on electrocardiographic ST-changes during
exercise.
Myocardial ischemia can also be detected by ST-changcs during exercise. The exercise test
(according to the so-called Bruce-protocol) is designed to gauge the functional capacity of
the heart. The basis of this test is the increased myocardial oxygen consumption caused by
exercise. The Bruce test is performed normally just before a patient's discharge from
hospital. During the course of a progressive increase in exercise load the patient's
electrocardiogram is monitored for evidence of additional myocardial ischemia.
Results of the Bruce test are measured by (a) typical ST-changes in the ECG (b) the level of
exercise load and (c) the absence/presence of ischemic pain during the test. Results of the
ECG-findings are recorded into: (0) no typical ST-changcs and (1) presence of typical ST
changes. Also the highest achieved level of exercise load is recorded (ranging from I 'low
effort' to 5 'very high effort').
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To measure severity of myocardial ischemia during exercise even four dimensions are
assumed to be important. The scale representing these four dimensions are the intensity,
extent and location of myocardial ischemia plus the degree of additional ischemia compared
to the necrotic zone.
This dimension refers to the presence or absence of ST-changes in and outside the necrotic
/.one and to the highest exercise load reached by a patient while being tested. The ST-
changes arc measured at the maximum degree of exercise load when ST-changes occur. It is
to be expected that ST-changcs occurring during a low exercise load are more severe then
during a high exercise load. First a distinction was made into patients with no ST-changes
during any kind of exercise load (severity weight '0') and patients with ST-changes. The
latter were further distinguished into severity groups according to their maximal level of
exercise load reached during the Bruce test. Only few patients endured an exercise load of
stage 4 and 5; since these form adjacent categories they arc given the same severity weight
of ' I ' . Patients with ST-changcs occurring during an exercise load at stage 3 and stage 4 arc
respectively given severity weights '2 ' and ' 3 ' . The highest severity weight is given to
patients with ST-changcs enduring a minimum of exercise; they were given severity weight
'4'. The number of patients in each severity category arc presented in table 6.8.
Table 6.8 Severity categories describing the intensity of ST-changes during exercise.
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It is assumed that the severity of ischemia during exercise increases when patients have
ECG-lcads which show ST-changcs. The number of ischemic wall segments according to
ST-changcs is used to develop a severity scale. When no ischemic wall segments are present
the severity weight '0' is given to the patients. If patients have one or two ischemic wall
segments, severity is assumed to be about equal and they are given severity weight ' 1 ' .
When three ischemic wall segments arc suspected according to the ST-changes the given
severity weight is '2' and patients with four ischemic wall segments are categorized into
severity group '4' . There arc no patients with ST-changcs in all five wall segments in our
population. The number of patients in each severity category is presented in table 6.9.
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Table 6.9 Severity categories describing the extent of ST-changes during exercise.
S«rnr> category
0 no S7"-cn</ng« 70
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2 ST-cVianges in J HÏJ// .vfgmfnw 2/
1 ST-c/uifign in 4 na// srgm<*nM 7
5«/>fo/a/ o/ nr/minf cases 20J
26/
¥65
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If ST-changes corresponding with the antcroscptal wall segments of the left ventricle arc
present it is assumed that the condition of those patients is more severe. Patients wilh
'antcroseplal' ST-changcs arc given severity weight '2' . in contrast to other patients which
arc given severity weight ' 1 ' . If no ST-changcs were present the severity weight is '0 ' . The
number of patients in each category is presented in table 6.10.
Table 6.10 Severity categories describing the location of ST-changes during exercise.
category DMcr/p/ion
0 no 57-c/wngM 70
2 ante/meow/ 5T-t7wng« JJ
S«»fofa/ o/ rr/n'anf cases 20J
iV//5sing cases 26/
7bfa/
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One of the specific purposes of applying a Bruce test is to detect the presence of additional
ischemia, on top of the ischemia at the nccrotic zone. To measure the severity of additional
ischemia, results from the ECG at rest are used together with results from the ECG during
exercise. The nccrotic zone is identified using typical Q-wavcs in the ECG at rest (sec §
6.2.3.). A distinction is made between four severity categories with different severity
weights for additional ischemia. Patients with no ST-changcs arc again given severity weight
'0'. If ST-changes appear only in the leads with Q-wavcs, a severity weight of ' 1 ' is given. If
patients had ST-changcs in the leads with Q-wavcs plus in the leads with no Q-wavcs or if
ST-changes exclusively occur in the leads with no Q-wavcs, additional ischemia is
suspected, and the patient is given severity weight '2' . The majority of patients who had no
Q-waves at all during hospital stay (n= 56) had no exercise ECG and were classified as
missing cases (n= 35). Of the remaining patients who had no Q-waves at all, 11 patients had
no ST-changes during exercise and in 10 patients ST-changcs were present; they arc
classified in severity category '2 ' . The number of patients in each category is presented in
table 6.11.
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Table 6.11 Severity categories
myocardial necrosis.
Srvrnïy caffflofy
0
2
.WJ/OM/ o/ rv/rwi/i/ CUJM
M/.v.ring cos»
describing additional ischemia during exercise
D<>scr/p»ion f n
m» 5T-cnan^«
•ST-c/wnflM on 5rtm<> /ocflf/on
57"-c/wngf5 on rome «nrf a^/riomi/ /oca/ion
or 57-c/wn^w on/y on arfW/7/ona/ Jocaf/on
compared to
?^«<"nci>5
70
87
20J
26/
6.2.2.3. Severity based on 'reversible thallium changes'.
Thallium outlines cardiac locations with reversible and non-revcrsiblc myocardial ischemia.
Particularly during exercise, the nuclidcs 'decrease' in ischemic zones and 'increase' in non-
ischemic /ones. These ischemic /ones arc visualized by a reduced nuclear activity during
exercise followed by a normal nuclear activity after exercise (so-called redistribution). The
thallium test is performed normally just before a patient's discharge from hospital.
According to the thallium test the left ventricular wall can be subdivided into seven wall
segments: scptal, anterior, apical, lateral, posterior, inferior and basal. For each wall segment
the scores (0) which means no thallium changes present at all, or (1) which stands for
(partially) redistributed thallium changes arc recorded.
From u clinical point of view a distinction has to be made between partial redistribution and
complete redistribution. 'Complete redistribution' means that the cardiac area was
cncounlcrd by acute reversible myocardial ischemia; partial redistribution means that the
cardiac area may be injured by 'subacutc' reversible myocardial ischemia or myocardial
necrosis. However, only few patients in our population showed partially redistributed
thallium.
It is assumed that the severity of myocardial ischemia increases, if more wall segments show
typical thallium changes. The extent of reversible thallium changes is measured by the
number of wall segments with thallium changes. If no thallium changes occurred then
patients are given severity weight "()'. Patients with thallium changes in one or two wall
segments arc considered to be about equal as far as severity is concerned and arc given
severity weight ' 1 ' . Patients with thallium changes in more than two wall segments did not
occur in our data. The number of patients in each category is presented in table 6.12.
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Table 6.12 Severity categories describing the extent of reversible thallium changes.
5cv«-nry category DMcn/Wion FnrfurnriVf
0 no nrirrrifrte f/ia//('um c7wnj>« 67
ƒ rrv*rs/Wc r/ui//ium c/umg» in / or 2 HYI// /9
86
M««'ng C O J « J78
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As was mentioned before it is assumed that myocardial ischemia in the antcroscptal wall of
the left ventricle has a more severe prognosis than in other wall segments. If no reversible
thallium changes arc present, patients are allocated to the lowest category with severity
weight ' 0 ' . When reversible thallium changes arc present in anterior, scptal or apical wall
segments, patients get the highest severity weight of ' 2 ' , in comparison to patients with
thallium changes in the other four wall segments who receive severity weight ' I ' . The
number of patients in each category is presented in table 6.13.
Table 6.13 Severity categories describing the location of reversible thallium changes.
Sf vrnry category Dr5cn]prion
ƒ irvmifrte r/ia//ium c/iang» no«-a/iten>jrp- /6
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6.2.3. Severity of myocardial necrosis.
Myocardial necrosis is generally caused by thrombotic occlusion of coronary arteries. The
location and the extent of the infarction will depend on the anatomical structure of the
arteries, the site of current and previous occlusions and the adequacy of the collateral
circulation. Acute myocardial necrosis is characterized by irreversible injury of the heart
muscle. The severity of these irreversible changes is very important with respect to the
remaining ventricular function. Several techniques can be used to measure the heart's
irreversible damage. Among the techniques of observation used by cardiologists, results
from electrocardiograms, laboratory tests and thallium tests are supposed to be primary
guidelines in specifying and detecting the severity of myocardial necrosis.
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6.2.3.1. Severity based on electrocardiographic Q-waves.
The electrocardiogram (ECG) is a graphic record of the electrical currents generated by the
heart. The ECG can show which portion of the heart has probably been damaged. It
measures to a certain extent the magnitude of the damage. Specific ECG characteristics for
myocardial necrosis arc most frequently the disappearance of the so-called R-wavc and the
formation of the so-called Q-wavc. These Q-wavcs arc not always present at the moment of
admission but can develop within several hours. Q-waves on the ECG give an indication of
presence as well as location of myocardial necrosis.
Characteristic Q-\vavcs on the ECG arc collected for each time period. If more than one
ECG was performed in one period, the one most deviant from the normal situation is
considered to be relevant. The nccrotic wall segments of the left ventricle, observed by the
ECG, can be distinguished into: scplal, anterior, lateral, posterior and inferior'.
The results of the ECG interpretation were used to distinguish the characteristic Q-waves in
each group of leads, corresponding with each wall segment into: 0: no characteristic Q-
wuves and 1: Q-wavcs indicating necrosis.
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Necrosis extending over more than two wall segments is assumed to be more severe than
necrosis restricted to one or (wo wall segments. Although the extent of necrosis is difficult
to measure using ECG, its data arc often used to predict to some degree the magnitude of
necrosis. In this study extent refers to the number of wall segments with typical Q-waves. It
is assumed that severity of myiKurdiul necrosis will increase when Q-wavcs arc found in the
ECG leads representing more wall segments.
If no Q-waves arc present patients get a severity weight of '0 ' . Patients with Q-wavcs
corresponding with one or two wall segments arc considered to be equivalent as far as
severity is concerned: they arc given a weight of T . If there arc three or four (or five) wall
segments with Q-wavcs, a severity weight of respectively '2' and '3 ' is given.
Typical Q-wavcs are defined:
Serial Q-wavcs in leads V1-V2 (V.I)
Anterior: Q-wavcs in leads V2-VS
1 «Herat: Q-waves in leads I. AVI.. Vft
IVslcrior: lnvcrsed Q or high R-waves in leads VI. V2 and T-wave changes in VI. V2
Interior: Q-wavcs in leads II. III. AVI'.
A/mrun?mrnf o/ /we a/rA «wc/ptt
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As far as the extent of necrosis determined by significant Q-wavcs in the left ventricle is
concerned, there appear to be four different severity categories in the patient population ut
hand (see table 6.14.). Patients with no significant Q-wavcs present during the total hospital
stay are grouped into one category with severity weight "O": the number of patients in this
category is 56. Most patients (n=331) have consistent Q-waves corresponding with 1 or 2
wall segments with no changes during hospital stay; they form the second category with
severity weight ' 1 ' . Patients with consistent Q-wavcs corresponding with three wall
segments (n=46) and patients with increasing Q-wavcs in wall segments (n=29) arc grouped
into one category with severity weight '2 ' . Q-wavcs corresponding with four or five wall
segments do not occur in the population. In total three severity categories representing
myocardial necrosis are distinguished based on the extent of significant Q-wavcs measured
by the ECG at rest.
Table 6.14 (Combined) Severity patterns and categories representing the extent of Q-waves
during the total hospital stay measured by ECG at rest.
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A separate severity indicator is constructed which refers to the location of necrosis in the
myocardium. It is assumed that Q-wavcs corresponding with the antcroscptal site will be
more severe than in the other sites of the left ventricle. If no Q-wavcs arc present, these
patients are given severity weight '0' . In case Q-wavcs are present corresponding with non-
anteroseptal wall segments, patients receive severity weight ' 1 ' . Patients with Q-wavcs
corresponding with the anleroseptal wall segment arc given the highest severity weight of
Sever/fy g
The severity of myocardial necrosis measured by the location of Q-waves during hospital
stay can be represented by three different categories (table 6.15.). Once again patients with
no significant Q-wavcs during stay (n=56) form one category and arc given severity weight
'0' . Patients with consistent non-antcroscptal Q-wavcs (n=275) form a second category with
severity weight ' I ' . Patients with consistent anteroscptal Q-waves (n=122) and patients with
a deterioration from non-antcroscptal to antcroseptal Q-waves in a later phase of the stay
(n=9) are brought together in one category with severity weight '2 ' .
Table 6.15 (Combined) Severity patterns and categories representing the location of Q-waves
during the total hospital stay measured by ECG at rest.
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6.2.3.2. Severity of myocardial necrosis measured by enzyme changes in
the blood.
When heart muscular cells die, typical cellular enzymes arc secreted into the blood. Within
the fust days of a myocardial necrosis there will be an abnormal rise of these enzymes in the
blood. After several days the enzyme release will return to its normal level. The enzyme
release can be detected through laboratory analysis of the blood. The enzymes most
commonly analyzed arc Scrum Glutamic Oxalacctic Transaminasc (SGOT), Lactic
Dchydrogcnasc (LDH) and Creatine Phosphokinasc (CPK). The enzyme release during the
course of the infarction can often be used to estimate the size of the infarction. However, not
only the value of enzymes but also the time-span in hours in which these enzymes 'peak' is
an important indicator of the severity of myocardial necrosis.
For ull patients the following data have been recorded for each time period of their stay:
hours of pain
- SGOT-value
- SGOT-pcak value time
- CPK-valuc
- CPK-pcak value time
- LDH-valuc
the duration of ischemic pain from onset of pain to the hospital
admission;
the highest SGOT-valuc measured in a time period;
the time in hours after which the SGOT-pcak is reached,
measured from the moment of hospital admission;
the highest CPK value measured in a time period;
the time in hours after which the CPK-pcak is reached.
measured faim the moment of hospital admission;
the highest LDH-valuc measured in a time period; the lime in
hours to reach the LDH peak is considered to be of less
importance as far as severity of necrosis is concerned.
The mean duration of ischemic pain from onset of pain to the admission at the hospital is
approximately four hours, but looking at the median, most patients have only one or two
hours of pain. The mean time after which an enzyme peak is reached in hospital, is 20 hours
for SGOT and 18 hours for CPK.
Since the enzyme release pattern can differ for certain types of patients, for each type a
different approach to data analysis must be taken. Our research population can be
distinguished into:
1. patients with acute myocardial necrosis whose enzyme peak is reached during (he
acute phase (T-0);
2. patients with acute myocardial necrosis whose enzyme peak is reached within
three days (T-l); this is the common pattern (sec figure 6.16);
Figure 6.16. Enzyme release pattern in patients with acute myocardial necntsis measured by a
peak in T-l.
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3. patients with acute myocardial necrosis whose enzyme peak is reached after three days
(T-2);
4. patients with recurrent myocardial necrosis show in general two enzyme peaks, one in
the first part of the stay and another caused by a second increased enzyme release (sec
figure 6.17);
Figure 6.17. Enzyme release pattern in patients with recurrent myocardial necrosis measured
by peaks in T-l and T-2.
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5. patients with subacutc myocardial necrosis (necrosis happening just before admission
to the hospital) who have an enzyme peak just before hospital admission (see figure
6. IX).
Figure 6.18. F.nzyme release pattern in patients with subacute myocardial necrosis measured
by a peak before admission.
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A generally accepted rule in cardiology (De Zwaan c.a.. 1988) is that the highest enzyme
peak value during stay times the time-span in hours to reach this peak will give an indication
of the total amount of enzymes released during the phase of development of necrosis. If the
total amount of cn/ymes increases, the infarct-sizc and severity of necrosis is assumed to
increase. So. to measure the severity of necrosis based on enzymatic changes, the following
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general rule is applied; an area measure is calculated multiplying the highest enzyme value
during stay with the time in hours after which the peak was reached from the very first
moment the patient is complaining of typical ischemic pain.
Because of the different types of enzyme curves, it will be necessary to adapt this general
rule to more specific situations. A further description of constructing the SGOT-arca index is
given below.
If the enzyme peak falls in time periods T-0 or T-1 the following formula is applied:
SCOT area measures the highest SGOT-value during hospital stay (SGOTV) * (pain
before admission in hours (PBA) + the time in hours until the SGOT-peak is reached
starting from the moment of admission (SGOTT)).
If the enzyme peak falls in time period T-2 or T-3, the formula was shortened to: SGOT=
SGOTV * SGOTT. It is assumed that if the enzyme peak occurs after 72 hours, the duration
of pain before admission (PBA) is evidently irrelevant.
If patients have enzyme values below or equal to their so-called normal value, they arc
expected to have no necrotic abnormalities. Therefore, all enzyme values have to be
corrected by their normal values. This implies that in both formulas described the SGOTV
has to be replaced by: (SGOTV minus 'normal' value). If the cn/.ymc scores arc below this
standard, the calculated area measure is set to zero: no significant enzyme release. If a
negative area measure is obtained, the patients concerned also receive a zero value. Mean
'normal' enzyme values, that are used in our analysis arc: SGOT: 20 U/l, CPK : 90 U/l and
LDH :250 U/l.
If a patient is also suffering from liver disorders certain types of enzymes arc expected to be
unspecific to predict the severity of myocardial necrosis. The enzymes SGOT and LDH, arc
particularly influenced by liver disorders. The presence and amount of cell destruction in the
liver is specifically measured by the enzyme called Serum Glutamic Pyruvatic Transaminasc
(SGPT). If the SGPT-score is higher than 100 U/l, the SGOT and LDH scores arc considered
to be unreliable: consequently eacht type of enzyme measure is considered as missing for
these patients.
The same formula is applied if patients have recurrent necrosis during their hospital stay
(n=l 1). The duration of the second enzyme peak then starts from the moment that the patient
experiences heavy ischemic pain for the second time during hospital stay and ends when a
second enzyme peak is reached. Two area measures could be calculated but the latter is used
as the most relevant.
Missing data.
In applying the rules above, we did encounter considerable problems with regard to musing data. The duration
of ischemic pain before admission to the hospital was unknown (i.e. lacking in the medical record) for 121 of
the 464 patterns (26 %). Another problem concerns patients with so-called subacute infarction whose enzyme
peaks are unavoidably underestimated because they had their enzyme peak before hospital admission. If one or
more scores in the formulas were missing, the patients concerned are generally excluded from further data
analysis. To minimize this loss of cases, theoretical values have been substituted for missing data. In three
specific instances substitution of theoretical values for missing data has taken place:
Patients with unknown duration of ischcmic pain before hospital admission, while their peak value lime was
known. In this situation the mean duration in which an enzyme peak is normally reached (24 hours in case of
S(KJT and 20 hours in case of CPK) has been substituted for the total peak value lime (including duration of
ischcmic pain).
Patients, with an unknown peak value lime, while the duration of iscbemic pain before hospital admission was
known. For a large part this concerned patients with a subacule infarction, who on admission already had the
highest enzyme score. In case an cn/.ymc peak is reached in period T-0, a period of 4 hours is substituted for the
unknown peak value lime, because it is expected that the first laboratory results would be available by that time.
In some cases the duration till the enzyme peak is reached in T-l was unknown; the total duration is then
substituted using the same rule as described for the situation above.
Patients with both unknown duration of ischemic pain and unknown peak value time. If both variables were
unknown and the cn/ymc peak occurs in T-0 or T-l. the same rule as described above is applied for the total
time period concerned.
Substitution of theoretical values for missing data could imply that the reliability of the severity-indices is
affected, certainly in the cases of patients with a sub-acute infarction. ()n the other hand, the number of patients
included in analysis is salvaged as much as possible and the severity-indices may have become more
representative In order to study the effect of the substitution, the severity indices in both instances (missing data
excluded and included) have been calculated. Correlations between the three enzyme severity-indicators did
Increase somcwhiil (especially in T-0) due to the inclusion of patients with substituted data. Comparing the
outcome of both versions it was concluded that the inclusion of the theoretic values docs no substantially harm
to the original means and standard deviations. Thus, more patients could be included in subsequent analyses.
I Tic cn/.ymc release with Inclusion of theoretical values will henceforth be used.
The cn/.ymc release is u reliable and oficn used measure for the patient's severity of
myocardial necrosis with respect to his or her hospital stay. Therefore, this measure is taken
as an indicator for the severity of myocardial necrosis. If the enzyme peak falls in period TO
then (he area measure of TO is taken, if the enzyme peak falls in Tl the area measure from
Tl is taken and so on. An exception is made for patients with u recurrent infarction while in
hospital. For these patients (n= 12) the cn/.ymc output can rise again and a change in
severity of necrosis measured by enzyme values will then be relevant. For these patients the
cn/.ymc release of the first infarction is taken and the second infarction is seen as a
complication; a separate variable is constructed which distinguished patients who have a
recurrent infarction while in hospital from patients who have only one infarction. The three
types of cn/.ymc release for the patient population at hand arc presented in tables 6.19-21.
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Table 6.19 Severity categories indicating myocardial necrosis estimated by total SGOT-release.
Description Fm"^«enci«
0 no sign. SCOFcnanges 2
ƒ < / 5flO f t//7 */iours; 8 i
2 7500 - JOOO (t//7 * /tours; 84
1 J000 - 6000 ((//? * «ours; 96
4 6000 - 9000 f (7// * «ours; 46
5 9000 - 72000 f (7/7 * /lours; 28
6 >/2OO0(l//7*/iours; 78
Su/wora/ o/ n?/evanr cases J57
Aftssing cases 707
7bw/ 464
Table 6.20 Severity categories indicating myocardial necnisis estimated by total CPK-releasc.
Severity caregory Description Frr^Mrncief
0 /io sig. CT'/C c/w/tges 9
2 /0O00 - 20000 f LW * «ours; 74
1 20fWf;-40000 ((/// */io«rs; 706
4 4ooor; - ófjoor; f t//7 * /wwrs; 60
5 > 60000 f 1//7 * /lours; 56
5«/>fom/ o/ n?/pvanf cases J90
Af i'sA7';ig cases 74
464
Table 6.21 Severity categories indicating myocardial necrosis measured by the LDII-peak
during stay.
Severity caregory
0
2
i
4
5
Sufcrora/ o/ne/evanr cases
Af iss/ng cases
D«crv»lto«
no sign. LD// c/w
700-/400 f(//7;
7400-2/00 ft///;
2/00 - 2*00 ft///;
>2*oof(//z;
7J0
54
20
70
408
56
7bra/ 464
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6.2.3.3. Severity of necrosis measured by 'irreversible thallium changes'.
Another method to measure myocardial necrosis is the so-called thallium test (see also §
6.2.2.3). In nccrotic parts of the heart the thallium uptake is severely reduced compared to
other parts. Irreversible thallium changes located by 'dark spots' measure myocardial
necrosis or sometimes severely injured tissue which possesses a longer lasting recovery
time.
Scores on the thallium test for each wall segment are: (0) no irreversile thallium changes and
(1) presence of irreversible thallium changes.
It is assumed that severity of myocardial necrosis will increase, if irreversible thallium
changes arc extended over more wall segments. The number of wall segments with
irreversible thallium changes is used as an indicator for the extent of myocardial necrosis.
The number of wall segments with irreversible thallium changes is connected with a severity
weight. If no irreversible thallium changes arc present, a severity weight of '0' is given. In
case one or two wall segments have irreversible thallium changes, severity is assumed to be
equal and patients arc given a severity weight of ' 1 ' . When three or more wall segments
show irreversible thallium changes, severity is expected to be high and those patients are
given a severity weight of '2' . The number of patients in each severity category is presented
in table 6.22.
Tuhle 6.22 Severity categories describing the extent of irreversible thallium changes.
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This indicator refers to the location within the left ventricle where irreversible thallium
changes may be observed. As discussed before, it is assumed that myocardial necrosis
present in the untcroscptal wall segment of the left ventricle is more severe than when
present in other wall segments. A severity indicator is constructed to measure the severity of
irreversible thallium changes based on their location in the left ventricle. If no irreversible
thallium changes arc present these patients arc given a severity weight of '0' . Patients with
irreversible thallium changes in the antcroscptal wall segment are given a higher severity
weight (severity weight of "2") than the remaining patients (severity weight of T ) . The
number of patients in each severity category is presented in table 6.23.
Table 6.23 Severity categories describing the location of irreversible thallium changes,
category
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6.2.4. Severity of ischemic pain.
Patients with myocardial ischemia often exhibit prolonged chest pain. Usually, patients with
myocardial infarction will experience severe typical pain in the precordial area and radiation
to the left shoulder and arm. In some cases the pain will be absent or minor and will be
overshadowed by the symptoms of acute complications. The presence or absence of typical
ischcmic pain is measured for each time period. Subsequently, a trend in ischcmic pain is
distinguished in the following way (sec table 6.24.): patients with no ischcmic pain during
the entire hospital stay arc grouped in severity category '0' (n=55); patients suffering from
ischcmic pain only during the acute phase of the stay (TO and Tl) arc grouped in severity
category ' 1 ' (n=307). Patients with (prolonged) ischcmic pain during the acute phase of the
stay as well as later on during hospital stay (T2 or T3) are grouped in severity category '2'
(n=95).
Table 6.24 Severity categories describing ischemic pain during stay.
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6.2.5. Severity of cardiac wall motion abnormalities.
Due to myocardial injury abnormal wall motion in the cardiac wall segments can occur. The
cardiac wall motion is measured usually by echocardiogram. Impaired contraction of
specific cardiac segments can be monitored and distinguished, by this technique. Mildly
injured zones lose part of their ability to contract (hypokinctic segments). Severely injured
segments may fail to contract (akinetic segments) or can bulge in opposite direction
(dyskinetic segments). So, abnormal cardiac wall motion can affect the heart's pumping
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performance (cardiac function: sec § 6.2.8).
By means of echocardiography it is possible to visuali/.c the contractile pattern of the seven
left ventricular wall segments: scptal. anterior, lateral, posterior, inferior, basal and apical.
For each wall segment, four types of wall motion abnormalities are distinguished:
0 : No wall motion abnormalities;
1 : Hypokinctic abnormalities: reduced wall motion;
2 : Akinetic abnormalities: absence of wall motion;
3 : Dyskinctic abnormalities: paradoxical wall motion;
• //iff/i.tt7y «ƒ cardVac tva// /
The intensity (or degree) of left ventricular wall motion abnormalities is measured by the
type of scgmcntal wall motion abnormalities. It is obvious that if no wall motion
abnormalities arc present, patients arc categorized in the lowest severity group of '0 ' .
Hypokinctic deviations arc assumed to be less severe; patients with only this type of wall
motion abnormality arc also grouped in severity category '0 ' . Akinetic or dyskinetic
deviations arc assumed to be more severe. Patients with cither akinetic or dyskinctic or both
wall motion abnormalities arc assumed to be equal as far as severity is concerned; they are
grouped in severity category ' 1 ' . The number of patients within each severity category is
presented in table 6.25.
Tnble 6.25 Severity patterns and categories describing the intensity in cardiac wall motion
abnormalities during total hospital stay.
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The extent of wall motion abnormalities refers to the number of wall segments with any kind
of wall motion abnormality. As mentioned above, seven wall segments are distinguished and
il is assumed that the severity of abnormal wall motion would increase when the number of
wall segments with abnormality increases. If no wall motion abnormalities arc present
patients will get a severity weight of"()'. Patients with wall motion abnormalities in one or
two wall segments arc considered to be equivalent as far as severity is concerned . They get
a severity weight of ' 1 ' . If there arc three or four wall segments with wall motion
abnormalities, a severity weight of ' 2 ' , respectively ' 3 ' is given. Patients with wall motion
abnormalities in five wall segments arc given a severity weight of ' 4 ' . Due to small
numbers, patients with wall motion abnormalities in six or seven wall segments are rccoded
into the same category group and obtain a score of ' 5 ' . The number of patients in each
severity category is presented in table 6.26.
M«isiwn«i/ of /««vrrt concr/Ms
Table 6.26 Severity categories describing the extent of cardiac wall motion abnormalities
during total hospital stay.
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This severity dimension refers to the expected vulnerability of any kind of abnormality in
the left ventricle. As discussed before abnormalities in the antcroscplal segments arc thought
to be more severe than abnormalities in the other segments, regardless of the extent or the
intensity (degree) of kinetic abnormalities. Patients with antcroscptal wall motion
abnormalities are placed in a higher severity category with a severity weight of '2 ' . Patients
with wall motion abnormalities in other segments of the left ventricle arc given a severity
weight of ' 1 ' . Patients with no wall motion abnormalities at all arc given a severity weight
of '0' (table 6.27.).
Table 6.27 Severity categories describing the location in cardiac wall motion abnormalities
during total hospital stay.
aiffgory I>MtTi/>fion Fflfguwic/M
0 no WYI// morion «/>no/7mi//ri>.s 22
/ non-f!nr?m.f<y?M/ HYI// morion «/wiorm/i/inVi /65
2 anffrosp/Mtf/HYI//morion a/wio/rna/ifiM /29
i/6
Af using casM /48
Tow/ 464
6.2.6. Severity of cardiac rhythm disorders.
Patients with myocardial infarction arc vulnerable of getting sudden, unexpected
disturbances in heart rhythm. A cardiac arrhythmia is defined as a deviation of the 'normal'
rhythm of the heart. Rhythm disorders are usually recognized by specific ECG-
abnormalilies. Both, myocardial ischemia as well as myocardia! necrosis can cause rhythm
disorders. Rhythm disorders may be present within the normal pacemaker cells in the sinus
node or AV node, in parts of the conduction system or in the remaining tissue of the atria
and ventricles.
For every hospital period five types of cardiac rhythm disorders were recorded (see table
6.28) as (0) not present and (1) present.
S^vtWry
Each type of cardiac rhythm disorder is given a severity weight representing the seriousness
of the rhythm disorder with regard to morbidity and mortality. It is assumed that the severity
of particular cardiac rhythm disorders will differ depending on time of occurrence during the
stay in hospital. A difference in severity weights is made between cardiac rhythm disorders
during the acute phase (time periods TO and T-l) and the follow-up phase (time periods T-2
and T-3). The severity weights for each cardiac rhythm disorder specified for the period of
incidence arc presented in table 6.28.
Table 6.28 Severity weight of different cardiac rhythm disorders in relation to the phase of
«lay.
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The severity of cardiac rhythm disorders is measured by the most severe rhythm disorder
occurring during the acute phase, respectively the follow-up phase of the stay. This means
that if two or more different rhythm disorders arc present only the most severe (the one with
the highest severity weight) is taken into account. It is expected that the rhythm disorder
with the highest severity weight will be sufficient in measuring the overall severity of
cardiac rhythm disorders.
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The severity categories arc determined by the type of rhythm disorders and the appearance
of these disorders in the acute phase or the follow-up phase. A multivariate analysis giving
insight into the patterns of appearance of these characteristics provides many unique
combinations of cases. Because of the uniqueness of each of these severity patterns, no rules
can be established to combine the many 'pattern' groups of rhythm disorders into one
ordinal dimension or scale. All ten categories of rhythm disorders that occur in our
population arc presented in table 6.29 as a nominal scale (a to j). A large group of patients
(n=222) have no rhythm disorder at all during hospital stay; they are allocated to one
severity category 'a'. The next largest group of patients with rhythm disorders concerns
patients with sinustachycardia, exclusively within the first three days of the infarction
(n=105); they are grouped into the nominal category 'b'. Patients with ventricular flutter/-
fibrillations, exclusively within three days of the infarction (n=18) arc grouped in severity
category 'd'. Patients with atrial fiuttcr/-fibrillations are divided over three different severity
categories: patients with this arrhythmia, exclusively within the first three days of infarction
('c', n= 21). patients with this arrhythmia within the first three days of infarction combined
with sinustachycardia or non-sustained ventricular tachycardia in the follow-up phase ('g',
n=6) and patients with recurrent atrial flutter/-fibrillations (first three days and later on) ('h',
n=31).
Patients having sinustachycardia or non-sustained ventricular tachycardia in a later phase of
the infarction without any previous arrhythmia ('e'. n=18) are distinguished from patients
with recurrent sinustachycardia or non-sustained ventricular tachycardia during hospital stay
('f, n=26). Patients with ventricular fiuttcr/-fibrillations during the first days of the infarction
combined with atrial fluttcr/-fibrillations or sinustachycardia later on ('i', n=7) arc
distinguished from patients who had sinustachycardia or atrial fluttcr/-fibrillations in the
beginning and still had ventricular fluttcr/-fibrillations or sustained ventricular tachycardia
later on ('j', n=9).
Table 6.29 Severity categories describing type and time of appearance of cardiac rhythm
disorders.
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Conduction disorders during the first three days of the stay of AMI-palicnls have a medical
significance that differs from conduction disorders after three days of the infarction. This
important notion is taken into consideration when looking at the trends in conduction
disorders for the patient population at hand. A rough distinction is made in acute conduction
disorders (during the first three days of stay) and conduction disorders in the follow-up
phase (T2/T3). The different types of conduction disorders in our patient population have
been listed. There appear to be seven different categories of conduction disorders (table
6.31). Patients with no relevant conduction disorder during hospital stay (n=372) arc
grouped in severity category 'a'. Patients with only Mobil/. I AV-block during the first three
days after infarction (n= 11) are grouped together in severity category 'b'. Patients with
Mobitz II AV-block or a third degree block with nodal escape rhythm exclusively during the
acute phase are grouped in category 'c' (n=36). Patients with an acute right bundle branch
block (n=ll, also including a few patients who have the same conduction disorder after
three days) arc grouped in severity category 'd'. Patients with third degree block with
ventricular escape rhythm exclusively during the first three days of infarction arc placed in
one severity category ('e', n=12). If patients have intermittent (recurrent) right bundle branch
block, they are grouped into a separate severity category ('f, n=18). Patients who have a
third degree block with ventricular escape rhythm after three days in hospital (alter having
conduction disorders during the first three days of infarction as well) arc grouped in another
severity category ('g', n=4).
Table 6.31 Severity categories describing type and time of appearance of cardiac conduction
disorders.
Afomi/ui/ if wiry category
a
c
ƒ
7bra/
DcicnpfHMi /•"nc<i
«o rom/ucfron t/woreter
«n<r? Motor: / /IV-Wot*
«cur? Motor; ///4V-fr/ot* or «fM/c f/ii're/rfc-
gr«' Wot* H;f/i not/«/ «•.«•«/if Wivr/i/n
«f«r<* r/^ '/ir /)ii/it//f /;r«;it7i Wot*
arure //lire/ t/pgrp*' />/ot* w7r/i vrnrricu/wr « ra -
p<> r/i^r/im
rpc//rrf«r rr'^ y/f W l r />r«nf/i Woct
//«re/ f/p^rpc Woel romto'/ifrf w7r/i v«*nrn'ftt/«r
f.sfrt/jp r/ivr//m iri/o//otv-u/7/>/ta5^
J72
//
J6
//
/2
/ff
6.2.8. Severity of heart failure.
The main function of the heart is to provide an adequate amount of blood for the various
body tissues. Heart failure is a condition in which the heart is unable to pump the required
amounts of blood into the circulatory system. Heart failure can be restricted to cither the left
or the right ventricle of the heart.
By means of echocardiography the Left Ventricular Ejection Fraction (LVEF) and the Left
Ventricular End Diastolic Dimension (LVEDD) can be obtained indicating the severity of
left ventricular failure. The collapse of Vena Cave Inferior (VCI) can be used as a severity
indicator for the pumping capacity of the right ventricle.
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6.2.8. Severity of heart failure.
The main function of the heart is to provide an adequate amount of blood for the various
body tissues. Heart failure is a condition in which the heart is unable to pump the required
amounts of blood into the circulatory system. Heart failure can be restricted to cither the left
or the right ventricle of the heart.
By means of echocardiography the Left Ventricular Ejection Fraction (LVEF) and the Left
Ventricular End Diastolic Dimension (LVEDD) can be obtained indicating the severity of
left ventricular failure. The collapse of Vena Cave Inferior (VCI) can be used as a severity
indicator for the pumping capacity of the right ventricle.
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6.2.8.1. Severity of heart failure in the left ventricle.
Vi*n/rjeu/ar £/>rft7>n Frac/iVvi fLVEF,).
Measurement of the LVEF by cchocardiogram is in most cases performed only once during
hospital stay. For the entire patient population at hand only 7 patients had two
cchocardiograms; in those cases the last score is used. The LVEF measurement is a
percentage-index normally (in healthy persons) ranging between 40 9? and 70 %. If the
LVEF decreases the severity of heart failure increases. The results of the LVEF are
categorized into severity groups, illustrated in table 6.32. In total, 141 patients have no
LVF.F-score because of missing data or mostly because cchocardiography has not been
applied during hospital stay. Most patients (n=183) have a 'normal' LVEF-valuc. In patients
with impairment of pumping function, 81 showed a slight impairment, 50 patients showed a
severe impairment and 9 patients showed a very severe impairment.
Table 6.32 Severity categories describing heart failure measured by the Left Ventricular
Ejection Fraction.
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The second indicator to measure left ventricle heart failure is the Left Ventricular End
Diastolic Dimension (LVEDD). This is the largest diameter at the end of the diastolic phase
(expressed in millimeters). It is assumed that severity of heart failure will increase if the
LVEDD increase. Patients arc categorized into two severity groups: "()' patients with
•normal' LVEDD of less than 55 mm (n=282) and ' 1 ' patients with deviating LVEDD of
more than 55 mm (n=36).
6.2.8.2. Severity of heart failure in the right ventricle.
The pumping capacity of the right ventricle can be measured by the percentage of collapse
in the Vena Cava Inferior (VCI-indcx). In normal conditions the VCI-indcx is expected to be
higher than 50 9h The percentages of the VCI collapse arc catcgori/cd into two severity
groups: '0', patients having 'normal' VCI of more than 50 9F (n=281) and ' 1 ' , patients with
deviating VCI of less than 50 9f- (n=37). During hospital stay, 18 patients show abnormal
wall motion in the right ventricle while 76 patients appear to have significant ST-changcs in
the right ventricle as indicated by ECG-lcads.
6.2.9. Severity of physical deficiencies and specific cardiac
complications.
Specific cardiac complications relevant in the context of this study arc: mitral insufficiency
(n=60), cardiac shock (n=48) and pericarditis (n=43). The previous cardiovascular and
cardiac deficiencies (§ 6.2. l-§ 6.2.8) will directly or indirectly cause specific deficiencies in
other organs. In some cases deficiencies (measured by 0-1 scores) like palpitations (n=24),
prc-collapse (n=36), syncope (n=39) and Cerebral Vascular Accident (CVA)/Transicnt
Ischcmic Attack (TIA) (n=9) may occur. Consequences of lefl-sidcd heart failure like
pulmonary edema (table 6.33) and dyspnea (n= 115). may be present. Right-sided heart
failure can lead to hepatomegaly (n=26), leg edema and ascitcs (table 6.34). Furthermore, a
patient's condition may be determined by observing his or her blood pressure. Low blood
pressure (systolic bp < 90 mm of mercury) is measured in terms of four severity categories:
'0', no low blood pressure (n=3()6), ' 1 ' , low blood pressure in only one time period (n=97),
'2', low blood pressure in two lime periods (n=44), '3 ' sustained low blood pressure in three
or four time periods (n=17). High blood pressure (systolic bp > 150 mm of mercury) is also
measured in terms of four severity categories: '0', no high blood pressure (n=352), ' I ' , high
blood pressure in only one time period (n=77), '2 ' , high blood pressure in two lime periods
(n=22), ' 3 ' sustained high blood pressure in three or four time periods (n=13). Myocardial
infarction may be followed by Angina Pectoris (AP). The New York Heart Association
(NYHA) has developed an international standard to measure AP given different stages of
exertion. For the patient population, patients arc categorized according to the NYHA-indcx
into : I; no AP (n=3O4), II; AP during heavy physical exertion (n=l); III; AP during minor or
moderate exertion (n=12)and IV; AP at rest (n=138).
A/«uu wwnf o/ n?searc/i
Table 6.33 Severity categories describing lung edema in AMI patients during stay.
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Table 6.34 Severity categories describing body edema in AMI patients during stay.
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In table 6.35 descriptive statistics of all severity indicators as described in this chapter arc
presented.
Table 635 Descriptive statistics on indicators of severity of illness in AMI patients during stay
(86 < n < 464).
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6.3. Background characteristics of patients.
Individual background characteristics may be related to a patient's severity of illness during
hospital stay (6.3.1). Specific contra-indications for medical treatment may also be related to
medical care costs (6.3.2). Next to individual background characteristics the enrollment of
patients in a research protocol is taken into account (6.3.3).
6.3.1. Individual background characteristics.
It might be expected that severity of myocardial infarction will vary according to typical
patient characteristics. For instance older patients arc assumed to be different with regard to
severity than younger patients. In addition, specific risk factors for cardiovascular disease
and the patient's medical history arc thought to be relevant.
The patient's background characteristics can be distinguished into six categories:
1I) demographic patient characteristics; this concerns the patient's age and sex.
(2) risk factors; these arc factors that might be related to myocardial infarction (like
smoking, high blood pressure, diabetes etc.).
(3) cardiovascular medical history; this concerns cardiovascular problems before the
current hospital admission which might be related to the severity of the myocardial
infarction during hospital slay.
(4) cardiovascular therapeutic history; this covers previous medical interventions with
respect to cardiovascular problems before the current hospital admission of the patient.
(5) non-cardiovascular medical history; this concerns former medical, non-cardiovascular
complications.
Data on variables belonging to these five categories of background characteristics have been
collected using the patient's medical record. Registration of these variables did result mostly
in dichotomous variables. For the patient population at hand, results arc presented in table
6.36. As can be seen from this table, risk factors like smoking and positive family history
with regard to heart diseases affect almost half of the patients. Nearly 5O9f of the patients
had angina pectoris before hospital admission, 28 9f suffered from hypertension and 11 %
were known to have coronary insufficiency. In 25 % of the cases patients suffered from (one
or more) previous infarction(s). To a lesser degree, patients had rhythm disorders (8 %),
peripheral and cerebral atherosclerosis ( 99T and 69f rcsp.) or heart failure (5 9f-). Other
cardiovascular deficiencies had occurred infrequently: 59h of all patients underwent
coronary bypass surgery and 3 9f- had received thrombolytic therapy. PTCA and pacemaker
implantation was performed in 1 9f of the patient population. In 9 * of the cases respiratory
problems (COPD), in 4 '#• kidney disorders and in only 19? liver disorders were present as
non-cardiovascular deficiencies.
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Table 6J6 Descriptive Statistics on the patient's backgn>und characteristics.
War.. 9/g i: 62.7J
- J « Afrn: 70.0% WOWKTI: JO.0%
-/hmi'/y m«flca/ nwfory f/warf aYwasrs)
- smot/ng
- of/if r rwt/a
Can//ov<wcuiar mfrf/ca/ /iwrory'-'
- of/if r fppricfl/r//»j, m/
coronary typ
f/irom/w/yf/c //if rapy
/TG4
infra
Afon-caroïovascu/ar mfrf/'ca/ /iw/ory:
-COPD
- or/if r comp/icaf/oas
• 77K" m?an va/u<> ii fh^ proporr/on o/ rp/eva/i/ COJM scoring
/V
42
49
/O
05
26
^
28
25
7/
09
06
08
05
Oi
0/
0/
00
02
05
Oi
0/
0/
00
09
04
0/
05
.49
.44
JO
.2/
.44
.25
.45
.4i
J2
.29
.24
.28
.2J
./7
.//
.09
.00
.75
.2/
./7
.08
.09
.or;
.29
.20
.09
.24
J87
449
46J
46J
449
462
46J
462
46i
460
46/
458
459
458
458
458
458
457
46/
46/
46/
46/
46/
46J
46J
46i
458
(y' on fn? oacJtjfrounrf
6.3.2. Contra-indications.
Contra-indications to diagnostic or therapeutic services are very important in explaining
decision-making in therapy and costs of treatment. It is quite clear that one treatment of
patients having an acute myocardial infarction is very much influenced by specific contra-
indications. This treatment concerns thrombolytic therapy. In 1987-1988 at the Department
of Cardiology in Maastricht thrombolytic therapy was normally not given to patients older
than 75. Furthermore if the duration of ischcmic pain before the moment of admission was
more than six hours, or if patients were in coma also no thrombolytic therapy was given.
The rules according to which decisions arc made may differ from hospital to hospital, from
one country to another or from year to year. In our patient population 78 patients arc older
than 75 years, 52 patients had ischcmic pain more than 6 hours before hospital admission
and 11 patients were in coma on the moment of admission.
6.3.3. Enrollment of patients in a hospital research program.
A patient's involvement in a scientific research protocol during his or her stay in the hospital
is also recorded. In the University Hospital of Maastricht projects for scientific and/or
educational purposes arc quite normal. If patients have been subject to a specific research
protocol of a clinical trial involving specific patient care, this characteristic is specially
recorded. One important research project was taking place during the period of
investigation; it concerns a multi-center clinical trial to compare the efficacy of the
experimental thrombolytic drug 'pro-urokinasc' to the standard drug 'strcptokinasc' (PRO-
urokinasc In Myocardial Infarction). Henceforth this clinical trial will be called the PRIMI-
prolocol, (Meyer, 1989). For the patient population at hand 59 patients had been allocated to
participate in this clinical trial. During the acute phase of the stay all patients involved in this
trial did receive thrombolytic therapy followed by a heart cathctcri/ation.
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7. Investigating hypothesized relations
between severity of illness and costs of
medical care.
In this chapter results regarding the relationship between the patient's severity of illness and
specific costs of medical care will be presented. Differences in costs observed in the
research population at hand will be analyzed. First, methods used in data analysis will be
outlined (7.1.). A distinction will be made between the relation of period-specific costs of
medical care and the period-specific classifications of severity of illness (sec model in figure
3.2.), and the relation of costs of medical care during total hospital stay and the (dynamic)
classifications of severity of illness (sec model in figure 3.3).
Next, in § 7.2. a period-specific cost analysis will be presented for costs of medical care made
during the acute phase of the stay. Costs of thrombolytic therapy, heart cathelcrization and
PTCA are generally made during this phase of hospital stay. It is assumed that differences in
these costs depend on differences in severity of illness during this time period.
The second type of analysis concerns the patient's total hospital stay (§ 7.3.). It stands to
reason that changes in severity of illness may be relevant in explaining length of stay and
costs of medical care during total hospital stay. The (dynamic) severity categories defined in
chapter 6 arc assumed to be more appropriate for this type of analysis. In § 7.3 the following
dependent variables will be analyzed: the length of stay, the costs of the CCU and other
costs of medical care (i.e. drugs, laboratory services, electrocardiograms, cchocardiograms
and exercise tests). Finally, the conclusions will be summarized (§ 7.4.) and results from this
chapter will be used to propose a Severity of Illness Classification (SIC) for patients with
Acute Myocardial Infarction (sec chapter 8).
7.1. Methods used in data analysis.
The main goal of the forthcoming analysis is to investigate which severity criteria have a
substantial effect on length of stay or specific costs of medical care.
The multivariatc models in chapter 3 will be translated into a path-analytic model. Path
analysis is a method of causal data analysis: relations between variables arc assumed to be
causally asymmetric and will correspond to the hypothesized relations between concepts in a
theoretical model. In such models one is usually interested in explaining a 'dependent'
variable (i.e. specific costs of medical care or length of stay) and the other variables may be
seen as the 'independent' variables (i.e. severity indicators) providing the explanation of the
variations within the dependent variable. Correlations between the dependent variable and
the independent (the explaining) variables can be differentiated into direct effects, indirect
effects (via other factors) and other correlational rest relations. The statistical distribution of
the dependent variable is usually assumed to be normal and the scale of measurement is at
least the interval scale. If the measurement level of the predictors is also interval, relations
arc usually thought to be linear. No interactions arc assumed to exist between the causal
factors with regard to the dependent variable. In this case a linear regression analysis can be
performed.
In this study the dependent (costs) variables are ratio-scales, but the independent (severity)
variables will vary from nominal to interval-scales. In such case one can usually perform an
analysis of covariance: the effects of the interval variables can be examined after controlling
for the nominal variables and vice versa. For instance, the effect of enzyme release
(independent interval variable) on length of stay (dependent variable) can be investigated
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separately for men and women (nominal variable). However, if we are interested both in the
effects of sex (factor) and enzyme release (covariate) on e.g. the length of stay, a
combination of analysis of variance and regression analysis should be performed. This is
done in analysis of covariance, which is a combination (a hybrid) between regression
analysis and analysis of variance. The analysis of variance-part in analysis of covariance is
identical to a procedure referred to as dummy-regression analysis, in which the nominal
variables are broken down into so-called dummy variables. One of the advantages of using
dummy regression analysis is that all effects of interval as well as nominal independent
variables on the dependent variable can be examined within the terminology of regression
analysis.
* Dummy-variable construction.
Severity of illness measured by categories representing nominal variables can be broken
down into dummy variables. Dummy variables (or '0-1' type variables) obey the 'simple
contrast' assumptions in analysis of variance. One of the advantages of this contrast is that it
will discriminate between patients who have no deficiencies ('normal') and patients with
clinical deviations from 'normal'. Combinations of K-l dummy variables will be used when
the nominal variable contains K classes. All dynamic severity categories expressed in a
nominal scale can thus be represented by dummy variables. This concerns the categories
representing cardiac rhythm disorders (sec § 6.2.6) and the categories representing cardiac
conduction disorders (sec § 6.2.7.). All other severity categories arc assumed to have an
order; these categories can also be decomposed to dummy variables. Another advantage of
using dummy variables is that patients having missing values on the severity indicators can
be represented by a special dummy variable. This way, the total patient population can be
included in the regression analysis and an unnccccssary reduction in the number of patients
can be avoided in data analysis. These missing categories concern the severity categories of
coronary stenosis, myocardial ischemia measured by Bruce tests and thallium exercise tests,
myocardial necrosis measured by cn/ymc rates and thallium exercise test, ischemic pain,
cardiac wall motion abnormalities, the LVEF and specific physical deficiencies. All dummy
variables used in the forthcoming analyses arc described in appendix 16.
* Procedures in data analysis.
First, all correlations between dependent and independent variables are screened for
statistical significance. All independent variables having statistically significant correlations
with the dependent variable in question will be presented in a correlation matrix. In order to
reject null hypotheses involving effects in the regression model a 95 % probability level of
statistical significance is maintained. In case of nominal variables first a 'one-way' analysis
of variance is made and eta'is calculated. Subsequently, each variable will be tested for
significant effects on the dependent variable. A general linear regression model will be
applied using the least squares estimation (Schroedcr c.a. 1986, Fox. 1991). The regression
analysis is made by introducing blocks of independent variables. Variables having a
significant effect in an analysis will be included into a next step in which a new block of
variables is tested. The process will be repeated until all possible effects have been
investigated. The eventual regression analysis will contain only those variables having a
significant effect on the dependent variable. Only the results of the eventual regression
analysis model will be presented in the forthcoming paragraphs. Of course, if one contrast in
the K-l set of dummy variables belonging to a nominal variable with K categories appears
to be statistically significant, (he whole set will have to be included. All statistically
significant effects will be interpreted and presented in a path-analytic diagram showing the
relative importance of the variables (Beta-weights). As mentioned before: in multivariate
data analysis values on indicators of cases may be missing for specific or unclear reasons
(no test done or lost test scores). Several solutions may he applied to overcome this problem
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of missing data. The most valid solution is to eliminate all cases that have a missing value
for any variable considered relevant in analysis. This is sometimes called 'listwisc deletion
of missing cases'. Another solution is to compute measures of association for pairs of
variables separately which will result in different numbers of cases used for each measure.
This latter way is called 'pairwise deletion of missing cases'. In the data analysis of this text
a listwise deletion of missing cases will always be applied. This procedure could only be
applied because we have used the possibilities of defining 'missing category' dummy
variables.
A typical problem associated with data used in a regression analysis is (multi)collincarity; it
arises when two or more variables used as predictors in a regression function arc highly
correlated. In such a case the estimated parameters may be incapable of sorting out the
independent effects of each predictor on the dependent variable. In our data matrix
(multi)collinearity may appear in the variables that represent the severity dimensions of one
and the same deficiency (intensity, extent and location). Therefore in the analysis each of the
severity dimensions will be introduced in the analysis separately from both others to avoid
(multi)collinearity.
Another problem in regression analysis is hctcroskcdasticity in the variance of dependent
variable: this variance will tend to increase (or sometimes decrease) given the values of the
predictor. Transformations of the dependent variable may be performed to deal with
hetcroskedasticily (for instance a log transformation). However given the explorative
character of this study this type of solution for this problem has not been made in the
forthcoming analysis. We assume that the results of the analysis will not differ very much
when using a transformation. Another reason is that using a transformation will make the
interpretation of regression coefficients somewhat more difficult. To avoid hctcroskasticity
as much as possible, many confounding factors will be introduced in regression analysis and
also a residual analysis plus outlier identification will be made. An outlier identification is
applied after the eventual model results have been determined. Patients with extremely high
residual z-scorcs in their predicted values on the dependent variable arc then removed from
further analysis. These outliers will be removed from analysis for technical reasons only:
their extreme scores on the dependent variable tend to have a disturbing influence on the
slope of the regression parameters.
* The effect of severity of illness.
The central hypothesis in this study is described in chapter 3. We will repeat this hypothesis
here and place it within the context of the model of explanation of diagram 3.3. The length
of a hospital stay and the costs of medical care of AMI patients are assumed to be explained
by the patient's severity of illness during hospital stay. It is assumed that patients with a
severe condition will stay in hospital for a longer period of time and that they will have
higher costs of medical care.
As we have seen in chapters 5 and 6 several cardiac and cardiovascular deficiencies can be
measured in patients with acute myocardial infarction. The severity of each cardiac and
cardiovascular deficiency can be measured by means of one or more severity indicators and
each indicator can in turn be specified into one or more severity dimensions (intensity,
extent or location). The assumed effects of the categories reflecting severity of illness on
length of stay and medical costs are described in path-diagram 7.1. This diagram can be seen
as an elaboration of diagram 5.6. As can be seen in this diagram, the severity of the medical
deficiencies may cause direct or indirect effects on the costs of hospital care. For instance
one of the direct effects is that patients with severe heart failure will have higher costs of
hospital care; an indirect effect may result from one of the causes of heart failure, such as
specific cardiac rhythm conduction disorders. However, these causes of heart failure may
also directly affect the costs of medical care as well. It is to be expected that not all
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deficiencies arc 'important' in explaining (specific) costs of medical care. The question then
is which severity indicators arc really relevant in explaining medical care costs and
furthermore what the relative importance of each indicator is compared to other indicators.
Diagram 7.1 Causal relations between indicators of severity of illness and costs of hospital
medical care in patients having AMI (see also diagram 5.6).
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* Controlling fur conditional variables.
Many factors will play a confounding role in explaining the differences in length of stay or
costs of medical care by means of severity of illness. When only the severity indicators are
tested in regression analysis the significant effects may be 'spurious' (not real) and
regression coefficients may be overestimated or underestimated due to other factors which
have a 'disturbing' effect on the relation between the severity of illness and costs. In order to
approach the 'real' relations between severity and the costs as much as possible, these
factors must be included in regression analysis as controlling variables.
As we have seen in § 4.1. patients may be admitted to and discharged from the cardiology
department in various ways. The regular hospital admission of AMI patients is the one in
which the patient enters the hospital department arriving directly from home. However, not
all patients arc admitted in this regular way: some patients do get an infarction while in
hospital. Their direct reason for admission might be - for instance- unstable angina pectoris.
During (he period preceding the infarction these patients will also incur costs for medical
care and their overall length of stay will tend to be longer than patients who did get an
infarction outside the hospital. In both cases the patient's severity of illness might be similar,
yet the costs of staying will be different. So a correction has to be made for this specific type
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of admission (regular or already in hospital measured by DAD1NT0).
Some other patients are admitted via other hospitals, while they arc in various stages of
the infarction, but this usually occurs when the acute danger seems to have subsided. This
part of the population may have low costs, while at the same time they may have severe
complications during their stay. This may also influence the effect of the severity of illness
on costs. For instance, some of these patients may have very severe rhythm disorders and
may need specialized treatment; it is for this reason that they have been transferred from the
local hospital to our university hospital. However, compared to regularly admitted patients
with similar rhythm disorders their length of stay and costs will tend to be rather low,
because a substantial pan of their costs have been made in previous hospital. Furthermore,
the moment of entering the hospital during the illness episode may be relevant. Patients
entering the hospital in time period Tl will have different costs in comparison to patients
entering the hospital in T3 of the illness episode. Consequently, another correction has to be
made for patients coming from other hospitals specified according to the moment of hospital
entrance during the illness episode (measured by dummy variables DADEXT1.DADEXT2
and DADEXT3).
Patients may also have a regular or irregular discharge from hospital. The decease of the
patient may be seen as a non-regular type of discharge. Patients who die during hospital stay
will generally have lower costs compared to non-dcccascd patients. This study intends to
explain costs of medical care. However, in the explanation of mortality by severity of illness
a more epidemiologie definition of severity of illness will be necessary, in which clinical or
non-clinical risk factors for decease and the actual causc(s) of death during hospital stay will
have to be included. Within the economic analysis of costs the problem is: some patients
may score very high on the severity indices and at the same time have very low costs and a
very short length of stay, because they have died during stay. For instance patients with
specific severe rhythm disorders may have higher chances to die so their length of stay and
costs will be very low. On the other hand, non-dcccascd patients with these same rhythm
disorders arc expected to have a high length of stay and arc expected to have high costs. The
'real' effect of these specific rhythm disorders will be underestimated, if no distinction is
made between deceased and non-dcccascd patients. Another example is patients having a
cardiogenic shock. Patients with cardiogenic shock generally have a high risk of dying; their
length of stay and costs may be very low despite this severe complication. One might
misinterpret this complication as having a negative effect on costs. However, this effect will
turn out to be spurious (not substantial or non-real), if a distinction is made between non-
dcccascd patients and deceased patients. Furthermore, patients who die rather soon after the
moment of admission will have to be distinguished from patients who die after a prolonged
spell of illness in hospital. Thus, the moment (or period) of death of patients will have to be
included in each analysis (measured by dummy variables DDEATHO, DDEATM1,
DDEATH2 and DDEATH3).
Physicians at the cardiology department will generally act within the boundaries of the
medical protocol concerning patients with '(suspected) acute myocardial infarction'.
However, a physician docs have a certain freedom in treating a patient with AMI: he/she
may be thinking it necessary to keep patients 'under observation', thus prolonging their
stay. The reasons for acting this way may be because of specific co-morbidities (like
diabetes) or the appearance of complications (like lung embolism, kidney or liver disorders)
that arc not incorporated in our severity of illness-indicators because of their rarity of the
occurrence. Some of these reasons to keep patients in hospital longer may be uniquely
related to individual patients with specific illness characteristics. In addition to this
physicians may decide to prolong a stay in hospital if there are social indications to keep a
patient longer under observation. All these factors arc not incorporated in our model and
cannot be explained by our severity indicators. The effect of some severity indicators on
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costs, as measured in this study, may be overestimated because of these specific
circumstances. For the time being a simple solution is proposed in order to overcome this
problem. A 'regular' discharge of AMI patients is expected to be in time period T2. Patients
discharged in T3 will be distinguished from regularly discharged patients with a separate
dummy variable (DH0ME3); these patients may have specific complications or other
reasons not captured by our severity indicators, which tend to postpone their discharge.
At the other extreme, there arc some patients who leave the hospital relatively soon (within
three days) after the moment of admission. This other type of non-regular discharge may
also be due to factors not incorporated in our model. Patients may leave the hospital against
medical advice or may be transferred to another hospital, because that hospital is nearer to
the patient's home residence. They will have a very short length of stay and very low costs
due to other reasons than their severity of illness. This coincidence of very low costs and
(moderate) severity of illness might undermine the positive relation between severity of
illness and costs (c.q. length of stay). Therefore again a correction should be made to
prevent such an underestimation. Patients discharged in Tl will be distinguished by a
separate dummy variable (DHOME1).
Using DH0ME1 and DH0ME3 as typical 'confoundcrs' in regression analysis may
encounter some criticism. After all, the introduction of these conditional variables implies
that we assume that the 'real' relation between severity of illness during stay and the
dependent variables is obscured by two processes. The first process concerns the
postponement of discharge by physicians by factors not included in our indices of severity
of illness. For instance, patients who have an uncomplicated AMI may still stay very long in
hospital for other reasons (clinical or non-clinical). The second process concerns the patients
who appear to be (moderate) severe cases, but who arc nonetheless discharged very early
und usually will be transferred to other hospitals. The decision to use this solution in the
mullivariatc analysis is preferred to that of not correcting for these situations of bias, which
in our view is detrimental to finding the 'real' relationship between costs of care and severity
of illness. In the following paragraphs we will also provide the reader with alternative models
of analysis, in which we did not include these factors, so that a comparison of results will be
possible.
Another 'non-regular' discharge type from the cardiology department is: transferral to
another medical department in the same hospital. When patients are transferred to other
medical departments of the University Hospital, they will generally have specific
complications which need to be treated by physicians from other medical specialties. In this
special case, the overall length of stay will tend to be much longer, but it will not only be
caused by the severity of the cardiac problems. Thus, the effect of the severity indicators
measured in this study may be overestimated. Furthermore, it is clear that when patients are
transferred during an early phase of the slay they will have lower costs compared to patients
transferred later on. Therefore, the moment of transfer needs to be incorporated into the cost
analysis as well (measured by dummy variables DTRANS1, DTRANS2 and DTRANS3).
Results from the analysis may thus be interpreted as the effect of the severity of illness on
the length of stay and costs of care within the cardiology department only.
In cost analysis of medical care even the length of stay in days may play a confounding
role. Patients with severe conditions may have apparently high costs, but these higher costs
will be strongly related to their long length of their stay. So, specific care costs uniquely due
to the severity of illness and costs due the length of stay need to be separated. In other
words: there arc costs directly caused by the severity of illness and there are costs simply
related to length of stay. Corrections should be made to find the relation between costs and
severity of illness by restricting it to what is uniquely and directly due to the severity of
illness.
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Patients' background characteristics, such as age, sex, previous infarction or angina
pcctoris, are assumed to be related to the length of stay and the costs of medical care, as well
as the severity of illness. For instance, the illness condition of older patients will usually be
more severe and because of this these patients will have higher costs and a longer hospital
stay. Thus, to determine the impact of severity of illness on the costs of medical care one
should again statistically correct for old age.
All factors mentioned above may be strongly related to the severity of illness, the length of
stay and the costs of medical care. To measure the effect of severity of illness on length of
stay or cosls of medical care, a multivariatc analysis must be performed using the severity of
illness indices as 'independent' variables together with all conditional factors related to
severity of illness as well as to the dependent costs variables (c.q. length of stay). Only in
such a model can the 'real' influence of severity of illness on the cost of medical care (c.q.
length of stay) be determined. In the subsequent multivariatc analysis a patient's hospital
admission and discharge status together with his or her length of hospital stay and
background characteristics will be regarded as conditional variables in the explanation of
costs by severity of illness. The conditional variables can not be seen as an explanation of
costs (they are only correlated to costs), but must principally be regarded as correction
factors.
The relationships and effects between all variables are represented in a path-analytic model
(diagram 7.2), which forms an extension of diagram 7.1 by incorporating the model in
diagram 3.3. The severity of illness indicators can be opcrationalizcd into the many
(dynamic) severity of illness categories as described in §6 .
Diagram 7.2 Model explaining length of stay and costs of medical cure by indicators
representing severity of illness, given some conditional variables (see text)-
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7.2. Period specific cost analysis.
In this paragraph results are presented regarding the mullivariate analysis of:
* Costs of thrombolytic therapy in TO (7.2.1),
* Costs of (acute) heart cathetcrization in TO (7.2.2), and
* Costs of (acute) PTCA in TO (7.2.3).
In these analyses time-specific severity indicators will be used to explain cost variations
within period T-0.
7.2.1. Explanation of costs of thrombolytic therapy.
Thrombolylic therapy is one of the most important interventions when patients suffer from
acute myocardial infarction. To be effective it has to be administered within the first hours
that symptoms appear. Thus, the cost differences in thrombolytic therapy can only be
investigated for the first six critical hours of hospital admission (period TO). Several sources
may provide an explanation for cost differences: (1) the individual medical history and
personal characteristics of the patient; (2) curlier cardiovascular (or other) deficiencies, and
pre-admission diagnostics and treatment of cardiologie nature; (3) the severity of illness as
reported by the patient, for example, concerning the duration of ischemic pain; (4) the
severity of illness as registered by the admission ECG of the patient; this includes the
dclcrminalion of the severity of myocardial ischemia, myocardial necrosis, cardiac rhythm
disorders and cardiac conduction disorders.
A pic-analysis had to be performed in order to remove all non-stochastic (fixed) relations in
(he explanation of the costs of thrombolylic therapy. Non-stochastic relations will exist,
when there arc (protocol-based) contra-indications for treatment. All patients at the
University Hospital Maastricht over 75 years of age, in coma or with more than six hours of
typically ischemic pain are conlra-indicated for thrombolytic therapy during the period of
the investigation. Patients with these characteristics arc excluded from further analysis
(n-l2K). 28.5 '/f of the variance in costs of thrombolytic therapy can be 'explained' using
these three conlra-indications for treatment (AGE: 11.2 </f, COMA: 2.4 <*, PAIN more than
6 hours: 11.0 %. AGE and COMA: .6 </f , AGE and PAIN more than 6 hours: 3.3 %).
Furthermore, all patients (n=59) enrolled in the local PR1MI protocol did receive
thrombolytic therapy for the mere reason they participated. Because the dependent variable
is also constant for these patients, no statistical analysis could be performed for this group of
patients loo. From a statistical point of view the participation in this clinical trial alone
'explains' 16.6 'X of the variance in costs. In total 187 patients arc removed from further
regression analysis.
The remaining sample population (n=277) is used for explaining costs of thrombolytic
therapy seen as a stochastic dependent variable. In this population, presence or absence of
ischemic pain was recorded for 1X4 patients; 93 patients had missing values on this variable.
In order to include all patients in the regression analysis two dummy variables haven been
constructed (DPA1N1: patients with no ischemic pain contrasted with patients with ischemic
pain, and DPAIN2: patients with no ischemic pain contrasted with patients with missing
values). Four patients were removed as outliers because of extremely high costs. Some
descriptive statistics of this subpopulation arc given in table 7.3.
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Table 7J Descriptive statistics of the patient population used to explain costs of thronibolytic
therapy (Listwise deletion of missing cases, n = 254).
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About 29 % of the remaining patients receive thrombolylic therapy and the mean costs per
patient amount to 169.02 guilders (std.dcv. 270.74). Variables showing significant
correlations with the costs of thrombolytic therapy arc presented in appendix 17.
The extent and the location of myocardial ischemia arc positively correlated with costs of
thrombolytic therapy (lSEXT0:r=.24;p<.(K)l, ISLOC():r=.ll;p<.()5). Similar results arc
found for the extent and the location of myocardial necrosis (NECEXT():r=.2();p<.01,
NECLOC0:r=.19;p<.001). The dummy variable representing the contrast between no
ischemic pain and typically ischemic pain is also highly positively correlated to costs of
thrombolytic therapy (DISPAINl:r=.31;p<.001). The contrast between no ischemic pain and
missing values is highly negatively related (DISPAIN2:r=-.26;p<.(X)l). All other variables
(like severity of cardiac rhythm disorders, conduction disorders and background
characteristics) show no significant correlations with the dependent variable.
All significantly correlated variables arc used as independent variables in a multiple
regression analysis. In the eventual regression analysis only three variables have significant
parameters: the severity of necrosis location, the severity of the extent of ischemia and the
presence of ischemic pain (table 7.4). 17 % of the variance in costs of thrombolytic therapy
can be explained by these indicators.
Table 7.4 Results from regression analysis: the dependent variable is costs of thrombolytic
therapy in TO (Listwise deletion of missing cases, n = 254).
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Discussion.
It can bc concluded that for patients with (suspected) AMI, who do not have contra-
indications and who arc not involved in a randomized clinical trial, the probability of getting
thrombolytic therapy will increase if patients show signs of anteroseplally located necrosis
in the ECG. This probability will also increase, if patients show extensive left ventricular
wall ischemia in ECG, and if patients indicate that they arc having typical ischemic pain.
This last effect turns out to be twice as important as the others. The relative importance of
each effect on the costs of thrombolytic therapy (given by the beta parameters) is presented
in diagram 7.7. Cardiologists did confirm that the criteria found empirically are also
specified in the thrombolytic protocol which was used at the cardiology department during
1987-1988.
7.2.2. Explanation of costs due to (acute) heart catheterization.
For the patient population at hand the greater part of the costs due to heart catheterization
arc incurred during the acute phase of the infarction in TO (sec appendix 5). Differences in
costs in this time period will be analysed. Although heart calhctcrization may have been
performed in Tl and sometimes in periods T2 and T3, these costs will not be discussed here.
Non-stochastic relations as a result of l(X) 'if indications for acute heart catheterization
huven been eliminated from the eventual regression analysis. Enrollment in the PRIMI-
protocol was an indication for applying a catheterization. Circumstances with contra-
indications for catheterization were not present. In total 59 patients have been excluded from
regression analysis because of their enrollment in the PRIMI protocol (variance explained
amounts to 13.1 'X). In addition. 3 patients have been excluded from further analysis
because of extremely high cathctcrization costs (m=l()95.79, std.dev.=632.850). The
remaining sample population is used in explaining costs for acute catheterization. Some
descriptive statistics of this subpopulation arc presented in table 7.5. In this sample
population 26 % of the patients is given a catheterization and the mean costs per patient
amount to 231.18 guilders (sld.dcv.=4(X).96).
Table 7.5 Descriptive statistics «if the patient population used to explain costs of acute heart
catheterization during period TO (l.istwise deletion of missing cases, n = 378).
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Variables showing significant correlations with the costs of acute heart catheterization are
presented in appendix 18. Both indices expressing the severity of myocardial ischemia
measured by ECG on admission show significant correlations with the costs of acute heart
catheterization (ISEXCT0:r=.19; p<.(X)l and ISLOC():r=.14;p<.01). Similar results are
found for the variables expressing the severity of myocardial necrosis measured by ECG
(NECEXT0:r=.12;p<.01 and NECLOC0:r=.13;p<.01). A high correlation is found between
catheterization costs and receiving or not receiving thrombolytic therapy during current
admission (THROM:r=.50;p<.001). Earlier thrombolytic therapy, given before the current
hospital admission, appears to be positively correlated with costs of acute cathctcrizalion as
well (FTROM:r=.12;p<.05). The patient's age and sex appear to be negatively correlated
with the costs (AGE:-.20;p<.(X)l and SEX:r=-.20;p<.(XM). Furthermore, having an infarction
while in hospital is moderately correlated with costs of acute catheterization
(DADINT0:r=.27;p<.001).
Five independent variables do show significant parameters in the eventual regression
analysis: former and current administration of thrombolylic drugs, the extent of ischemia,
sex and type of admission (table 7.6). It may be concluded that the probability of getting a
cathetcrization during the first six hours of hospital stay for patients with (suspected) AMI
will increase, if patients rcccivc(d) thrombolytic therapy during the current or a previous
hospital stay. Moreover, patients with ST-changcs corresponding with many wall segments
arc likely to incur costs due (o cathetcrization. Female patients have a significantly lower
chance of receiving an acute catheterization. Lastly, patients who have an infarction while in
hospital (DADINTO) are more likely to receive a cathctcrization during the acute phase of
the infarction than other patients. As can be seen from ihc results of the regression analysis
(lablc 7.6), 37 9f of the variance in costs of acute cathctcri/ation is explained by means of
these indicators. All other factors offer no significant, additional explanation for the variance
in costs of acute heart cathetcrization.
Table 7.6 Results from regression analysis; the dependent variable is costs of acute heart
catheterization in TO (Listwise deletion of missing cases, n = 378).
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Discussion.
Costs of acute heart catheterization for patients with AMI are only partly explained by the
patient's severity of illness; ischemia (measured by ECG) extensive over more wall
segments has a moderate effect on the costs of acute heart catheterization. Medical
treatment, i.e. thrombolylic therapy, has an effect on costs of acute heart catheterization,
which is four times larger than the effect of the extent of ischemia. If thrombolytic therapy is
given (particularly during the current hospital stay) this certainly tends to increase the costs
of acute heart cathctcrizalion. Cardiologists did confirmc this conclusion. In 1987-1988 by
protocol it was defined that to ascertain the clinical efficacy of thrombolytic therapy a
cathctcrization was needed. In addition, female patients arc less likely to receive an acute
heart calhctcrization. There is no explanation for this finding. However, in other studies this
apparently 'strange' relation was also found (Stcingard 1991, Ayanian 1991). Lastly, patients
who have an infarction while in hospital arc more likely to receive a heart cathctcrizalion
during the first hours that symptoms appear. The relative importance of these variables on
the costs of acute cathctcrization (beta parameters) is presented in diagram 7.7 together with
the analysis results for the costs of thrombolytic therapy (sec § 7.2.1).
Diagram 7.7 Path-analytic model combining the explanation of costs of thrombolytic therapy
and costs of heart catheterization in TO by severity of illness. Beta parameters are shown
(1'airwi.se deletion of missing cases, 254 < n ^ 378).
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7.2.3. Explanation of costs due to (acute) PTCA.
Costs due to PTCA are incurred generally during the first six hours of hospital stay (see
appendix 12). The decision to perform an acute PTCA is, amongst other factors, based on
the insufficiency of coronary flow and the severity of coronary stenosis before PTCA and
after thrombolytic therapy. Another important criterion in the decision making process may
concern the severity of illness as indicated by the ECG. In addition, it is assumed that
patients who do receive thrombolytic therapy but whose coronary angiogram still indicates a
severe coronary stenosis, will have a higher chance of receiving a PTCA (interaction effect).
Of the 159 cathctcrizcd patients in TO, 82 patients (51.9 %) receive only thrombolytic
therapy and no PTCA, 18 patients (11.4 9f) receive only PTCA and no thrombolytic therapy,
32 patients (20.3 9f) receive both and 26 patients (16.5 %) do not get cither of these
treatments. Almost one third of the cathctcrizcd patients undergoes a PTCA. Costs of PICA
are constant for each patient (fl. 3677.24). Therefore, in the regression analysis, the cost of
PTCA can be substituted by a dichotomous variable 'PTCA: yes or no'. Some descriptive
statistics of the subpopulation used to explain costs of PTCA in TO arc presented in table
7.8.
Table 7.8 Descriptive statistics or patient populations used to explain costs of PTCA in TO.
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As can be seen from the correlations between the dependent and independent variables
(appendix 19) there is a positive correlation between the coronary intensity score and PTCA
(r=.24, p<.001). Chances to get PTCA seem to decrease somewhat when patients get
thrombolytic therapy (r=-.21, p<.001). A first regression analysis shows a very low
explained variance in the costs of PTCA. Subsequently, specific interaction effects have
been tested. The first interaction effect concerns getting thrombolytic therapy and the
intensity of coronary stenosis on the costs of PTCA (INTER 1). The second interaction effect
concerns getting ihrombolytic therapy and the extent of stenosis (INTER2). The reason why
this last term was calculated may not be very obvious at first, since the first interaction term
has a reasonably high correlation with the dependent variable (r=.31;p<.001) and the other
term not at all (r=-.O3;p=.3O). However, when both terms are used in multiple regression
analysis, it turns out that the first interaction effect is not significant anymore, when the
second interaction effect is included. This rather puzzling result may be explained by a
confounding effect of the extent of stenosis (STENEXO). After several analyses the crucial
variable in the analysis of performance of PTCA turns out to be the extent of stenosis
(STENEXO). Interpretation of results will improve considerably if patients with one vessel
disease (n=70) arc separated from patients with two or three vessel disease (n=59).
Descriptive statistics of these two subgroups of patients arc also presented in table 7.8. In the
correlation matrices for each sunpopulation (tables 7.9 and 7.10) we see that for patients
with one vessel disease there is a high negative correlation between costs of PTCA and
thrombolytic therapy (r= -.39;p<.(K)l) and a high positive correlation between the intensity
of coronary stenosis and costs of PTCA (r=.35;p<.001). For patients with two or three vessel
disease only the intensity of coronary stenosis shows a significant correlation with costs of
PTCA(r=.22;p<.01).
Table 7.9 Correlation matrix of severity of illness, costs of thrombolytic therapy and costs of
PTCA in TO for patients with one vessel disease (l.istwise deletion of missing cases, n = 69).
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Table 7.10 Correlation matrix of severity of illness, costs of thrombolytic therapy and costs of
PTCA in TO for patients with two or three vessel disease (Listwise deletion of missing cases, n
»58).
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Regression analysis using the data of patients with one vessel disease shows three significant
explaining factors: thrombolytic therapy, the intensity of coronary stenosis and the location
of necrosis. In total. 35 * of the variance in costs of PTCA for this subgroup of patients is
explained by these factors (table 7.11).
For the second group of patients with multiple vessel disease (two or three vessel disease)
the costs of PTCA can only be explained by the intensity of coronary stenosis (Beta:.22).
For this subgroup only 5 % of the variance in costs of PTCA could he explained.
Table 7.11 Results of regression analysis; the dependent variable is costs of PTCA in TO fur
patients with one vessel disease (Listwise deletion of missing cases, n = 69).
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In spite of the relative failure to explain costs of acute PTCA by our severity indices in
patients with two and three vessel disease, these costs can with a certain amount of success
be explained in patients with one vessel disease. Patients with one vessel disease have a
lower chance of getting a PTCA, if they receive thrombolytic therapy. However, chances of
receiving a PTCA increase, if they have a total coronary occlusion. If these patients have
anteroseptal necrosis, there is an additional chance of receiving a PTCA. The relative effect
of these variables on the costs of PTCA (beta parameters) is presented in diagram 7.12.
Patients with two or three vessel disease also have higher chances of receiving PTCA, if
they have total coronary occlusion; however the explained variance is rather low. For this
group of patients thrombolytic therapy turns out to have no relation to the costs of PTCA. To
interpret these results some cautionary remarks must be made regarding our model of
explanation; the analysis is hampered in several ways because it appears that next to the
intensity of coronary stenosis the decision to perform PTCA is also dependent on the
antegrade coronary flow and the adequacy of collateral blood flow. It is not possible in this
stage of the research to quantify the way cardiologists judge the (in)sufficicncy of this
collateral blood flow. In addition to this measurement problem, there arc many contra-
indications for performing PTCA which should be taken into account in data analysis. Some
of these contra-indications are almost uniquely related to individual patients. In summary,
our model of explanation is - in hindsight - not satisfactorily specified for all variables, that
may be related to both the costs of PTCA and the characterises of coronary stenosis.
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Diagram 7.12 Path analytic model used to explain costs of PTCA in TO by severity of illness in
patients with one vessel disease. Beta parameters are shown (Listwise deletion of missing cases,
Severity of illness
I
Stenosis Intensity
(-.93- 1.73))
Necrosis Location
(0-2)
F.xptiilni-d Variance (R*): .35
+.28
Thrombolytic
therapy
(0-1)
-.43
Costs of (acute)
PTCA
(fl.0.00 - 3677.44))
nt-wi 5fvfriry o/i7/w.« <wJ ro5M o//rwflcfl/ fair
7.3. Analysis of length of stay and costs in medical
care during total hospital stay.
In this paragraph results of the multivariatc analysis arc presented for:
* Length of hospital stay (7.3.1);
* Costs of coronary care unit (7.3.2);
* Other costs of medical care (drugs, laboratory services, electrocardiogram,
cchocardiogram and exercise tests) (7.3.3).
In this analysis (dynamic) severity categories deduced from the severity indicators as shown
in § 6 will be used to explain length of stay or cost variations. Furthermore all decisions and
rules on methodology and/or statistics will be applied that arc described in § 7.1.
7.3.1. Explanation of length of stay.
The overall length of stay is defined as the total number of days a patient is in hospital
irrespective of the medical speciality. This means that the number of days could have been
spent at other wards than those of the Department of Cardiology. For the total patient
population of 464 patients the mean length of stay amounts to 11.45 days (st.dcv.=9.60). The
duration of stay varies between 1 and 112 days. Seven patients were removed form analysis
because of their extremely long stay (m=66.29, std.dcv.=29.32). In the remaining
population, now amounting to 457 patients, the mean length of stay comes down to 10.61
days (st.dev.=5.95). Duration of stay now varies between 1 and 42 days.
Significant correlations between (dynamic) severity categories, background characteristics
and length of stay arc presented in appendix 20. For nominal predictors special tables will be
presented showing the relation with length of stay by means and standard deviations in each
category.
* Severity of coronary stenosis.
Variance in length of stay explained by the dummy variables representing the categories of
intensity of stenosis, the extent of stenosis and location of stenosis (sec § 6.2.1) turns out to
be rather low (Eta^ is resp. 0.16, 0.11 and 0.13). If the three sets of dummy variables arc
separately used as predictors in the regression analysis, none in the sets of variables is
statistically significant. If patients have a cathcterization their length of slay seems to
increase somewhat (r=.09; p<.05). This low positive correlation turns out to be non-
significant in the eventual regression analysis.
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* Severity of myocardial ischemia.
The severity of myocardial ischemia measured by the ECG at rest (sec § 6.2.2.1.) is
significantly correlated with length of stay. The correlation matrix (appendix 20) shows that
patients with antcroscptal myocardial ischemia (ISLOC) have a significantly higher chance
of staying in hospital longer in comparison to patients with non-antcroseptal ischemia
(r=.27;p<.001). In the eventual regression analysis this effect remains significant (table
7.19). The extent of myocardial ischemia (ISEXT) has a lower but nonetheless significant
correlation with the length of stay (r=.l l;p<.05). Patients with extensive myocardial
ischemia seem to have a significantly higher chance of staying in hospital longer. In the
eventual regression analysis this turns out to be a non-significant parameter. Furthermore,
when patients do have extensive myocardial ischemia chances arc high that it will be located
ƒ2ft /nvr.ffi'#a/iflx /iy/>o»/i«;zf rf /Wa/ioru befnwn wverify o/I / / /IMJ and ca$« o//ru-aTca/ can*
in ihc antcroseptal side of the left ventricle (r=.39;p<.001).
The dummy variables comprising the severity of myocardial ischemia measured by the
exercise test according to the Bruce protocol or measured by the thallium test (see §6.2.2.2.)
show no significant correlations with the length of stay. This is not surprising: normally
these tests arc performed when the moment of discharge has already been planned by the
treating physician. These tests arc usually made one or two days before the patient is
planned to leave the hospital. The results of these tests may be relevant for further treatment
decisions in an outpatient setting, but the tests have no large consequences for the total
duration of the current hospital stay.
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• Severity of myocardial necrosis.
According to appendix 20 the location of the severity of myocardial necrosis determined by
means of ECG (sec § 6.2.3.1.) turns out to be positively correlated with the length of stay
(NIX'I.OC:r=.lX;p<.(X)l). It seems that patients with antcroseptal necrosis tend to stay in
hospital longer than other patients. However, in the eventual regression analysis the so-
called effect turns out to be non-signitlcani. Furthermore, when patients have anteroscptal
necrosis, chances are high lhat they will also have antcroseptal ischemia (r=.63;p<.001).
However, in the explanation of length of stay, antcroseptal ischemia appears to be a more
important explaining factor than anlcroscptal necrosis. The extent of myocardial necrosis
(NECEXT) docs not turn out to have a significant correlation with the length of stay at all
(r=.()5;p=.15).
Severity of myocardial necrosis, measured by means of typical enzyme release (see §
6.2.3.2.), appears to have a significant relation with (he length of stay. An increase in length
of slay is generally moderately related with a patient's increase in enzyme release. As can be
seen in table 7.13, oneway variance explained by the CPK severity categories amounts to .06
(p<.(X)l). Only dummy variable DCPK5 (CPK release > 60000) has a significant (positive)
correlation with length of stay (r=.16;p<.(X)l). However, in the eventual regression analysis
this dummy variable has no significant effect anymore. The reasons for this arc complicated.
A high CPK enzyme release turns out to be correlated with pericarditis
(PERlC:r=.25;p<(X)l), mitral insufficiency (MITINS:r=.12;p<.01). a slightly impairment of
the l.VEF (DLVEFl:r=.ll;p<01) and sinuslachycardia or atrial fiuttcr/-fibrillations in the
acute phase combined with ventricular flutlcr/-fibrillalions or sustained ventricular
tachycardia in follow-up phase of slay (DRHYTHM9:r=.12;p<.01). These severity indices
Him out to be a better explanation for differences in length of stay than the CPK-index (table
7.19). Almost identical results arc found when severity of myocardial necrosis is measured
by S(iOT or I.DH en/ymes. These results arc therefore not presented here.
Within the set of dummy variables representing the severity of necrosis measured by
thallium test the only variable significantly correlated with length of stay appears to be
DNETHEXT1 (irreversible thallium changes in 1 or 2 wall segments: r=.09;rx.05). In the
eventual regression analysis the partial regression coefficient does not turn out to be
significant. Thus, severity of myocardial necrosis measured by the thallium exercise test will
have no consequences for the duration of the hospital stay.
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Table 7.13 Mean length of stay of patients in categories representing myocardial necrosis
estimated by total CPK release (n=457).
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* Severity of ischemic pain.
The severity of ischemic pain reported by the patient (sec § 6.2.4.) appears to have u
significant correlation with the length of stay. Patients who have ischemic pain only in the
acute phase of the stay (TO or Tl) appear to have a significantly lower chance of slaying in
hospital longer (DISPAINl:r=-.14;p<.(X)l). If patients also suffer from ischemic pain in a
later phase of the stay (i.e. : after three days) the chance of staying in hospital longer will
strongly increase (DlSPAIN2:r=.34;p<.(X)l). In total 13 % of the non-linear variance in
length of stay is explained by the severity of ischemic pain alone (table 7.14). In the
eventual regression analysis, patients with ischemic pain after three days turn out to have
significantly higher chances of staying longer in hospital (table 7.19).
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Table 7.14 Mean length of stay of patients in categories representing severity of ischemic pain
(n=457).
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* Severity of Cardiac Wall Motion abnormalities (CWM).
Given the correlations between the length of stay and three sets of dummy variables each
representing the dimensions in severity of cardiac wall motion abnormalities (see § 6.2.5.),
the most important dimension appears to be the categories representing the extent of cardiac
wall motion abnormalities. As can be seen from table 7.15 the mean length of stay of
patients increases when more cardiac wall segments show any kind of wall motion
abnormality. The variance explained exclusively by this dimension amounts to .12. The
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dummy variables representing the extent with significant correlations are: CWMEXT2
(CWM abn. in 3 wall segments; r=.12;p<.01), CWMEXT3 (CWM abn. in 4 wall
scgmcnts:r=.19;p<.001)and CWMEXT4 (CWM abn. in 5 wall segments :r=.19;p<.001).
Variance explained by the intensity and location categories of cardiac wall motion abnor
malilics is somewhat lower, but still significant (Eta~.06;p<.05 resp. .07;p<.001). However,
in the eventual regression analysis the severity of cardiac wall motion abnormalities offers
no additional explanation for length of slay. All three severity dimensions have been tested
separately in regression analysis and none of them have a significant effect on the length of
stay.
Why these effects arc not significant anymore may be illustrated by the categories
representing the extent of cardiac wall motion abnormalities. It turns out that if patients have
CWM abnormalities in 3 wall segments, chances of having a LVEF between 30 and 40 %
(DI.VEFl:r=.24;p<.01), of having pericarditis (PERIC:r=.13;p<.01), and of having recurrent
sinuMachycardia (DRHYTHM5:r=.14;p<.01) arc significantly higher. If patients have CWM
abnormalities in 4 wall segments chances of having an impaired LVEF increase
(I)LVl-;FI:r=.19;p<.(X)l and DLVEF2: r=.21;p<.(X)l). Patients with CWM abnormalities in 5
wall segments appear to have significantly higher chances of suffering from mitral
insufficiency (MITINS: r=.15;p<()l), from pericarditis (PERIC:r=.15;p<001), from rhythm
abnormalities like recurrent atrial fluttcr/-fibnHalions (DRHYTHM7:r=.16;p<.01) or from
acute sinustachycardia or atrial flultcr/-fibrillations combined with ventricular fluttcr/-
fibrillations or sustained ventricular tachycardia later on (DRHYTHM9:r=.15;p<.01). In
addition, the mortality risk in a later stage of hospital admission is significantly higher for
patients who have these extensive wall motion abnormalities (DDEATH3:r=.15;p<.01). As
will be seen later on, in the eventual regression analysis these latter variables turn out to
provide a better explanation of differences in length of stay than the extent of cardiac wall
motion abnormalities.
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Table 7.15 Mean length of stay of patients in severity categories representing the extent of
Cardiac Wall Motion abnormalities (n=457).
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* Severity of cardiac rhythm disorders.
As can be seen from table 7.16, variance explained by categories comprising the cardiac
rhythm disorders (§ see 6.2.6) amounts to .20. The correlations between the dummy
variables representing the categories of rhythm disorders and the length of stay arc
significant in four cases: when patients suffer from recurrent sinustachycardia or non-
sustained ventricular tachycardia (DRHYTHM5:r=.l8;p<.(X)l), when patients have acute
atria! fiutter/-fibrillations at the beginning of their stay and sinustachycardia or non-
sustained ventricular tachycardia in the follow-up phase (DRHYTHM6:r=.(W;p<.05), when
patients have recurrent atrial flutter/fibrillations (DRHYTHM7:r=.21;p<.(X)l) or when
patients have sinustachycardia or atrial flultcr/-fibiïllations in the beginning combined with
ventricular fluttcr/-fibrillations or sustained ventricular tachycardia in the follow-up phase
(DRHYTHM9:r=.28;p<.001).
In the eventual regression analysis the effects of five severity categories of rhythm disorders
turn out to be significant (table 7.19). A relatively moderate increase in length of slay occurs
for: (1) patients who have acute sinustachycardia or atrial fluttcr/-fibrillations combined with
ventricular flullcr/-fibrillations or sustained ventricular tachycardia in the follow-up phase
(DRHYTHM9). (2) patients who have recurrent atrial fluttcrAfibrillations (DRHYTHM7)
and (3) patients who suffer from recurrent sinustachycardia or non-sustained ventricular
tachycardia (DRHYTHM5). A relatively minor, but still significant increase in length of stay
results for: (4) patients who have acute ventricular fluttcr/-fibrillations within 3 days
followed by atrial fluttcr/-fibrillations or sinustachycardia in the follow-up phase of their
stay (DRHYTHM8) and (5) patients who only have acute sinustachycardia within the first
three days of the stay (DRHYTHMI). The last (unexpected) effect can be explained because
conditional dummy variables DDEATH1 and DDEATH3 arc presumedly acting us
suppressor variables on the original relation between DRHYTHM1 and length of stay (r=.-
O4;p=.18). Patients who have sinustachycardia at the beginning of their stay tend to die
sooner (in period Tl), so their stay is relatively short. At the same time, if patients with this
rhythm disorder stay alive, they will have a longer hospital stay. This implies that the
relationship between the occurrence of this rhythm disorder and length of slay tends to be
obscured and underestimated by early decease during stay. If one corrects this, the
relationship between severity of this rhythm disorder and length of stay turns out to be a
positive and significant one. The effect caused by DRHYTHM8 seems to occur by random
chance only: the effect is only just statistically significant.
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Table 7.16 Mean length of stay of patients in severity
appearance of cardiac rhythm disorders (n=457).
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* Severity of cardiac conduction disorders.
As can be seen in lablc 7.17. the variance in length of stay explained by categories
representing cardiac conduction disorders (see § 6.2.7) amounts to 4 % . The only dummy
variable that has a significant correlation with the length of stay appears to bc DC0NDUC5
(recurrent right bundle branch block (RBBB):r=.13;p<.05). However, in the eventual
regression analysis the parameter belonging to this conduction disorder appears to be not
significant. Patients who have a recurrent RBBB during their stay tend to have a severe
impaired Left Ventricular Ejection Fraction (DLVEF2:r=.19;p<.001) and this will eventually
cause a prolonged hospital stay. At the same time these patients lend to have
sinustachycardia or atrial flutlcr/-fibrillations in the beginning combined with ventricular
fluticr/-fibrillations or sustained ventricular tachycardia in the follow-up phase of stay
(I)RIIYTHM'):r=.16;p<.(X)l) and this will also result in a longer hospital stay. The third
factor related to RBBB is pericarditis (PERIC:r=.13;p<.001) and this factor lends to explain
apart of the assumed effect of RBBB on the length of hospital stay too.
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Table 7.17 Mean length of stay of patients in severity categories representing type and time of
appearance of cardiac conduction disorders (n=457).
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* Severity of heart failure.
The severity of heart failure of patients (sec § 6.2.8.1.) measured by the Left Ventricular
Ejection Fraction (LVEF) is positively and significantly related to their length of stay.
Variance explained by this indicator alone amounts to .17 (table 7.18). The dummy variables
representing the LVEF severity categories that show a positive significant correlation with
the length of stay are DLVEF1 (r=.24;p<.()01) and DLVEF2 (r=.27;p<(K)l). Strangely
enough, scores on LVEF lower than 20 * seems to have no correlation to length of stay
(DLVEF3:r=-.O56;p=.12). This may be explained by the high mortality risk of these patients
within ten days; there is a moderately high correlation between this dummy variable and
DDEATH2 (r=.29;p<.001) . This factor is also correlated to MITINS (mitral
insufficiency:^. 17;p<.001) and DRHYTHM5 (recurrent sinustachycardia:r=.2();p<.(X)l).
For patients with an LVEF between 20 9? and 30 '7r (DLVEF2) this effect is also not
significant. This can be explained because these patients tend to have higher chances of
dying in a later phase (DDEATH3:r=.25;p<.001) , of having pericardit is
(PERIC:r=.17;p<.001), of having antcroscptal ischemia (ISLOC:r=.19;p<.00l) and two
types of cardiac rhythm disorders, i.e. recurrent atrial flutter/-fibrillatitins and
sinustachycardia or atrial fluttcr/-fibrillations in the beginning combined with ventricular
fluttcr/-fibrillations or sustained ventricular tachycardia in the follow-up phase
(DRHYTHM7:r=.17;p<.001, resp. DRHYTHM9:r=.31;p<.001).). The only significant
dummy variable in the eventual regression analysis is DLVEF1 (table 7.19). This means that
if patients have an LVEF between 30 % and 40 %, chances of staying longer in hospital will
increase significantly.
The severity of heart failure measured by the Left Ventricular End Diastolic Dimension
(LVEDD) is positively correlated with the length of stay (r=.15;p<.OOI). However, in the
eventual regression analysis the LVEDD has no significant effect on the length of stay. This
may be explained by the correlations this factor has with the LVEF dummy variables
(DLVEFl:r=.ll;p<.05, DLVEF2:r=.28;p<.001 and DLVEF3:r=15;p<.001).
The severity of right sided heart failure (sec § 6.2.8.2.), measured by the collapse of the
Vena Cava Inferior (the VCI-indcx) shows a weak positive correlation with the length of
stay (VCI:r=. 13;p<.05). Patients with a VCI index less than 50 9f seem to have a higher
chance of staying in hospital for a longer period of time. However, the effect is not
significant in the eventual regression analysis. Patients with VCI lower than 50 9f have more
72(5 //ivttf/ga/mg /i>-po//iMiz«/ rWa/ioru frernwn severity o//7//i«s a/id costs o/medico/ can»
chances of being in a LVEF category lower than 30 % (r=.16;p<.001), and are more likely to
suffer from typical cardiac rhythm disorders, like recurrent atrial flulter/-fibrillations
(DRHYTHM7:r=.13;p<.01) or acute ventricular fluttcr/-fibrillations combined with atrial
flutlcr-/fibrillations or sinustachycardia later on (DRHYTHM8;r=.12;p<.01). Furthermore,
these patients show a higher probability to have mitral insufficiency (r=.13;p<.001). All
these factors have a direct effect on the length of stay, and the assumed effect of VCI on
length of hospital stay will be explained by these deficiencies.
The correlations of right ventricular infarction, measured both by ECG ST-changcs as well
as by abnormal wall motion with length of stay appear not to be significant
(ISRV:r=.07;p=.()9 and CWMRV:r=.()6;p=.13). In the cvcnlual regression analysis these
factors have no substantial effect on the length of stay at all.
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Table 7.18 Mean length of sCay of pa t i en t s in sever i ty ca tegor ies representing the Left
Ventricular Kjection Fraction (n=457).
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* Severity of physical deficiencies and specific cardiac complications.
Physical deficiencies (sec § 6.2.9.) correlated with the length of stay are palpitations
(PALP:r=.16;p<.()0l), prc-collapsc (PRECOL:r=.21 ;p<.()01), syncope/collapse
(SYCOL:r=.15;p<.(X)l), dyspnea (DYSP:r=.26;p<.(X)l), edema in the lower abdomen or in
the extremities (BEDEMA:r=.l();p<.05) and lung edema (LEDEMA:r=.15;p<.01). In the
eventual regression analysis only prc-collapsc offers an additional explanation of the
duration of hospital stay (table 7.19). The parameters of all other physical deficiencies
significantly correlated with the length of stay turn out to be non-significant in the eventual
regression analysis. For instance, patients who have lung edema have a higher mortality risk
in period T3 (after ten days). Impairment of cardiac function is highly correlated with lung
edema and this turns out to be tine of the genuine factors influencing a longer stay. Patients
having palpitations during their stay arc more likely to suffer from specific rhythm disorders,
like recurrent atrial flutter/ -fibrillations (DRHYTHM7:r=.18;p<.01) or atrial flutter/ -
fibrillations or sinustachycardia in the first part of their stay combined with ventricular
flutter/-fibrillaiions or sustained ventricular tachycardia later on in their stay
(DRMYTHM9:r=.21;p<.01). In addition to all this, the probability that these same patients
have pericarditis increases (PERlC:r=.13;p<.01) and they have a higher probability to die
during period T3 (DDEATH3:r=.13;p<.01).
Patients suffering from syncope/collapse tend to have atrial flintcr/-fibrillations or
sinustachycardia in the first part of their stay combined with ventricular flutter/ -fibrillations
or sustained ventricular tachycardia later on in their stay (DRHYTHM9:r=.25;p<.01).
Patients with syncope/collapse also have more chance of suffering from mitral insufficiency
(MlTlNS:r=. 19;p<.01) and/or CVA/TIA (CVA:r=.21 ;p<.01).
Having dyspnea during stay is (cor)rclatcd to many factors in the medical model, which tend
to explain the moderately positive correlation between dyspnea and length of slay. Dyspnea
patients will have more anlcroscptal myocardial ischemia (ISLOC:r=.25;p<.01). tend to
suffer from ischemic pain in the later part of their stay (DISPAIN2:r=.34;p<.(X)l) and will
have cardiac rhythm abnormalities like recurrent atrial fluller/-fibrillations
(DRHYTHM7:r=.21;p<.01). Also LVEF-scorc deviations tend to be higher in these patients
(DLVEFl:r=.24;p<.01 and DLVEF2:r=.27;p<.01), and they will have a higher probability to
die during period T3 (DDEATH3:r=.28;p<.(X)l).
Patients with body edema arc likely to have cardiac rhythm abnormalities like recurrent
atrial flutterAfibrillations (DRHYTHM7:r=.21;p<.01). to have high deviations on the LVEF
score (DLVEF2:r=.27;p<.01) and to have mitral insufficiency (MITINS:r=.29;p<.(H)l).
These same patients will also have higher chances of dying within period T3 (DDEATH3:
r=.28;p<.(X)l).
Other cardiac complications correlated with the length of slay arc: mitral insufficiency
(MITINS;r=.19;p<.05), CVA/TIA (CVA:r=.21 ;p<.()01) and pericarditis (PERlC:r=.27;
p<.(X)l). All assumed effects of these factors arc also significant in the eventual regression
analysis (table 7.23). Cardiogcnic shock shows a significant negative correlation with
hospital stay (CSHOCK:r=-.23;p<.(K)l). This correlation may be explained by the high
mortality rate of these patients which is considerable (in T():r=.44, in Tl:r=.47 and in T2:
r=.44). Dying in hospital during these periods is presumedly the reason why this type of
complication offers no additional explanation in the eventual regression analysis.
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* Characteristics of admission and discharge.
From the analysis it may be concluded that, apart from the manifold effects of the patient's
severity of illness conditional factors like type of admission and type of discharge arc
significantly related to the length of stay: patients coming from other hospitals have a
shorter length of stay, if patients are transferred to other medical departments their total
length of stay will increase and if patients die in hospital within ten days their overall length
of stay is of course shorter. If patients die after ten days their length of hospital stay will
however increase importantly.
* Background characteristics.
From all individual background characteristics (sec § 6.3.1) the only variables showing
significant correlations with the length of stay arc: AGE (r=.14;p<.01) and SEX (r=.l4;p
<.01). In the eventual regression analysis the parameters belonging to these variables turn
out to be non-significant. Generally speaking, sex and age arc correlated with one or more
severity indicators: the older the patients the more severe their illness is and vice versa. Age
is sometimes assumed to be a reliable predictor for the length of stay. For the patient
population under survey only 2 9£ of differences in length of stay can be explained that way.
When a difference is made between deceased and non-dcccascd patients the age seems to be
more relevant in the deceased group (LOS:r=.36;p<.(X)l).Patients who die in hospital after a
prolonged stay appear to be much older than patients who die acutely.
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Table 7.19 Results from the eventual regression analysis: dependent variable is total length of
stay in hospital for AMI-patienls (Listwise deletion of missing cases, n = 454).
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Discussion.
It may be concluded that in patients with AMI. the severity of illness will significantly
increase the length of slay at the hospital. Relevant severity indicators contributing each to
an increase in length of stay arc (1) antcroscplally located ischemia. (2) prolonged ischemic
pain after three days of hospital stay, (3) specific cardiac rhythm disorders, (4) a LVEF-scorc
between 30 9f and 40 %, (5) pre-collapsc, (6) pericarditis. (7) mitral insufficiency and (8)
CVA/TIA. The variance explained by these severity indicators is 46.9 %.
In almost all cases the effects presumed from other severity indicators that have significant
correlations with the length of stay but that have non-significant parameters in the regression
analysis turn out to be explained by the correlations with one or more medical deficiencies.
The only exception to this is the presumed effects of a LVEF-scorc lower than 20 * and
cardiac shock which become non-significant because of the correction for deceased patients.
So, these severity indicators still might be seen as factors indirectly causing a shorter length
of stay. Inclusion of the 'death' variables next to the severity of illness indicators increases
the variance explained to 59.8 <*. From the analysis it turns out that patients who die within
ten days have a very short length of stay. But patients who die after ten days will have an
extremely long length of stay.
The additional variance next to severity of illness explained by the type of admission and
transfer turns out to be low (total is 48.1 % rcsp. 53.0 <*). When 'transfer' variables arc
included in the regression analysis, they turn out to have a decreasing effect on the
regression coefficient of CVA/TIA. This complication will increase the length of stay at the
cardiology department with about four days while the overall length of stay increases by
approximately ten days.
Next to the severity indicators introduction of other forms of non-regular discharge
(DHOME1 and DH0ME3) will increase the variance explained to 58.9 %. None of the
above mentioned severity indicators become non-significant in the eventual regression
analysis, except for two types of cardiac rhythm disorders (DRHYTHM4 and
DRHYTHM6). In the eventual analysis these effects are interpreted as spurious (patients arc
expected to have typical complications not included in this study), but some caution is still
in place. These two cardiac rhythm disorders might have substantial effects on lenght of
stay. But this can only be established if other factors influencing the length of stay, which we
have not measured in this study, arc included in the data-analysis.
When the DHOME-variables are introduced in the last step of the regression analysis the
value of some regression coefficients of severity indicators like ISLOC (first B=1.4 now
B=0.7), DISPAIN2 (first B=4.1 now 2.4) and DRHYTHM8 (first B=4.9 now 2.5) turns out
to decrease. All other indicators show only a minor decrease in their regression coefficients.
For the time being, the present solution involving a model in which the regression
coefficients are subjected to a strict form of conlroll is preferred in spite of the risk of
underestimating the effects of some indicators of severity in illness. In total 79 % of the
variance in length of stay is predicted by the severity of illness and conditional factors
together. The relative importance of these variables on the length of stay (beta parameters) is
presented in diagram 7.20.
Diagram 7.20 Path-analytic model in which an explanation is given of total length of hospital
stay in patients having AMI (Listwise deletion of missing cases, n=454).
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7.3.2. Explanation of costs of the coronary care unit.
The costs of the coronary care unit of a patient arc defined as ihc average material and
personnel costs per CCU-day multiplied by the number of days the patient is admitted to the
CCU (see § 6.1.3.). For the total patient population of 464 patients the mean CCU costs
amount to 1398.27 guilders (std.dev.= 1572.43); costs vary between ().(K) and 15074.80
guilders. Three patients have been excluded from the analysis because of their extremely
high CCU costs (m= 11016.20. std.dcv.=37()1.2O). The mean CCU cost of the remaining
patients is 1335.68 guilders (std.dcv.= 1349.77; n=461); costs now vary between 0.00 and
8407.10 guilders. Correlations between severity of illness, background characteristics,
length of stay and CCU costs arc presented in appendix 21.
• Severity of coronary stenosis.
Some correlations between CCU costs and the dummy variables representing the intensity,
extent and location of coronary stenosis (sec § 6.2.1) appear to be statistically significant. If
we restrict ourselves to correlations higher than 1.101. three of them seem to be relevant.
Patients having such a decrease in stenosis that no further deficiencies can be detected
during stay appear to have higher CCU costs (DSTENEXTl:r=.12;p<.01). Similarly,
patients with decreasing scores on the location index to about 'normal' values seem to have
higher CCU costs (DSTENLOCl:r=.14;p<.01). The third correlation concerns the one
between having a heart cathelcri/alion during stay and the CCU costs; having a
catheterizalion appears to increase the CCU costs. When dummy regression analysis of CCU
costs is done using each of the three stenosis indices separately, only patients who have
decreasing scores on the index of location of stenosis appear to incur significantly more
CCU costs, even if we control for type of stay (i.e. type of admission and type of discharge
in hospital). However, this 'effect' is explained by the enrollment in the PRIMI-protocol; if
patients participate in this clinical trial they receive a cathcicrization twice. It is assumed that
rypr>f/i«i;«/ nr/mioru bfruw/i sewrj/y <>ƒ IM/IM.V ONI/ C M « O/ mr</i<yi/ «inr 7.?/
this is the reason why they are kept under prolonged observation in CCU. The enrollment in
PRIMI itself appears to have no relation with the CCU costs.
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* Severity of myocardial ischemia.
The extent of myocardial ischemia measured by ECG at rest (see § 6.2.2.1.) appears to be
moderately correlated with CCU costs, (ISEXT:r=.18;p<.(X)l). and if the ischemia is located
in the antcroscptal wall segment of the lcfi ventricle CCU costs will rise substantially
(ISLOC:r=.32;p<.(X)l). In the eventual regression analysis only the locution of myocardial
ischemia provides an additional explanation for differences in CCU costs (table 7.26). If
patients tend to have a high score on the location index of myocardial ischemia, they will
have higcr CCU costs. As one can sec from the correlation matrix in appendix 21, the extent
of ischemia appears to be highly correlated with the locution of ischemia (r=.37;p<.(X)l).
We can reasonably assume that the severity of myocardial ischemia measured by exercise
test will have no effect on the CCU costs. These tests arc normally planned just before the
patient leaves the hospital and are certainly not performed when a patient is staying at the
CCU.
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* Severity of myocardial necrosis.
According to appendix 21, the severity of myocardial necrosis (sec § 6.2.3.1.) measured by
the ECG at rest shows moderate correlations with CCU costs for both the extent of necrosis
(NECEXT:r=.18;p<.001) and the location of necrosis (NECLOC:r=.3();p<.(X)l). However, in
the eventual regression analysis, both effects turn out to be non-significant. The extent of
necrosis appears to be correlated with the extent of myocardial ischemia (r=.22;p<.(K)l).
Similarly, the location of the necrosis appears to be very highly correlated with the location
of cardiac wall motion abnormalities (r=.61 ;p<.(X)l).
As can be seen from table 7.21 variance explained by the severity of myocardial necrosis
measured by CPK-scverity categories (sec § 6.2.3.2.) amounts to .18. Patients with a
relatively low CPK release tend to have a shorter CCU-stay with low costs
(DCPK1 :r=-.15;p<.01). This is, however, not confirmed in the eventual regression analysis.
If patients have a very high CPK release, chances of staying in the CCU resulting in
relatively high CCU costs increase (DCPK4:r=.13;p<.01 and DCPK5:r=.36;p<.(X)l). The
CPK release (DCPK4 and DCPK5: area measure > 40.(XX)) appears to have an significant
increasing effect on CCU costs in the eventual regression analysis (table 7.26). Myocardial
necrosis measured by the other enzymes (SGOT and LDH) shows about the same
correlations with CCU costs, but these factors offer no additional explanation for costs like
CPK does, even when included separately in the same analysis.
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Table 7.21 Mean CCU costs of patients in categories representing myocardial necrosis
estimatied by total CPK release (n=461).
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* Severity of ischcmic pain.
Severity measured by ischcmic pain (sec § 6.2.4) appears not to be significantly correlated
with the CCU costs. No significant correlations arc found if patients have only ischcmic pain
in the acute phase of ihc stay (DISPAINl:r=.O7;p=.()8) or if patients apart from this initial
pain, suffer from pain after three days of hospital stay (DISPAIN2:r=.O6;p=.O9). In the
eventual regression analysis il lurns oul that patients with ischcmic pain do not stay in the
CCU longer than patients without ischcmic pain.
or C
• Severity of Cardiac Wall Motion abnormalities (CWM).
The important dimension in the severity of cardiac wall motion abnormalities as measured
by the intensity, the extent and the location (sec § 6.2.5) appears to be the location scale.
Variance in CCU costs explained by this indicator alone amounts to .12 (table 7.22). In
dummy regression analysis (which includes also patients who do not receive an ccho-
cardiography) the variance explained amounts to .18. Patients appear to have much higher
CCU costs if they have wall motion abnormalities in the anteroseptal wall segment of the
left ventricle (DCWMLOCl:r=.4();p<.(X)l). This effect remains significant in the eventual
regression analysis (table 7.26). Variance explained by the intensity-index of wall motion
abnormalities alone amounts to only .03 (if patients who do not have cchocardiography arc
excluded from analysis). In dummy regression analysis (n=461) the explained variance of
this factor alone amounts to .10. In the eventual regression analysis the assumed effect of
this factor was not significant anymore: this can partly be explained by the fact that patients
who show typical akinetic or dyskinctic cardiac wall motion tend to have a low left
ventricular ejection fraction (correlations of DCWMINT1 with DLVEF1 and DLVEF2 are
rcsp. .26 and .38, both significant at p<.(X)I) and these last factors do explain CCU costs
better. The non-significance in the effect of the intensity dimension of CWM abnormalities
is furthermore explained by the simultaneous emergence of typical cardiac rhythm disorders:
patients who have akinetic or dyskinctic wall motion abnormalities tend to suffer somewhat
more from recurrent sinuslachycardia or non-sustained ventricular tachycardia during stay
(DRUYTMM5:r=.l();p<.05) and they arc more likely to have sinustachycardia or atrial
fliittcr/fibrillalion in the beginning combined with left ventricular fluttcr/-fibrillalions or
sustained ventricular tachycardia in the later phase of their stay (DRHYTHM9:r=.13;p<.01).
Due lo the complications mentioned above the intensity-dimension of cardiac wall motion
abnormalities has no significant effect on CCU costs in the eventual regression analysis.
Variance explained by the extent of cardiac wall motion abnormalities alone amounts to .10
(n=313). In dummy regression analysis (n=461. with inclusion of patients who do not have
echocardiography) the variance explained amounts to .17. The effects of the first two
dummy variables (DCWMEXT1 and DCWMEXT2) arc not significant, but the three higher
numbered ones representing four wall segments and more seem to have significant effects
on the CCU costs. In the eventual regression analysis these seemingly important effects are
actually explained by the same factors mentioned in the preceding analysis: this is hardly
surprising, since there appears to be a strong positive correlation between the intensity and
extent scales (r=.59;p<.OO;n=313).
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Table 7.22 Mean CCU costs of patients within severity categories representing the location of
Cardiac Wall Motion abnormalities (n=461).
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* Severity of cardiac rhythm disorders.
As can be seen from table 7.23 variance of CCU costs explained by the severity of cardiac
rhythm disorders (see § 6.2.6) alone amounts to .34. The correlations between the dummy
variables representing the various severity categories and the CCU costs arc significant for
four variables: (1) sinustachycardia or non-sustained ventricular tachycardia in the follow-up
phase of stay (DRHYTHM4:r=.16;p<.001), (2) recurrent sinustachycardia or non-sustained
ventricular tachycardia (DRHYTHM5:r=.22;p<.()01), (3) acute ventricular flultcr/-
fibrillations followed by atrial fluttcr/-fibrillations or sinustachycardia
(DRHYTHM8:r=.13;p<.01) and (4) acute sinustachycardia or atrial flutter/fibrillations
combined with ventricular fiuttcrAfibrillations or sustained ventricular tachycardia in the
follow-up phase of stay (DRHYTHM9:r=.45;p<.001). Patients with these specific rhythm
disorders have a significantly higher chance of incurring high CCU costs. The supposed
effects belonging to these rhythm abnormalities turn out to be significant in the eventual
regression analysis (table 7.26).
// may conc/«<ffa! //ia/ s/?fc//?c fypf5 o/ cardiac r/ry//im d/sordfrr nave juo.y/an/i'a/ «jjtcw on
//if CCf/ cosw; pa//fn/s wi7/i (7,) rfcwrrfn/ s/nM.s/ac/i>'carrf/a or non-my/a/nffl" vfn/n'c«/ar
/ac7ivcard/a, or (2,) smMS/ac/i>rara7a or non-sus/a/nf</ /ac/i>rar</ia in/o//ow-ap p/iajf, or (J,)
acw/f VF/F comfc/nf J wi'/n ,4 F/F or 5/nMj/ac/rycar</ia in /O//OH'-W/7 pnasf, or f4) acu/f
Jinuj/acnycardia or ^4F/F como/'nfJ wi//i VF/F or 5WJ/ainfd vfn/r/c«/ar /acnycarJ/a in
/o//o>v-wp pnasf wiV/ navf /ii^/ifr CCf/ cos/5.
s^iwify o/ i//n«5 onrf cas« o/mf <fica7 care
Table 7.23 Mean CCU costs of patients in severity
appearance of cardiac rhythm disorders (n=461).
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* Severity of cardiac conduction disorders.
Variance of CCU costs explained by cardiac conduction disorders (see § 6.2.7.) alone
amounts to .06 (table 7.24). Two conduction severity categories appear to be relevant with
respect to CCU costs: recurrent right bundle branch block (DCONDUC5:r=.15;p<.001) and
third degree AV-block combined with ventricular escape rhythm in the follow-up phase
(DCONDUC6:r=.l6;p<.(X)l). However, in the eventual regression analysis only the first
type of conduction disorders appears to have a significant effect (table 7.26). Why the
assumed effect of the other type (DCONDUC6) is nonsignificant is partly explained by the
fact that patients who have high levels of total CPK enzyme release (DCPK5) typically
develop a third degree AV-block combined with ventricular escape rhythm in the follow-up
phase (r=.18;p<.(H)l). and these enzyme values turn out to have a substantial increasing
effect on the CCU costs. Furthermore, this conduction disorder tends to be accompanied by
acute sinustachycardia or atrial flutler/-fibrillations combined with ventricular fluttcr/-
fibrillations or sustained ventricular tachycardia in the follow-up phase
(DRMYTHM9:r=.18;p<.(K)l) or acute ventricular fiuttcr/-fibrillations followed by airial
flutier/fibi illations later on (DRHYTHM8:r=.18;p<.001). These two factors provide a better
explanation for CCU costs.
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Table 7.24 Mean CCU costs of patients in severity categories representing type and time of
appearance in cardiac conduction disorders (n=461).
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* Severity of heart failure.
Variance of CCU costs explained by the severity of heart failure as measured by the Left
Ventricular Ejection Fraction (sec § 6.2.8.1.) amounts to .15 (table 7.25). Patients with a
LVEF between 20 % and 40 9? show moderately high correlations with CCU costs
(DLVEFl:r=.26;p<.001 and DLVEF2:r=.28;p<.()01). In a dummy regression analysis
containing only the three LVEF-variablcs, two of the three arc statistically significant
(DLVEF1 and DLVEF2) and the third (DLVEF3) is just non-significant (p=.06). When the
length of stay and the type of admission and discharge arc included in the analysis, all three
effects are significant. When all other severity-indicators arc added to the regression
equation, then only the presence of an ejection fraction between 30 % and 40 % (DLVEF1)
will cause a significant rise in CCU costs (table 7.26). Having an ejection fraction between
20 % and 30 % (DLVEF2) or less than 20 % (DLVEF3) will not increase CCU costs at all.
This rather puzzling effect may be explained by other severity indicators. In general, patients
tend to have a low ejection fraction when they have cardiac wall motion abnormalities in the
anteroseptal area. As we have seen above, patients with this abnormality tend to have higher
CCU costs. Furthermore, specific rhythm disorders arc associated with a low ejection
fraction: recurrent sinustachycardia is positively correlated with an ejection fraction lower
than 20 % (DRHYTHM5:r=.20;p<.001) and ventricular flutter/fibrillations or sustained
ventricular tachycardia in the latter part of the stay is highly related to an ejection fraction
between 20 and 30 % (DRHYTHM9:r=.30;p<.001). Both factors will at the same time cause
a sharp rise in CCU costs. Also, a LVEF score between 20 % and 30 % will be related to a
longer length of stay (LOS:r=.30;p<.001) which naturally will be associated with a higher
chance of incurring CCU costs.
The severity of heart failure measured by the Left Ventricular End Diastolic Dimension
(LVEDD) appears to be correlated with CCU costs: patients with deviating LVEDD of more
than 55 mm show a significantly higher chance of incurring CCU costs (r=.16;p<.001). But
in the eventual regression analysis the LVEDD has no significant effect on CCU costs. This
may be explained by the fact that patients showing LVEDD-dcviations will generally suffer
from cardiac wall motion abnormalities in the antcroseptal side of the left ventricle
(CWMLOCl:r=.14;p<.001) and this factor will cause substantially high CCU costs.
Furthermore there are positive correlations between the LVEF-dummy variables and the
LVEDD, for instance the correlation between LVEDD and DLVEF2 is .28 (p<.001) and that
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with DLVEF3 is .17 (p<.(X)l). Although the relative effect of these last dummy variables on
the CCU costs is not significant, this will help to make the effect of LVEDD in the eventual
regression analysis non-significant.
Severity of heart failure located in the right ventricle, measured by the collapse of the Vena
Cava Inferior (VCI) index (see § 6.2.8.2.), seems to be somewhat weakly correlated with
CCU costs (r=.17;p<.(X)l). In addition when patients have cardiac wall motion abnormalities
in ihc right ventricle, chances arc that they will have somewhat higher CCU costs
(CWMRV:r=.0y;p<.05). However, in the eventual regression analysis both effects turn out to
be non-significant, because patients with limited collapse of the vena cava inferior have
higher chances of suffering from cardiac wall motion abnormalities in the antcroscptal side
(DCWML0Cl:r=.16;p<.(X)l). They also tend to have a low score on the LVEF index
(LVEF2:r=.17;p<.(X)l). and typical conduction disorders (DCONDUC6:r=.15; p<.001).
They will - perhaps as a result of this - have a prolonged stay in hospital (DH0ME3:
r=.16;p<.(X)l). Patients suffering from cardiac wall motion abnormalities in the right
ventricle (CWMRV) will generally have supravcntricular rhythm disorders and a high level
of CPK cn/.ymc release in the blood scrum. Right-ventricular infarction measured by ST-
changes turns out to have no correlation with CCU costs at all (ISRV:r=.00;p=.49).
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Table 7.25 Mean CCU costs in patients within severity categories representing the Left
Ventricular KJeclion Fraction (n=461).
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* Severity of physical deficiencies and specific cardiac complications.
Physical deficiencies (sec § 6.2.').) which arc significantly correlated with CCU costs are
palpitations (PALP:r=.15;p<.(X)l), prc-collapse (PRECOL:r=.16;p<.(X)l), syncope/collapse
(SYCOL:r=.08;p<.05). dyspnea (DYSPN:r=. 15;p<.01), low blood pressure
(LBLPRES:r=.14;p<.01) and lung edema (LEDEMA:r=.15;p<.01). In the eventual
regression analysis none of these physical deficiencies turns out to be an additional
explanation for the CCU costs.
Patients who have palpitations during their stay arc more likely to have atrial flutter/-
fihrillalions or sinustachycardia in the first part of their stay combined with ventricular
fluttcr/-fibrillations or sustained ventricular tachycardia later on in their stay
(DRHYTH!vW:r=.22;p<.(X)l). In addition to this, these patients have a greater chance of
suffering from pericarditis (PERIC:r=.13;p<01). Both confounding factors explain the
assumed effect of palpitations on the CCU costs.
/J7
Patients suffering from pre-collapse during their stay will also have higher chances of
having atrial flutter/-fibrillations or sinustachyeardia in the first part of their stay followed
by ventricular fluttcr/-fibrillations or sustained ventricular tachycardia later on
(DRHYTHM9:r=.19;rx.001). At the same lime their length of stay is positively correlated
with prc-collapse during slay (LOS:r=.24;p<.(X)l) and their hospital discharge tends to be
rather late (DHOME3:r=.13;p<.001). All three factors will explain any presumed effect of
prc-collapse on the CCU costs.
Patients who have a syncope/collapse during their stay are more likely to sutler from
anteroscptally located cardiac wall motion abnormalities (DCWMLOCl:r=.20;p<.(X)l) and
will have a longer stay in hospital (LOS:r=.19;p<.(X)l). At the same time these patients lend
to be discharged rather late (DHOME3:r=. 13;p<.01).
Patients who have lung edema during their stay arc likely to suffer from antcroscptally
located cardiac wall motion abnormalities (DCWMLOCl:r=.25;p<.(X)l) and at the same
time arc likely to have atrial flutter/-fibrillations or sinustachycardia in the first part of their
stay followed by ventricular fluttcr/-fibrillations in the latter part of their slay
(DRHYTHM9:r=.2();p<.(X)l). Also, these patients suffer from recurrent sinustachycardiu
during their stay (DRHYTHM5:r=.15;p<.()01). Finally, they tend to have low a Left
Ventricular Ejection Fraction, between 20 <* and 30 <* (DLVEF2:r=.32;p<(X)l). All factors
mentioned above will explain any assumed effect between lung edema and CCU costs. All
other physical deficiencies caused by AMI hitherto not mentioned have no significant effect
on the CCU costs.
Specific cardiac complications highly correlated with CCU costs arc pericarditis (PERIC:
r=.34;p<.001) and mitral insufficiency (MITINS:r=.l l;p<.()5). Only pericarditis has u
significant increasing effect on the CCU costs in the eventual regression analysis (table
7.26). Patients having mitral insufficiency arc likely to stay longer in hospital
(LOS:r=.20;p<.(X)l). At the same time they tend to be in the highest category of the total
CPK-relcase (DCPK5:r=.22;p<.001). Other complications like cardiogenic shock
(CSHOCK:r=-.05;p=.13) and CVA/TIA (CVA:r=-.()3;p=.27) show no significant
correlations with CCU costs at all and turn out to have no effect on the CCU costs.
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* Characteristics of admission and discharge, and length of hospital stay.
From the results from regression analysis (table 7.26) it may be concluded that in addition to
the patient's severity of illness, conditional factors like type of admission and type of
discharge are also significantly related to the CCU costs. Patients admitted via other
hospitals ten days after having stayed in the previous hospital have significantly lower CCU
costs. If patients are discharged in T3 or, if patients arc transferred to other medical
departments in T3, CCU costs tend to be relatively high. If patients die within ten days their
CCU costs are relatively lower.
* Background characteristics.
None of the patient's individual background characteristics (sec § 6.3.1) show significant
correlations with the CCU costs. In the eventual regression analysis each presumed effect
involving background characteristics is not statistically significant. In almost all cases the
background variables are highly correlated with one or more indicators measuring severity
of illness.
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Table 7.26 Results from the eventual regression analysis: dependent variable is CCU costs for
AMI patients (Listwise deletion of missing cases, n = 459).
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Discussion.
It may concluded that the severity of illness of patients with AMI has an important
increasing effect on CCU costs. Severity indicators explaining an increase in CCU costs are
(1) antcroseptally located ischemia measured by ECG at rest. (2) very high cn/ymc release,
(3) antcroseptally located cardiac wall motion abnormalities,(4) specific cardiac rhythm
disorders, (5) specific cardiac conduction disorders. (6) a LVEF between 30 '* and 40 W
and (7) pericarditis. Variance explained by these severity indicators alone is 58.1 '<•.
In almost all cases the presumed effects of other severity indicators having significant
correlations with the CCU costs but having non-significant effects in the eventual regression
analysis turn out to be explained by the correlations with one or more of the already
mentioned deficiencies. Some of these severity indicators turn out to be also significantly
correlated with the length of stay. Because of this their presumed effects on CCU costs turn
out to be non-significant in the eventual regression analysis. Introducing the length of stay as
a conditional variable next to the severity indicators docs increase the variance which can be
explained to 59.0 9L Inclusion of the 'death' dummy variables next to the severity of illness
indicators increases the variance explained to 60.1 '/?. Death within ten days of the slay is
negatively associated with CCU costs.
Next to the severity of illness indicators, the variance explained by the type of admission
and transfer turns out to be low (total is 58.5 % resp. 59.39F). However, the beta parameters
arc significant in the eventual regression analysis. One may conclude that patients coming
from other hospitals will generally be admitted to the routine nursing unit and not to the
CCU. Patients transferred to another medical department in the same hospital will have
higher CCU costs, probably due to specific complications or co-morbidities. Other ly|>cs of
non-regular discharge (DHOME1 and DHOME3) in addition to the severity indicators, will
increase the additional explained variance, to 63.5 '#. All the presumed effects of severity
indicators mentioned do stay significant in the eventual regression analysis when the
conditional variables arc introduced. When the DHOME-variables arc introduced in the last
step in regression analysis some regression coefficients of severity indicators such as
DRHYTHM8 (first B=l693.5 now B=1434.1) and DC0NDUC6 (first B=397.6 now 2(K).87)
turn out to decrease. All other significant effects of indicators show only a minor decrease in
the regression coefficients. Similar to the previous analysis there is a prcfcrrcncc for the
solution in which the regression coefficients arc subjected to strict control by confounding
variables which may cause some underestimation of the effects. In total 67 % of the variance
in CCU costs is predicted by the severity of illness and conditional factors. The relative
importance of these variables for the CCU costs (beta-parameters) is presented in diagram
7.27.
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Diagram 7.27 Path analytic model in which an explanation is given of the CCU costs for
patients having AMI (Listwise deletion of missing cases, n=459).
l-irrccts of dummy variable» In hrcakcu are nm significant at the 5 * level. Only beta parameters are shown.
7.3.3. Explanation of other costs of medical care.
Relations between costs of drugs, costs of laboratory services, costs of ECG, costs of
echocardiography and costs of exercise tests with severity indicators are analyzed in the
same way as length of stay and CCU costs. For reasons of shortness only the results of each
analysis will be summarized here. Correlation matrices and results from regression analysis
will be presented in the appendices.
* Explanation of costs of drugs.
Severity indicators which have a substantial effect on the costs of drugs according to the
results in appendix 27 arc: (I) severity of ischemic pain; patients still having ischemic pain
after three days incur higher costs for drugs, (2) severity of rhythm disorders; patients with
acute sinustachycardia or atrial nutter/fibrillations combined with ventricular fluttcr/-
fibrillations or sustained ventricular tachycardia later on have higher costs for drugs, (3)
severity of heart failure measured by Left Ventricular End Diastolic Dimension (LVEDD);
patients with LVEDD of more than 55 mm have higher costs for drugs, and (4) one physical
deficiency caused by AMI; patients with edema located in ankles or feet will have higher
costs for drugs. All other severity indicators turn out to have no substantial effect on the
costs of drugs. In almost all cases severity indicators as well as costs of drugs (appendices
22-26) appear to be highly associated with the length of stay. When length of stay of patients
is introduced in regression analysis presumed effects of a number of severity indicators turn
out not to be significant anymore. Costs of drugs have a very high positive correlation with
the patient's length of stay (r=.78;p<.(KM). One could say that - besides some functional
medical deficiencies directly or indirectly caused by myocardial necrosis - the costs of drugs
can be explained on a day-to-day basis. The severity of illness may be seen as an indirect
factor for costs of drugs; because more severe patients will slay in hospital longer their costs
of drugs will rise accordingly. Furthermore, next to the patient's severity of illness and
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length of stay, conditional factors like type of admission and type of discharge are in some
cases significantly related to costs of drugs: patients who get an infarction while in hospital
have lower costs of drugs, and if patients arc transferred to other medical departments during
the acute or post-acute phase of their stay, their costs for drugs will also he lower. Individual
background characteristics of patients arc irrelevant in the prediction of costs of drugs. In
total 75 * of the variance in costs of drugs is predicted by both severity of illness and these
conditional factors.
• Explanation of costs of laboratory services.
Severity indicators having a substantial effect on costs of laboratory services delivered to
AMI-patients are (appendix 33): (1) the location of myocardial necrosis; patients with
antcroseptally located necrosis will have higher costs for laboratory services than other
patients. (2) CPK-cnzymc release; if the CPK enzyme release is miuJcralcly high (between
10.(KX) and 20.000 U/l * hours) or extremely high (> 60.(XX) U/l * hours) patients will also
have higher costs for laboratory services, (3) severity of ischemic pain; patients with
ischemic pain only in the beginning as well as patients with prolonged ischemic pain will
have higher costs for laboratory services, (4) severity of rhythm disorders; patients with
acute ventricular fluttcr/-fibrillations combined with atrial flu(tcr/-fihrillations or sinus-
tachycardia later on and patients with acute sinustachycardia or atrial flullcr/HhnlIalions
combined with ventricular fluttcr/-fibrillations or sustained ventricular tachycardia later on
will have higher costs for laboratory services, (5) severity of conduction disorders; patients
with an acute third degree AV-block with ventricular escape rhythm will incur higher costs
for laboratory services, (6) severity of right sided-hcart failure; patients with a collapse of
the Vena Cava Inferior of less than 50 9f will incur higher costs for laboratory services and
(7) one specific complication; patients with a CVA or T1A during their stay will have higher
costs for laboratory services.
All other severity indicators showing (significant) relations with the costs of laboratory
services (appendices 28-32) also appear to be highly associated with the length of slay or
with one of the severity criteria mentioned above and will therefore produce no substantial
effect on these costs. The costs of laboratory services arc moderately correlated to the
patient's length of stay (r=.36;p<.001). It may concluded that when patients stay in hospital
longer, costs of laboratory services will increase. In addition, patients who get an infarction
while in hospital have lower costs for laboratory services. This is also the case if patients die
immediately within period TO. Furthermore, when patients arc transferred to other medical
departments their costs for laboratory services (requested by cardiologists) will naturally be
lower. Data analysis also shows that patients attending the PRIMI-protocol will have higher
costs for laboratory services, irrespective of their severity of illness, their length of stay and
type of admission or discharge. Individual background characteristics of patients turn out to
have no additional predictive value. In total 72 % of the variance in costs of laboratory
services is predicted by the severity of illness plus conditional factors.
* Explanation of costs of ECG.
The only severity indicator having a substantial effect on the costs of ECG of AMI-paticnts
turns out be the severity of rhythm disorders (appendix 40); patients with sinustachycardia
or non-sustained ventricular tachycardia exclusively in the follow-up phase and patients with
acute sinustachycardia or atrial fluttcr/-fibrillations combined with ventricular fluttcr/-
fibrillations or sustained ventricular tachycardia later on will have higher costs for ECG. All
other severity criteria having a significant associations with the costs of ECG (appendices
34-39) turn out to have no substantial effect on these costs, when at the same time the
conditional factors are introduced in the regression analysis. An extremely high correlation
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is present between the length of stay and costs of ECG (r=.87;p<.001), indicating that the
longer the patient's hospital stay the higher the costs for ECG. This is not surprising since
AMI patients routinely get at least one ECG per hospital day. So the question to explain the
cost of ECG may be answered by explaining the patient's length of hospital stay. If patients
die or arc transferred, then chances of having high costs of ECG will naturally decrease.
Individual background characteristics of patients have no predictive power whatsoever on
the costs for ECG. In total 89 9f of the variance in costs of ECG is predicted by the
combination of severity of illness and conditional factors.
* Explanation of costs of echocardiography.
Severity indicators having a substantial effect on costs of echocardiography are (appendix
44) lung edema and pericarditis; if patients suffer from lung edema or pericarditis costs of
echocardiography will rise significantly. Other severity indicators that arc significantly
associated with these costs (appendices 41-43) turn out to have no substantial effect on costs
of echocardiography; in almost all cases these costs also highly correlated with the length of
stay at the CCU. The length of stay at the CCU turns out to be the crucial 'in between' factor
in the data analysis since this variable is highly correlated with costs of echocardiography
(r=.48;p<.(X)l); costs of echocardiography tend to rise, if patients stay in CCU longer. This
is not surprising since specific results of echocardiography arc normally used to decide
whether or not a patient can leave the CCU. In addition to this, if patients die during slay, get
discharged within three days or arc transferred to other medical departments within ten days
costs will naturally be lower. Again, individual background characteristics of patients do not
seem to be relevant in predicting costs of echocardiography. In total 32 % of the variance in
costs of echocardiography is predicted by the severity of illness combined with the
conditional (actors.
* Explanation of costs of exercise tests.
From regression analysis (appendix 48) it may be concluded that the severity of illness has a
low but negative effect on the costs of exercise tests (Bruce or thallium). It turns out that if
patients have recurrent atrial flutter/fibrillations, or if they have edema in ankles or feet, or if
they have a CVA or TIA an exercise test is generally not performed. Other severity
indicators significantly associated to costs of exercise tests (appendices 45-47) appear to be
cither closely related with (one of) the mentioned severity criteria or with (one of) the
conditional factors. Patients will normally get an exercise test just before they leave the
hospital. Patients coming from other hospitals or being discharged within three days, or
deceased patients (the latter may be obvious) have lower chances of getting an exercise test.
The same holds for older patients; they turn out to have significantly lower costs for exercise
tests. In total 25 '# of the variance in costs of exercise tests is explained by the combination
of severity of illness and conditional factors.
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7.4. Conclusions.
The results of the regression analysis regarding the differences in costs of ten types of
specific medical care given to patients with Acute Myocardial Infarction explained by (.1)
the patient's severity of illness, (2) medical treatment, (3) contra-indicalions for medical
treatment. (4) participation of patients in clinical trials. (5) background characteristics, and
(6) conditional factors related to characteristics of the patient's hospital stay will now be
summarized.
1. Severity of illness.
In general, the influence of the patient's severity of illness on medical cure costs tends to
show variations in strength: sometimes the effects arc relatively large, sometimes no effect is
to be found at all. Four degrees in the strength of the relative influence on costs and length
of stay may be distinguished (A-D).
A) Severity of illness in AMI-paticnts has a large effect on their length of stay and
their CCU costs.
Differences in length of stay and CCU costs arc not explained by exactly the same severity
indicators, although some indicators have an effect on both dependent variables. The
patient's length of stay is, for the greater part, explained by the clinical causes and
consequences of myocardial necrosis, but not so much by the severity of the necrosis itself.
One of the causes of AMI, myocardial ischemia, will increase hospital stay, particularly if it
is located in the antcroscplal side of the left ventricle. Consequences of AMI like specific
cardiac rhythm disorders, heart failure in the left ventricle, pericarditis, mitral insufficiency
and CVA/TIA will each increase the length of stay substantially. Furthermore, (still)
experiencing ischemic pain after several days in hospital or having a prc-collapsc during
stay are additional factors that will prolong hospital stay. The stay in (and costs of) the CCU
for patients with AMI, will increase partly as a result of the same factors that also have an
effect on length of stay: antcroscptal myocardial ischemia, specific cardiac rhythm disorders,
heart failure in the left ventricle and pericarditis. However, other factors, explaining the
patients' length of stay have no additional effect on CCU cost. On the other hand high scores
on some severity indicators, such as an extremely high enzyme release (CPK),
antcroscptally located cardiac wall motion abnormalities and recurrent right bundle branch
block are relevant and typical for an increase in CCU costs.
B) Severity of illness in AMI-patients has a moderate effect on costs of thrombolytic
therapy and costs of laboratory services.
Whether patients receive thrombolytic therapy is dependent on their acute severity condition
on admission: patients with antcroscptally located necrosis (indicated by typical Q-wavcs in
ECG) and extended myocardial ischemia over more wall segments in the left ventricle
(indicated by typical ST-changcs in ECG) have a higher chance of getting thrombolytic
therapy. Furthermore, this chance increases if patients suffer from ischemic pain on
admission.
Severity indicators related to myocardial necrosis have an effect on costs of laboratory
services: patients with antcroscptally located necrosis or with a moderately or extremely
high enzyme release will generally get more laboratory tests. If patients suffer from ischemic
pain there is an additional reason for doing more laboratory tests, probably to check for
recurrent infarction. Furthermore, the consequences of myocardial necrosis also have an
additional effect on the costs of laboratory services: if patients suffer from specific rhythm
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or conduction disorders, if they show right ventricle failure, or if they get a CVA/TIA, this
will certainly lead to more laboratory services. Regardless of these severity indicators, the
costs of laboratory services are also highly correlated to the patient's length of stay: if
patients stay in hospital longer, costs will naturally rise.
C) Severity of illness in AMI-patients has a relatively weak effect on the costs of
acute cathetcrization, costs of acute PTCA, the total costs of drugs, the costs of
ECG and the costs of echocardiography.
The costs of acute cathetcrization turn out to be weakly influenced by the patient's severity
of illness. Patients with ischemia extended over more wall segments have higher chances of
receiving a cathetcrization. However, the results indicate that whether or not patients receive
thrombolytic therapy may offer a better prediction for cosls of acute catheterization.
One vessel disease during TO will increase the costs due to (acute) PTCA. If these patients
show occluded coronary stenosis this will certainly enlarge chances of getting a PTCA.
Furthermore, if myocardial necrosis is located in the antcroscptal area chances that PTCA
will be performed will somewhat increase.
The total costs of drugs and ECG are strongly related to the patient's length of stay and the
way patients arc admitted to and discharged from the hospital. These costs will rise
progressively with the length of stay. The costs of cchocardiography arc strongly correlated
to the length of stay at the CCU; if patients tend to stay at the CCU longer the costs of
cchocardiography will definitely rise. The severity of illness of AMI may be seen as the
indirect cause of specific costs. As we have seen in previous data analysis, severely ill
patients will stay longer at the hospital (c.q. at the CCU). Because of this they will
presumedly have higher costs for drugs, ECG and cchocardiography. Thus, severity
indicators explaining the length of stay at the hospital or the costs of CCU may be
considered indirectly responsible for increasing the costs of drugs, ECG or
cchocardiography. The severity of illness also has a direct effect on the latter costs. The
costs of drugs, for instance, will increase additionally if patients still have ischemic pain
after several days in hospital, if they have very severe cardiac rhythm disorders, if they have
right-sided heart failure or if they have edema in the ankles or feet. The costs of ECG's will
increase additionally if patients have severe cardiac rhythm disorders. The costs of
cchocardiography will increase, if patients suffer from lung edema or pericarditis. As a
general conclusion one might state that the severity of illness of AMI patients does have
indirect as well as direct effects on these specific costs.
D) The severity of illness will not increase costs due to exercise tests.
In contrast to previous results, specific types of severity of illness will tend to decrease the
cosls made by exercise tests. If AMI patients have recurrent atrial fluttcr/-fibrillations, have
edema in the ankles, feet or abdomen, or suffer from CVA/TIA during slay, they have lower
chances of incurring costs for exercise tests.
2. Medical treatment.
Medical treatment as such will sometimes have a strong relation to the costs for other
medical care, regardless of the severity of illness. From the data analysis it is found that
thrombolytic therapy is highly positively correlated with the costs due to acute heart
catheleri/ation; acute ihrombolytic therapy appears to go hand in hand with subsequent
acute heart cathctcrization, apparently to ascertain the effects of the treatment. On the other
hand, acute thrombolytic therapy is negatively associated with the costs due to PTCA for
patients with one vessel disease. Patients having had acute ihrombolytic therapy seem to
have lower chances of getting a PTCA.
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3. Contra-indications.
Obviously, conira-indications will have a restrictive impact on incurring costs of treatment.
The only specific conira-indications in this study concern those for thrombolytie therapy. At
the cardiology department in our study three major contra-indications for this form of
treatment did exist at the time of investigation: having ischemic pain for more than six
hours, being in coma, or being older than 75 years. All AMI patients with one of these
contra-indications do not incur any costs for thromholytic therapy at all.
4. Participation of patients in clinical trials.
Enrollment in a clinical trial will naturally influence the costs of medical care. In the patient
population at the time of investigation this concerned only one specific project (i.e. PRIM1-
trial), in which 54 patients participated. Enrollment in this clinical trial involved a standard
incurrence of costs for thrombolytic therapy, heart cathcteri/ation and laboratory services.
5. Background characteristics.
A patient's background characteristics turn out to have no predictive value for costs of
medical care, if one takes into account the patient's severity of illness on admission or
during hospital stay. The only exceptions arc the patient's age and sex; older patients will
have a lower chance of incurring costs for exercise tests. Al the time of investigation, the
patient's age (older than 75 years) did form a decisive contraindication for ihromholylic
therapy. It has also been found that female patients have a significantly lower chance lo gel
an acute heart cathctcrizalion.
6. Conditional factors related to characteristics of the patient 's hospital stay.
Although conditional factors have essentially been used in the regression analysis to
distinguish real effects from spurious effects between severity of illness and costs, these
factors themselves also turn out to have significant predictive power towards cosls of
medical care. These significant (partial) relations between conditional factors and costs
could not be explained by the severity indices used in the data analysis. For instance,
deceased patients differ very much in costs compared to non-deceased patients.
Furthermore, patients who die very soon during their stay have a shorter length of slay and
therefore relatively lower costs in contrast to patients who die after a long time in hospital.
Because the actual cause of death of these patients has not been included in this study, the
factor 'decease during hospital stay' may be regarded as an important 'explanation' for
costs.
Other non-regular forms of discharge not explained by the severity of illness turn out to have
significant relations with particular costs. An extremely early discharge will (quite naturally)
lead to a very short length of stay and lower costs; circumstances not investigated in this
study such as transfer to another hospital might be the reason for this significant (partial)
relation. A non-regular late discharge will quite naturally be related to the length of stay and
CCU costs, probably due to factors not captured by our severity indices, such as rare
complications or comorbiditics. Patients coming from other hospitals turn out to have a
shorter length of stay and have lower CCU costs. If patients arc transferred to another
medical department within the same hospital because of specific complications, their total
length of stay will increase. Although these factors will contribute in the prediction of
medical care costs they must not be regarded as an explanation for these costs.
The results from the mullivariate data analysis as outlined in this chapter will be used to
propose a patient classification system for patients having Acute Myocardial Infarction. The
methodology of this procedure will be outlined in chapter 8.

8. Classifying acute myocardial infarction
patients according to their seventy of
illness.
In this chapter a Severity of Illness Classification (henceforth SIC) will be proposed for
patients with Acute Myocardial Infarction. First, the empirically based conclusions of this
analysis will he compared with the assumptions made by other classification systems used to
explain costs of care (8.1.). Next the methodology of the system will be proposed in which
patients will be categorized into groups to explain length of hospital stay (8.2.). Then, the
predictive validity of the SIC will be compared to the predictive validity of the DRG's (8.3.).
Some applications of a SIC will be given (8.4) and finally conclusions of this chapter will be
shortly summarized (8.5.)
8.1. Comparison of severity indicators empirically
found in this study and assumptions of other
studies.
All severity indicators found to be relevant in explaining costs of care in AMI-puticnls have
been summarized in table 8.1. If one compares the empirically found severity indicators in
this study with the indicators used in other studies (sec § 2.2) some interesting differences
can be observed. The DRG system differentiates AMI patients with and without specific
cardiovascular complications. Although some of the severity indicators found to be relevant
in this study are included in the complication category (i.e. specific rhythm and conduction
disorders and left ventricular heart failure), the DRG-systcm docs not take into account the
time at which these deficiencies occur during the patient's hospital stay. Specific illness
characteristics such as the location of myocardial ischemia and necrosis, the (time of)
appearance of ischemic pain, the total enzyme release and the location of cardiac wall
motion abnormalities, which have important effects on the costs, arc not specified by the
DRG system. Furthermore, the DRG system categorizes patients who died during hospital
stay into one separate group. However, one of the conclusions of chapter 7 is that not all
patients who die in the hospital have a short stay or low costs.
The same remarks can be made for the Disease Staging system and the PMC system with
one exception: both systems place patients with specific complications into separate
categories. These systems also do not specify the time of occurrence of these complications
nor do they use typical severity indicators obtained from medical history or diagnostic tests.
Disease-specific patient classification systems which place the severity of illness in a more
central role (APACHE II, Mcdisgrps and CSI, sec § 2.2.) arc much more comparable with
regard to the empirical results in chapter 7. The severity indicators used by the APACHE II-
systcm (table 2.7) do not match at all with the severity indicators found in this study. The
APACHE II-systcm is expected to be less suitable for explaining costs of medical care in
AMI patients because this system is developed for, and mainly used in, the Intensive Care
Units in which patients with various types of illness may lie. The MEDISGRPS-systcm uses
more specific severity indicators (table 2.8). ECG-data that arc expected to be relevant for
the construction of severity categories in the MEDISGRPS-systcm arc: ischemia/atrial
fibrillations, myocardial infarction and third degree heart block. Following the results in
chapter 7, the location of ischemia and necrosis (in the antcroscptal area) turns out to be
important. Atrial fibrillations are also found to be important, certainly if this is followed by
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ventricular fibrillations. Other indicators distinguished by MEDISGRPS such as
cardiomcgaly, rales, cardiomyopathy, coma and respirations have either not been
investigated in this study or turn out to have no direct effect on the costs of medical care.
According to MEDISGRPS, heart failure places a patient in a high severity category, but
from our results a distinction needs to be made between left and right sided heart failure.
Absolute enzyme values (i.e. CPK) are also used in the MEDISGRPS-systcm but only
relatively high area scores arc found to be relevant in our study.
The severity indicators used in the CSI-system (table 2.6) are more akin to the indicators
found in our study. Still, the CSI-system makes no distinction in the location of ST-changes.
A third degree block and life-threatening arrhythmias are mentioned as relevant indicators.
Indicators like cardiac output ( more or less comparable with LVEF and LVEDD) are used.
The CSI-system is the only system that uses chest pain as a severity indicator, but it
emphasizes the duration of pain rather than the incidence of pain during stay. In our study,
the incidence of ischemic pain is found to be an important indicator. Severity indicators
based on physical deficiencies, such as pulmonary edema, cyanosis and dyspnea are also
found to be relevant. Other CSI-indicators, such as fever, urine output, white blood counts
have not been investigated in this study. The cardiologists consulted did consider these
indicators of less importance in measuring the severity of AMI-paticnts. Specific
complications (i.e. pericarditis, mitral insufficiency and CVA/TIA) are distinguished
separately; the CSI system applies a weighting rule to measure the overall severity of illness
in case of such specific complications or other diseases.
It may be concluded that with regard to AMI patients, large differences exist among the
indicators used in patient classification systems. Relevant indicators used in the
Computerized Severity of Illness (CSI)-systcm are somewhat akin to those found in this
cnyumuJ sludy
Differences in indicators used to classify patients arc generally caused by the differences in
the purposes for which a classification system is developed. There arc systems which
originally arc developed to predict utilization of resources and costs (DRG and PMC) and
systems which arc developed to predict death rates and to analyze quality of care within
disease specific categories (Disease Staging, CSI, APACHE II and MEDISGRPS).
Differences also exist in the type of criteria used to classify patients: some systems use
medical abstract data such as diagnosis and procedures (DRG, PMC and Coded Disease
Staging), while others use specific clinical indicators obtained from diagnostic results and
the patient 's medical history (Clinical Disease Staging, CSI, APACHE II and
MEDISGRPS). There arc also differences in the methodology used to find criteria for costs
differences. There arc systems which use criteria derived from a combination of an empirical
data analysis and professional judgement (such as DRG and PMC). Most systems are
generally only based on the judgement of medical experts (Disease Staging, CSI, APACHE
II and MEDISGRPS).
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Table 8.1 Severity indicators explaining cost of medical care in patients with Acute Mvocardial
Infarction, which are relevant according to the results of the (dummy) regression analysis
reported in chapter 7.
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8.2. Severity of Illness Classification (SIC) for AMI
patients.
Based on the results of chapter 7 one may conclude that three separate classifications of
AMI patients arc possible: one explaining variations of acute care costs, another for
explaining variations in length of stay and thirdly, one forCCU costs. A naive question that
may arise is how to develop one overall classification system which will be able to explain
each specific type of costs of medical care. Using only the criteria which have an effect on
the length of stay (and related costs) will be at the expense of the predictive value of the
CCU costs, and vice versa. The severity on admission may not be a good predictor for the
CCU costs and total length of stay. Another question that may arise, for instance is, if the
relevant severity criteria having an effect on the CCU costs can be substituted by severity
criteria having an effect on the length of stay. Therefore, all correlations between the
different indicators have been tested for statistical significance. However, we did not
succeed in finding adequate substitutions for the different indicators that could also be
confirmed from a medical point of view.
So, for the time being priority will be given to develop a classification system based on
indicators having an effect on length of stay. This choice has been made because this
dependent variable is also often used in other classification systems. Another reason is that
overall length of stay is generally assumed to have a relative high correlation with the
overall costs of medical care. The total length also includes the length of stay at CCU and it
is also correlated to other costs of medical care (drugs, ECG, laboratory services). So, in this
chapter priority will be given to the development of only one severity of illness
classification: a severity of illness classification explaining length of stay (SIC-LOS).
However, the same methodology can be applied if one wishes to explain acute care costs and
CCU costs in more detail.
Methodology of a SIC-system.
In order to classify patients into severity categories, the combination of indicators found to
be relevant in regression analysis need to be examined. Relevant severity indicators will be
used as severity criteria for a classification of AMI patients. For instance, it seems plausible
to slate that patients with antcroscptally located ischemia have a shorter length of stay than
patients who, next to this deficiency, also have prolonged ischemic pain after three days. If
on lop of these deficiencies, patients also have specific cardiac rhythm disorders, hospital
slay will be even longer. Thus, the combinations in which the severity criteria occur in
patients is crucial to the classification process. In order to develop the SIC-systcm, the
following rules have been applied:
1. The number of categories of patients used in the classification system must be limited.
At the same time all categories should have 'clinical' relevance or be 'clinically valid'
regarding their expected duration of stay. This means that the classification is of no
(clinical) value, if the cardiologists involved in this study do not individually endorse
the classification proposed or do not reach a consensus with regard to the classification.
So, the classification is developed in cooperation with an experienced cardiologist.
2. The measurement level of the criteria used in the classification is generally considered
us an ordinal scale.
3. Additive proceedings leading to unidimcnsional scales will be avoided, and more
general techniques of non-parametric scale construction will be used. Thus a
multidimensional analysis with crosstabulations will be proposed to find the empirical
combinations of severity criteria (score patterns).
4. The categories must he defined as mutually exclusive. If patients have patterns of
scores which provide difficulties for classification and at the same time have low or
unique frequencies, these patients will be placed in 'adjacent' categories as much as
possible. Cases defined as 'non-classifiable' should not exceed a maximum of 5 9h
5. Only severity indicators found to be significant in explaining length of slay in
regression analysis (see § 7.3.1.) will be used as criteria in the classification process.
6. Scores for relevant severity criteria will be recoded into a dichotomous (2 classes) or
trichotomous (3 classes) rank order using the values of the unstandardi/cd partial
regression coefficients (sec below). The reason for this reduction is that otherwise the
combination of various severity criteria may lead to numerous types of severity
categories containing only very small numbers of patients.
7. If patients have missing values for a severity criterion they will get the label (or score)
belonging to the category representing the lowest severity for that criterion. In doing
so all patients can be classified.
8. Only score patterns having a relevant number of patients will form a separate severity
category. The minimum number per category will be set at 1.5 % of the patient
population (this is an arbitrary choice).
9. Deceased patients will form two additional categories; score-patterns arc assumed to
be not relevant for these patients. This will be done because deceased patients differ
very much in length of stay and costs compared to non-dcccascd patients.
Severity criteria relevant for the SIC-LOS classification will be described and a redefinition
of scores for these criteria will be presented according to rule 6.
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Four combined severity categories describing the location of myocardial ischemia have been
distinguished (sec table 6.7). The partial regression coefficient for this indicator is +.70 (sec
table 7.19). Patients with no ST-changes or disappearing ST-changcs arc -if no other
deficiencies arc present- expected to stay 6.7 days, which constitutes the intercept value of
the regression function (observed: m=8.8; std.dcv.=2.9; n=23). Thus, the length of slay for
patients with non-anteroseptal ST-changes (observed: m=9.7; std.dev.=4.7; n=277) is
expected to increase with .70 day. The length of stay for patients with antcroscptal ST-
changes (observed: m=12.4;std.dcv.=7.7;n=148) is expected to rise with 1.4 days and for
patients with ischemia extending to the antcroscptal wall segment this will be 2.1 days
(observed: m=15.9; std.dev=4.7; n=7). According to rule 6, a new distinction will be made
between (0) patients having no ST-changes or having ST-changcs corresponding with the
non-antcroseptal wall segment and patients with ST-changcs corresponding with the
antcroseptal wall segment (1). This recoded criterion will be used in the pattern analysis for
the construction of a severity classification.
2.
Three classes in the severity of ischemic pain have been distinguished (sec table 6.24). Only
prolonged ischemic pain after three days in hospital turned out to produce a significant
increase in length of stay (B= +2.4. see table 7.19). Patients without ischemic pain
(observed: m=7.7; std.dev.= 10.0; n=54) or patients with ischemic pain in the first three days
of hospital admission (observed: m=10.0; std.dev.=4.9; n=306) are expected to have no
substantial increase in length of stay. So, the expected length of stay for patients with
prolonged ischemic pain after three days in hospital (observed: m=14.68; std.dcv.=6.8;
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n=91) will increase with 2.4 days. Therefore, a distinction will be made between (0) patients
without ischemic pain or with ischemic pain restricted to the first three days in hospital and
(1) patients with prolonged ischemic pain still present after three days in hospital. This
recoded criterion will be used in the pattern analysis for the construction of a severity
classification.
J. >
Ten types of cardiac rhythm disorders have been distinguished (see table 6.29). Only five
types of rhythm disorders turn out to produce a significant increase in length of stay (see
table 7.19):
I: acute sinustachycardia (observed: m=10.16; std.dcv.=4.9; n=105; B=+l.l);
2: recurrent sinustachycardia or non-sustained ventricular tachycardia (observed:
m=14.9; std.dcv.=8.9; n=26; B=+2.4);
3. recurrent atrial flultcr/-fibrillations (observed: m= 15.33; std.dcv.=8.2; n=31; B=+3.2);
4. acute ventricular flultcr/-fibrillations combined with atrial fluttcr/-fibrillations or
sinuslachycardia in follow-up phase (observed: m=13.(); std.dcv.=7.2; n=7; B=2.5);
5. acute sinustachycardia or atrial fluttcr/-fibrillations combined with ventricular flultcr/-
fibrillalions or sustained ventricular tachycardia in the follow-up phase (observed:
m=23.7; std.dcv.=4.2; n=9; B=+5.0).
After consulting our cariologists and given the values of the partial regression coefficients a
distinction is m;idc into three classes: (0) patients who have no cardiac rhythm disorder at all
or who have cardiac rhythm disorders with no significant effects on the length of slay
according to the results in chapter 7, (1) patients with acute sinustachycardia and (2) patients
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be used in the pattern analysis for the construction of a severity classification.
The Lcll Ventricular Ejection Fraction score was previously combined into four classes (sec
table 6.32.). The LVEF-scorc lying between 30 </f and 40 <tf has a significant effect on the
length of stay of patients (sec table 7.19; B=+I.4), a LVEF-scorc higher than 4 0 % or lower
than 30 '# will not lead to a substantial increase in length of stay (see table 7.19). Only
patients with a LVEF-scorc between 30 '# and 40 * (observed: m= 13.77; std.dcv.=6.1;
n=8 1) show an additional increase in hospital longer. Therefore, a distinction will be made
between (0) patients with a LVEF-scorc higher than 40 **f or patients with LVEF-scorc lower
than 30 '#, and (1) patients with a LVEF-scorc between 30 % and 40 %. This recoded
criterion will be used in the pattern analysis for the construction of a severity classification
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Specific complications related to AMI and leading to a significant increase in length of stay
arc (sec table 7.19):
1. pre-collapse (observed: m=15.16; std.dcv.=8.2; n=32; B=+l.4);
2. mitral insufficiency (observed: m=13.7; std.dcv=9.2; n=56; B=+l.l);
3. pericarditis (observed: in= 15.7; std.dcv=8.5; n=42; B=+2.3);
4. CVA/T1A (observed: m=19.3; sld.dcv.= 15.8; n=8; B=+3.6).
One new complication criterion is constructed; a distinction will be made between patients
with none of these complications during stay (0). patients with pre-collapsc or mitral
insufficiency (the length of slay will approximately increase with 1 day); henceforth type ' 1 '
complications and patients with cither pericarditis, or CVA/T1A, or both prc-collapsc
combined with mitral insufficiency; henceforth type '2' complications. The expected length
of slay in the last instance will approximately increase with 2 or 3 days. This recoded
criterion will be used in the pattern analysis for the construction of a severity classification.
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Although the death of a patient during hospital stay can be seen as a consequence of severity
of illness, the analysis has shown that it is an important factor in explaining differences in
length of stay of AMI patients. Patients who die during their hospital stay have a different
length of stay from patients who do not. Furthermore, a distinction must be nude between
patients who die early during stay and patients who die from complications after a prolonged
spell of illness. A distinction will therefore be made between: ({)) surviving patients. (I)
patients who die within ten days (observed in period TO: m=l.7; std.dcv.=l,9; n=H>; B=-6.3,
in Tl : m=2.4; std.dcv=.8; n=l9; B=-5.9, in T2: m=6.1; std.dcv.=2.4; n=14; B=-4.4) and (2)
patients who die after ten days in hospital (observed: m=24.O; std.dcv.=6.0; n=7; B=+ll.4).
This recoded criterion will be used in the pattern analysis for the construction of a severity
classification.
Pattern analysis.
A pattern analysis even with the six recoded severity criteria described above still turns out
to lead to numerous severity categories. Theoretically 74 different patterns (including the
two 'deceased' categories) may occur (i.e.; in the order of the criteria mentioned:
2*2*3*2*3+2=74); 59 of these patterns are empirically observed in the population in
question. To reduce the number of severity patterns, a final pairing of criteria is proposed.
Firstly, the criteria location of ischemia and ischemic pain wil! be combined into one new
critcron; from a clinical point of view both severity criteria arc representatives of the
impaired flow in the coronary artery system.
Anteroseptally located ischemia and prolonged ischemic pain after three days will each lead
to an approximate increase in length of stay of nearly two days. Clinically speaking the
criteria can be regarded as closely related to each other, so our assumption will be that the
weights of the criteria are comparable. If patients have no anlcroscptal ischemia and have no
prolonged ischemic pain both severity criteria will be used to place a patient into the lowest
category. If patients have only anlcroscptal ischemia or only prolonged ischemic pain they
are placed into the middle category. If patients have both antcroscptal ischemia and
prolonged ischemic pain they are placed into the highest category.
Secondly, the relevant cardiac rhythm disorders and the LVEF-crilcrion will be combined
into one new criterion; both represent functional deficiencies as a consequence of
myocardial ischemia and/or necrosis, and may as such be regarded as closely related to each
other.
Acute sinustachycardia and a LVEF-scorc between 30 $ and 40 % will each lead to an
increase in length of stay of approximately one day. If patients have neither rhythm disorders
nor a LVEF-score between 30 ^ and 40 ^ , both severity criteria will be used to place a
patient in the lowest category. If patients have cither acute sinustachycardia or a LVEF-score
between 30 *£ and 40 <£, they will be placed into the next category. If patients have cither
severe rhythm disorders (see point 3, rhythm category '2') or acute sinustachycardia
combined with a LVEF-score between 30 % and 40 %, they will be placed in the next
highest category. The highest severity category consists of patients having severe rhythm
disorders combined with a LVEF-score between 30 % and 40 %.
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The remaining four severity criteria (Location Ischcmia/Ischemic pain. Rhythm
disordcrs/LVEF. Complications and Survival/Death) can theoretically be combined into 38
different patterns (including two 'deceased' categories i.e. in the order of the criteria
mentioned: 3*4*3+2=38). Empirically 37 patterns can actually be found in our patient
population. The observed patterns will be used to construct a severity classification by
applying the nine methodological rules described earlier.
Eventually, 17 severity categories arc distinguished (sec for the results table 8.2., and for an
exhaustive description of each severity pattern sec appendix 49). The categories in this
classification will described below.
Severity category ' I ' includes patients who survive, who have no anteroseptally located
ischemia, no prolonged ischemic pain, no relevant cardiac rhythm disorders, no relevant
LVF.F-scorc and no relevant complications (n=108).
All other severity categories include AMI patients with deviations from this lowest severity
category. The severity categories will be described below by giving the deviations from this
lowest severity category. Category '2' to '15' include patients who survive, category '16'
and '17' include the patients who die during stay.
Severity category '2' includes patients:
(a) with cither antcroscplally located myocardial ischemia (n=41), or
(b) with prolonged ischemic pain (n=17).
In total 58 patients have been grouped in this category.
Severity category '3 ' includes patients with a single complication of type ' 1 ' (n=12).
Severity category '4 ' includes patients:
(a) with cither acute sinustachycardia (n=42), or
(b) with a LVliF-scorc between 30 % and 40 9? (n=14).
In addition, a rest category of 7 patients has been included who have type ' 1 ' complications
on top of the above deficiencies.
In total 63 patients arc grouped in this category.
Severity category '5 ' includes patients with anteroseptally located myocardial ischemia
combined with prolonged ischemic pain (n=13).
Severity category '6 ' includes patients:
(a) with acute sinustachycardia combined with a LVEF-scorc between 30 % and 40 %
(n=5). or
(b) with severe rhythm disorders (n=8), or
(c) with severe rhythm disorders combined with a LVEF-scorc between 30 % and 40 %
(n=2).
In total 15 patients arc grouped in this category.
Severity category '7' includes patients with solely a complication of type '2' (n=12).
Severity category '8' includes patients:
(a) with antcroseptally located myocardial ischemia combined with acute sinustachycardia
(n=l()).or
(b) with anteroseptally located myocardial ischemia combined with a LVEF-score between
30<* and4O*(n=l3), or
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(c) with prolonged ischemic pain combined with acute sinustachycardia (n=6), or
(d) with prolonged ischemic pain combined with a LVEF-score between 30 % and 40 %
(n=5).
In addition, a rest category of 4 patients has been included who have a type '1' complication
on top of the above combinations of criteria.
In total 38 patients arc grouped in this category.
Severity category '9 ' includes patients with antcroscptally located myocardial ischemia
combined with prolonged ischemic pain, combined with cither acute sinustachycardia (n=6),
or a LVEF-score between 30 * and 40 9f (n=2). In addition, 1 patient has been included
who has a type ' 1' complication on top of the above deficiencies. In total 9 patients arc
grouped in this category.
Severity category '10' includes:
(a) patients with antcroscptally located myocardial ischemia combined with cither: (1)
acute sinuslachycardia combined with a LVEF-score between 30 % and 40 % (n=5),
or: (2) severe cardiac rhythm disorders (n=5) or: (3) severe cardiac rhythm disorders
combined with a LVEF-scorc between 30 '* and 40 9f (n=l); or
(b) patients with prolonged ischemic pain combined with cither: (1) acute
sinustachycardia combined with a LVEF-scorc between 30 % and 40 '# (n=0) or : (2)
severe cardiac rhythm disorders (n=3), or: (3) severe cardiac rhythm disorders
combined with a LVEF-scorc between 30 9f and 40 % (n=l).
In total 15 patients are grouped in this category.
Severity category '11' includes:
(a) patients with acute sinustachycardia, a LVEF-scorc between 30 % and 40 %, and a
type ' 1 ' complication (n=2); or
(b) patients with a type ' 1 ' complication combined with cither: (1) severe cardiac rhythm
disorders (n=8), or: (2) severe cardiac rhythm disorders combined with a LVEF-scorc
between 30 <7r and 40 9( (n=0).
In total 10 patients are grouped in this category.
Severity group '12' includes patients:
(a) with a type '2 ' complication combined with acute sinustachycardia and/or a LVEF-
score between 30 % and 40 % (n=4); or
(b) with a type '2 ' complication combined with severe cardiac rhythm disorders (n=2); or
(c) with a type '2 ' complication and severe cardiac rhythm disorders combined with a
LVEF-score between 30 7f and 40 % (n=2).
In total 8 patients are grouped in this category.
Severity category '13' includes:
(a) patients with anteroscptally located myocardial ischemia and a type ' 1 ' complication
combined with: either acute sinustachycardia and a LVEF-scorc between 30 % and 40
% (n=2) or: with severe cardiac rhythm disorders (n=3), or: (3) with severe cardiac
rhythm disorders combined with a LVEF-score between 30 ^ and 40 % (n=0); or
(b) patients with prolonged ischemic pain and with a type ' 1 ' complication combined with
either: acute sinustachycardia and a LVEF-score between 30 % and 40 % (n=0), or:
with severe cardiac rhythm disorders (n=2), or: severe cardiac rhythm disorders and a
LVEF-score between 30 <7r and 40 % (n=2j.
In total 9 patients are grouped in this category.
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Severity category '14' includes:
(a) patients with antcroseptally located myocardial ischemia and prolonged ischemic pain
combined with a type ' 1 ' complication, and with: either acute sinustachycardia
combined with a LVEF-score between 30 % and 40 % (n=0), or: with severe cardiac
rhythm disorders (n=l), or: severe cardiac rhythm disorders combined with a LVEF-
scorc between 30 % and 40 % (n=l); or
(b) patients with antcroseptally located myocardial ischemia and prolonged ischemic pain
combined with a type '2 ' complication and with: either acute sinustachycardia
combined with a LVEF-scorc between 30 % and 40 % (n=0), or: with severe cardiac
rhythm disorders (n=4), or: severe cardiac rhythm disorders combined a LVEF-score
between 30 % and 40 % (n=l).
In total 7 patients arc grouped in this category.
Severity category '15' includes:
(a) patients with antcroseptally located myocardial ischemia combined with a type '2'
complication and with: cither acute myocardial sinustachycardia and/or a LVEF-score
between 30 % and 40 % (n=3), or: severe cardiac rhythm disorders (n=3), or: severe
cardiac rhythm disorders combined with a LVEF-score between 30 % and 40 % (n=0);
or
(b) patients with prolonged ischemic pain combined with a type '2' complication with:
cither acute sinustachycardia and/or a LVEF-score between 30 % and 40 % (n=l), or:
with severe cardiac rhythm disorders (n=l), or: severe cardiac rhythm disorders
combined with a LVEF-scorc between 30 % and 40 % (n=3).
In total 11 patients arc grouped in this category .
Severity group '16' includes patients who die in hospital during the acute and post-acute
phase of their stay, i.e. periods TO to T2 (n=43).
Severity group '17' includes patients who die in hospital during period T3 (n=7).
In total 438 patients have been now classified in one of these 17 nominal severity categories.
Higher category numbers do not stand for an linear increase in severity of illness, but in
general the measurement level of S1C-LOS will lie between the nominal and ordinal scale. A
remaining group of 19 patients (4.2. %) can not be classified because of their atypical
patterns in severity; together they form a rest category (category '18').
The age distribution in the severity categories (appendix 50) varies considerable. Patients in
SIC-LOS ' I ' arc in average 60.1. years compared to an average age of 80.6 years in
category '17'.Also the distribution of female and male patients in some severity categories
lends to vary considerably. For instance 27.6 * of the men arc grouped into the lowest SIC-
LOS category ' 1 ' compared to only 17.5 % of the women. In some severity categories large
differences in age exist between male and female patients. For instance in categories 2,4,8,9,
and 11 (appendix 50) the average age of women is about six years higher than that of men.
Women with AMI appear to be relatively more severe but this must also be seen in relation
with the fact that they arc relatively older compared to the men with AMI.
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Table 8.2 Severity of Illness Classincation of AMI patients concerning Length «if Stay (SIC-
LOS), n=457.
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8.3. Comparison of the predictive validity of the
Severity of Illness-classification and that of
Diagnosis Related Groups-classification.
The mean standard deviation and number of patients for length of stay specified lo the
Seventy of Illness Classification and the DRG classification arc presented in tables 8.3 and
8.4. The severity categories turn out to be rather homogenous within each group regarding
the length of stay. i.e. the values of the standard deviations in length of stay within each
severity category appear to be rather narrow. Patients belonging to categories 1 and 2
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(n=166) will have the lowest length of stay of: about 8 days. Patients belonging to categories
3, 4, 6 and 7 (n=102) will have a mean length of stay of about 10 days. A smaller group of
patients belonging to the severity categories 8 and 12 (n=46) will have a mean length of stay
of about 12 days and patients belonging to severity categories 5. 9. 11 and 13 (n=4l) will
stay about 13 days. Patients belonging to severity category 10 (n=15) will have a very long
slay of about 16 days. Patients belonging to severity category 14 and 15 (n=18) will have an
extremely long stay of about 24 days. Patients who die soon after the infarction (severity
category 16) will have a very short length of stay of approximately 3 days in comparison to
patients who die after a protracted illness (severity category 17), whose stay tends to amount
to approximately 24 days.
Table 8 J Mean, standard deviations and number of patients regarding length of stay by the
Severity of Illness Classification (SIC).
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According to the DRG-classification of the same patient population (table 8.4) the mean
length of stay of patients belonging to DRG 121, 'complicated AMI' (n=87) appears to be
approximately 15 days and that of patients belonging to DRG 122, 'non-complicated
infarction' (n=300) this amounts to approximately 10 days. Deceased patients belonging to
DRG 123 have a mean length of stay of approximately 6 days. The standard deviations in
length of stay within each DRG are rather high especially in DRG 121 and 123, this in
contrast to the standard deviations in the Severity of Illness Classification.
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Table 8.4 Mean standard deviations and number of patients regarding length of stay by the
Diagnosis Related Group classification (DRG).
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722
/2J
4.7S
9.7S
6.J2
7.26
J.74
7.79
87
5/
7?>w/ 70. J7 5./2 4J8
£/«': /S. J % fun<7/i.f.wyi7j/>/V /></f/>nu (n=/9.) am/ ouf/i>rj (/i
Variance of length of stay explained by the Severity of Illness Classification amounts to 58.3
%, in comparison to 18.3 '# explained by the DRG classification. Next, a two-way analysis
of variance is performed to evaluate the discriminatory power of both classifications. Results
of this analysis arc presented in table 8.5.. Both the Severity of Illness Classification as well
as the DRG classification appear to offer significant explanations for length of slay. This
means that, given the severity of illness classification, the DRG classification offers an
additional prediction in length of stay. The two-way interaction effect of SIC-LOS * DRG
also appears to be significant. This means that the combination of both systems of
classification will add a significant part to the prediction of length of slay. A specific
ana/y.s'i.s wa.s dune f o pinpoint the w.iy fiuth systems comp/cment each other. L'sing dummy
regression analysis the main effect of DRG was differentiated into two 0-1 variables in
which the non-complicated AMI-catcgory is seen as the 'baseline'. The main effect of SIC-
LOS was differentiated into sixteen 0-1 variables in which the 'normal' category 1 is seen as
the 'baseline'. After the differentiation all possible (14) interaction effects are computed. All
32 dummy variables arc brought into the regression analysis using length of stay as a
dependent variable. It appears that only two interaction effects arc significant at the 5 %
level and that these concern the parameters belonging to category 13 and 14 in the SIC-LOS
classification coupled with the complicated AMI group in the DRG classification. So, it
seems that differences in the definition of 'complications' between the SIC-LOS
classification and the DRG classification will explain this effect. Patients arc categorized in
DRG 121 'complicated AMI' based on one (or more) specific complications; a list of 40
specific cardiovascular complications is used, some of which arc not specifically
investigated in this study (i.e. aneurysm heart wall, coronary vessel ancurysm. pulmonary
embolism, cardiac arrest, papillary muscle rupture and acute renal failure).
The total variance explained by SIC-LOS dnd the DRG classification amounts to 63.2 * .
The SIC-LOS classification, however, proves to explain much more of the variance than the
DRG classification. Variance explained uniquely by the SIC-LOS classification is 42.2 *
and variance explained uniquely by the DRG classification amounts only to 2.2 9K Thus, it
may be concluded that next to the SIC-LOS classification the DRG classification will give a
very small but significant additional extra prediction in length of stay.
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Table 8.5 Results of a two-way analysis of variance using length of stay as dependent variable
and the classifications of S1C-I.OS and DRG as predictors. I'm I ass ifi able patients in SIC-I.OS
(n=l9) and outliers (n=7) have been removed from analysis. Adjusted sums of squares method,
n=438.
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We do believe that other types of classifications of AMI patients must be constructed if one
wishes to analyze specific costs of medical care in a valid way. Nevertheless, we have
compared the value of the SIC-LOS classification and the DRG classification in predicting
both the overall costs of medical care and specific costs of medical care. Results from this
comparison are summarized in table 8.6.
Table 8.6. Comparison of the predictive value in specific costs and overall costs of medical care
in AMI patients classified according to SICLOS and DRG (outliers and unclassifiable patients
excluded), 437 $ n ^ 445.
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To obtain a comparison of the predictive validity of other patient classification systems (with
regard to hospital costs), results from the study performed by Thomas e.a. (1986,1991) may
be used. In this study different classification systems were applied to the same data set
derived from several hospitals. The validity of these systems to predict costs of patients
classified in the three DRG's 'Acute Myocardial Infarction' has been evaluated. Some
results from this study are summarized in table 8.7. According to Thomas e.a. the capability
of these classification systems to explain costs for AMI patients is relatively low, except for
Coded Disease Staging. However, some caution is necessary when these results are
compared to those found in this study. There appear to be important differences in the length
of stay of AMI patients between American and Dutch hospitals; in the U.S.A. the length of
slay is considerably lower. The SIC-LOS classification sofar is only capable to explain the
length of stay in one Dutch hospital. Furthermore, the poor performance of these systems
compared to SIC-LOS with regard to explaining overall costs of medical care may not be
caused by the inadequacies of the systems themselves but may lie in the incorrect
assumption that classifying patients according to the likelihood of death or the length of stay
will automatically explain accumulated costs of medical care during a hospital stay. From
literature we have not been able to find studies which compare the predictive power with
regard to the length of stay for these systems for the same data-set of AMI-patients.
Tuhle 8.7 Variance explained «if total costs or medical care within adjacent DRG's 121-123 by
different classification systems (adjusted for hospital differences).
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8.4. Applications of SIC-LOS.
It is important (hat the application of a patient classification system is in accordance with the
original purpose for which it is developed. The purpose of this study is to develop a method
for Severity of Illness with the aim to explain differences in length of stay and (specific)
costs of medical care. The possibilities in applicating such a system have not been
investigated yet and furthermore the system has to be validated by using other data sets.
Some thoughts about the application of the system will here be presented, but it is believed
that the real value of it can only be established after several feasibility studies have been
performed.
Our conclusion is that at least three different types of classification of AMI patients are
necessary if one aims to analyze cost differences in medical care during hospital stay in a
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reliable way. Only one is proposed in this thesis; the other two will still have to he
developed in the near future.
One global set of clinical indicators is found to be relevant for this threefold classification
(sec table 8.1). Normally these indicators arc not directly available to every caregiver or
researcher in a computerized way but these arc often collected by physicians on separate
registration forms (certainly in the hospital under observation). The lime necessary to collect
these data from the medical record and the cardiology registration form by trained
physicians is estimated to be 15-20 minutes. However, data acquisition would certainly be
facilitated, if the cardiology registration form would be available as computerized data. A
computer program will have to be developed to classify patients automatically in the
severity categories.
A severity of illness classification for AMI patients developed to explain costs of medical
care can not be used to explain the likelihood of death. However, a part of the methodology
used to define and opcrationalizc severity indicators may be useful for this purpose. This
would result in a research design that lays more emphasis on the clinical risk factors before
hospital stay, but this would lead to a completely different study.
A patient classification system which classifies patients retrospectively is considered (o be
appropriate when applied within long term management of care; it is considered to be
inappropriate for daily medical practice and for the treatment of individual case types. A
severity of illness classification could serve as a supplement to well defined patient
categories in which patients are categorized according to their diagnoses (lor instance the
DRG-system). In that case a validated SIC-systcm may be used for:
* f/ie eva/ua/ion <?ƒ ;/ie care-mix and m€o7ca/ care.
Continuous evaluation of medical performance is supposed to be inherent to high quality of
medical care. Evaluation of individual case types is often discussed by a group of medical
professionals. A severity of illness classification may be helpful to evaluate medical
performance on a departmental level; questions and outcomes may be discussed such as
'what number and type of AMI patients have been treated during which period of lime?';
'are there changes in mortality rates or severity rates compared to former periods of time?';
'what arc the consequences of changes in the AMI medical protocol on the distribution in
categories of severity of illness and mean costs of care of these patients?'.
£>ƒ care.
Changes in number and type of patients will affect nursing departments and ancillary
departments. For instance, changes in severity of illness, in the sense that a substantially
higher number of severely ill patients are treated, will certainly have an effect on the nursing
bed requirement. A SIC may provide information that is important from a management point
of view. Results of the SIC may help to answer questions like 'arc there trends in the number
of severely ill patients who need highly intensified care or who need to stay in hospital for a
long period?'.
From our results it may be concluded that severity of illness of patients is an important
factor causing costs differences in medical care. When a hospital uses a classification system
such as DRG for clinical budgeting, deviations from the budget may be traced to changes in
the severity of illness of patients treated. Determination and evaluation of clinical budgets
may improve when specific information on the distribution of severity of illness is available.
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When patients arc categorized in their severity of illness groups it is possible to correct the
analysis of the utilization of hospital resources for this factor and find the real impact of
organisational variables on the resource use.
<?ƒ care
A severity of illness classification is often used in specific research programs to assess the
quality of care given to clinical patients. Iezzoni says (1991) that in such studies: 'a severity
standardization is necessary to control for the confounding influence of patient severity in
comparisons of outcome that might be related to severity. Quality assessment generally
focuses on the severity manifestations prior to medical intervention, assuming that once this
severity is considered, residual poor outcomes arc more likely to result from substandard
care. Severity adjustments thus theoretically minimizes the potential for misjudgments about
quality due to poor outcomes outside the control of the health care provider'.
It is believed that the major application of a SIC system will lie in specific scientific
research. For instance, it may be used to analyze differences in the severity of illness of
patients having a similar diagnosis between general and university hospitals. Another
application may be to analyze differences in costs of medical care between similar types of
hospitals for severity-adjusted patient groups
8.5. Conclusions.
Results from empirical analysis have been used to develop a Severity of Illness
Classification (SIC) aimed at explaining length of stay for AMI patients. The patient's
severity of illness is regarded as a multidimensional concept. Six criteria were found to be
important for explaining the patient's length of stay. To group AMI patients in clinically
valid categories which arc homogeneous with regard to length of stay, empirical
combinations of the six criteria have been used to construct a Severity of Illness
Classification. For the patient population at hand this has resulted in 17 categories
classifying 95 % of all AMI patients.
At this stage of research we arc only able to compare the predictive validity of the SIC-LOS
classification compared to the DRG system. Analysis of variance has shown that the
predictive validity of the SIC-LOS classification in terms of length of stay and costs is much
higher than that of the DRG classification for the same patients. The predictive validity of
the SIC-LOS in terms of costs of CCU and accumulated costs of acute care (thrombolytic
therapy, heart cathcicri/ation and PTCA) was relatively low but still higher than the DRG's
predictive validity. The latter is not surprising since our analysis showed that certain specific
severity indicators did provide better explanations for these types of costs. Some indicators
turned out to be typical for an increase of specific costs but did not have any effect on other
types of costs. For instance if patients have a high CPK enzyme release they will stay longer
at the CCU but this variable has generally no effect on length of stay. The severity of illness
on admission will have an effect on the acute care costs, while the severity during hospital
stay (the course of the illness) will influence the patient's length of stay and other costs
made during that stay.This might also be the reason that the predictive value of the overall
costs of care of AMI patients was rather low using the new classification. Similar results
were found in other studies using other severity systems to explain overall costs differences
in AMI patients. In order to reach a high predictive validity in explaining costs of medical
care, the severity of illness of AMI patients will have to be defined in more specific ways
dependent on the type of costs one intends to explain.
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9. Conclusions and discussion.
9.1. Conclusions.
* Research objective.
In the previous chapters an attempt has been made to explain cost differences in medical
care given to hospitalized patients with Acute Myocardial Infarction (AMI). The central
hypothesis investigated in this research is that the severity of illness is the crucial factor for
variations in costs of medical care in patients having a similar discharge diagnosis.
Secondly, the objective of this study is to develop a patient classification system for
hospitalized patients with Acute Myocardial Infarction which classifies these patients
according to their severity of illness in economically homogeneous categories.
* Methodology.
Relations between cardiac and cardiovascular deficiencies in AMI patients huvc been
hypothesized in a causal model. The severity of several of these deficiencies (coronury
stenosis, myocardial ischemia/necrosis, rhythm and conduction disorders, heart failure and
specific complications) has been measured by means of specific clinical indicators. Ivuch
indicator is opcrationalized by means of three severity dimensions (intensity, extent and
location) using severity weights derived from a panel of three cardiologists. The severity of
illness has been measured by time-specific indicators (measured during several lime periods
within the hospital stay) and by dynamic severity indicators (reflecting changes in severity
during stay).
Effects of the severity indicators on specific costs have been investigated. The analysis was
performed for acute care costs, costs of CCU, length of stay and other costs of care. To
guide the analysis of costs in medical care a general causal model has been developed which
includes the clinical severity indicators and which at the same time has taken into account
some non-clinical patient characteristics (like age, type of admission and type of discharge).
* Results.
Costt
Acute care costs have been analyzed separately as costs of thrombolytic therapy, costs of
(acute) heart catheterization and costs of (acute) PTCA. The severity of illness turns out to
have an effect on costs of thrombolytic therapy; ischemic pain on admission, ischemia over
more wall segments and antcroseptally located necrosis as indicated by admission ECG
results will increase the probability that costs will be induced due to thrombolytic therapy.
Other factors, such as contra-indications (high age, being in coma and the duration of
ischemic pain before admission) have a restrictive impact on costs of thrombolytic therapy.
It was found that the severity of illness has a relatively weak effect on the costs of acute
heart catheterization and the costs of acute PTCA. Medical treatment prior to the
cathctcrization, i.e. thrombolytic therapy, turns out to have a relatively high predictive value
for these costs. The severity of illness on the moment of admission can be seen as an indirect
cause for these costs; more severely ill patients tend to get thrombolytic therapy and as a
result of this they will get an acute heart catheterization. Furthermore, for patients with one
occluded coronary vessel the probability of getting an acute PTCA will increase. It was
concluded that the severity of illness measured on the moment of admission will explain
costs of acute care to some extent.
«ƒ CCt/ am/ /pn#r/i »ƒ ^
Severity of illness has a relatively large effect on the length of stay and the costs made in the
Coronary Care Unit (CCU). More specifically, factors like anteroscptally located ischemia
measured by ECG, specific cardiac rhythm disorders, left ventricular heart failure and
pericarditis will substantially increase the length of stay and the CCU costs. A high enzyme
release, specific cardiac conduction disorders and anteroscptally located cardiac wall motion
abnormalities prove to be typical for an increase in the CCU costs. Furthermore, suffering
from prc-collapsc, having ischemic pain, having mitral insufficiency or CVA/TIA will lead
to a longer stay in hospital. It is concluded that the severity of illness certainly has a large
effect on the CCU costs and (he length of stay. However, severity indicators explaining
length of stay turned out to be different from severity indicators explaining CCU costs.
«ƒ mf </ic<i/ carp.
Other costs of medical care have been separately investigated as costs of laboratory services,
drugs, ECG, cchocardiography and exercise tests. Costs of laboratory services were partly
explained by the severity of illness. For the patient population in this survey it turned out
that enrollment in a clinical (rial will increase the costs of laboratory services substantially.
Costs of drugs and costs of ECG explained in a more indirect way by severity of illness.
These costs turned out to be strongly related to the length of stay; severely ill patients tend to
stay in hospital longer and as a result of this costs of drugs and costs of ECG's will be high.
Furthermore, when patients stay in CCU longer, chances of getting an cchocardiography will
increase. Apart from this, several specific severity indicators produce an additional increase
in these costs. Costs of exercise tests arc hardly influenced by severity of illness; these tests
arc normally planned for every patient just before hospital discharge. Some severity
indicators turned out to influence the costs of exercise tests in a negative way. These tests
are normally not performed if the patient suffers from specific severity conditions (contra-
indications).
Patient's background characteristics turned out to have almost no predictive value for costs
of medical care, if one controls for his or her severity of illness. The only exceptions were
the patient's age and sex; older patients usually tend to get no exercise test and female
patients appear (quite uncxplicably) to have lower chances of getting an acute heart
calhclcri/.ation.
Next to the severity of illness, a conditional factor influencing costs of medical care
considerably was the death of patients during stay. Patients who die early on during hospital
stay will of course have very low costs in contrast to surviving patients. Surviving patients
will have lower cost compared to patients who die in hospital after protactcd illness. The
severity indicators defined in this study arc not able to explain the occurrence of death
during hospital stay.
* Classifying AMI patients according to their severity of illness.
Within costs analysis in AMI patients a major distinction had to be made between their
severity of illness on admission and their severity of illness during hospital stay. In addition,
the various types of costs of medical care can only be explained by severity indicators that
characteristically belong to these cost types. For AMI patients many types of classifications
according to severity of illness can be constructed depending on the types of costs that need
to lie explained.
For the time being a single severity of illness classification (SIC-LOS) for AMI patients is
proposed based on empirically determined severity criteria, which turned out to have a
significant effect on the patient's length of stay. Severity of illness in this context is seen as a
multidimensional concept; the degree and the combination in which medical deficiencies arc
found in AMI patients is important to classify them into a number of severity categories. In
the SIC-LOS classification. 17 severity categories have been distinguished. Data analysis
has shown that the SIC-LOS classification offers a better explanation for length of stay,
costs of drugs, costs of laboratory services and costs of ECG (Eta' is resp. 58.3 * , 49.2 %,
18.4 % and 50.1 %) than the DRG-classification (Eta' is rcsp. 18.3 * . 10.4 %. 2.9 * and
15.1 %). The predictive validity of SIC-LOS in terms of explaining CCU costs and
accumulated costs of acute care (thrombolytic therapy, acute heart cathctcri/iilion and acute
PTCA) was much lower, but still higher than that of the DRG-systcm. The decrease in
explained variance by the SIC-LOS classification is not surprising since our data analysis
showed that other severity indicators were giving better explanations for these types of
costs.
It can be concluded that in order to reach a high predictive validity in explaining medical
care costs, the severity of illness in AMI patients has to be defined in various ways
depending on the type of costs one wants to explain. This can also be seen as the reason why
one overall severity of illness classification with a high predictive validity for the total
hospital costs of medical care is a goal which is difficult or even impossible to reach.
This study has shown that the severity of illness of patients is certainly a factor to be
considered in costs-analysis of their medical care. However, the patient's severity of illness
is nol an absolute, universal and unidimcnsional concept as is often assumed. The severity of
illness is found to be a very complex, dynamic and multidimensional concept which can be
defined in various ways. In cost-analysis a differentiation of specific types of care will be
necessary to understand the complex interplay between severity characteristics and costs.
However, we do believe that the approach used in the development of severity indicators,
the analysis of costs of care and the classification of patients into severity categories may
serve as a general methodology to explain specific types of cost in medical care in other
patient groups as well.
9.2. Discussion.
In order evaluate the methodology and results in this study some general criteria for patient
classification systems as discribed in § 2.1. and some other issues will now be discussed.
The medical meaningfulness/contcnt validity refers to the definition of the severity weights
used for the indices and the eventual recoding and classification of AMI patients. The
severity weights were established after individually consulting three cardiologists. The
proposed weights must be seen as an attempt to create a relative severity scale and cannot be
regarded as a 'golden standard'. Standardization in severity measures is and always will be a
goal difficult to attain.
The SIC-LOS classification does have a high degree of clinical credibility because it is
based on clinical indicators which are normally used by cardiologists to diagnose and treat
the patient. It is believed that the severity categories are still recognizable for cardiologists
because they are based on empirically observed patterns of severity-scores within the
population under survey. However, further research using other data sets combined with
ongoing critical evaluation from physicians is necessary to ascertain the medical content
validity of our severity scales and the severity classification.
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The predictive validity in this study refers to the degree to which the severity indicators used
in this study are able to explain costs differences. The variance explained is found to vary
depending on the type of costs. The explanation of costs of acute care by means of the
severity indicators has the lowest predictive validity. Variance explained by the severity
indicators regarding costs of CCU and length of stay (which will by assumption indirectly
explain other costs of care such as drugs, ECG etc.) is relatively high.
This study was limited to patients belonging to the DRG's 'acute myocardial infarction'
admitted to one university hospital in the Netherlands during a specific time period of 16
months. The results may be influenced by local hospital practice. The results could have
been different in other hospitals anuVor during other periods of investigation. The reliability
of results can only be evaluated, if comparable studies show similar results. Another
problem is that the proposed Severity of Illness Classification for AMI patients has been
based on results from data analysis of the same data set. In order to test the reliability of our
Severity of Illness Classification, the same classification rules should be applied to a
different set of data. Therefore, this study must be seen as a first investigation to obtain
insight into the factors that influence costs and to classify patients according to their severity
of illness.
The reliability of our results may also be influenced by the quality of the data used. The data
quality depends for a great part on the scoring technique of data. In this study, physicians
who were especially instructed for this purpose have performed the scoring of our data
retrospectively (after the patient's discharge) using the patients' medical records as main
source. Thus, the data collection was based on sources normally meant for clinical use.
Furthermore, some severity indicators found to be important for cost explanation may have
been influenced by retrospective interpretation of medical data. For instance the scoring of
ECG-data was found be inconsistent in some cases. A more appropriate design would
include a prospective way of data collection with especially instructed physicians, but this
may be very difficult to achieve for acute illnesses like myocardial infarction. Another bias
in the data may have resulted from the interpretation of test results by the cardiologists. At
this stage of the research it was not possible to judge the impact of errors in the scoring of
data on the results of the data analysis and the eventual classification. Lastly, the severity
indices used in this study have been based on results of diagnostic tests commonly available
at the time of investigation. New diagnostic technologies in the field of cardiology may give
additional and more reliable data for severity criteria. New treatment technologies may also
affect the relation between severity of illness and the costs of medical care. In further studies
is it necessary to take such specific changes in diagnostic and treatment practice into
account.
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From a strict point of view a patient classification can only be used for the purpose for
which it was originally developed. The proposed SIC-LOS may therefore only be used to
evaluate and compare the length of stay (and costs strictly related to length of stay such as
costs of ECG, drugs and laboratory services) in AMI patients classified according to the
DRG-systcm. To evaluate and compare acute care costs and CCU costs another patient
classification must be used, which may or may nog have a relation with the first
classification. So, for general policy and administrative purposes within hospitals the added
value of a severity of illness system has to be evaluated in terms of the extra effort or costs
necessary to construct and apply such a system. Although it is believed that a severity of
illness classification may be useful for internal hospital management, we expect that its
value is much higher in specific scientific studies, such as analyzing differences in severity
and costs between various hospital institutions for a well defined patient group.
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The requirement of versatility and flexibility refers to the capability of a classification
system of combine categories in various ways of form new classifications for other goals.
The S1C-LOS as presented in this study may only serve as a tool to analyze the length of
stay in AMI patients. Combination or aggregation of the 17 categories to test the feasibility
for other purposes has not been employed. However, it is found that for various costs-
analysis several classifications of AMI patients must be determined. In our opinion
versatility and flexibility must refer to the set of clinical indicators necessary for u multi-
purpose classification of patients. For cost analysis of medical care of AMI patients the
clinical indicators as described in table 8.1 may be suitable. Further studies may reveal
severity indicators that are important in explaining death/survival or the outcome in terms of
the improvement in the patient's condition.
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Specific types of medical data arc necessary to determine the categories in the proposed
severity of illness classification. Normally these data arc not available in a computerized
form. The time necessary to collect these data from the medical record and the cardiology
registration form by trained physicians is estimated to be similar to other severity systems
based on clinical data (approximately 15-20 minutes). However, data collection would
certainly be facilitated, if a computerized cardiology registration form would be available.
Furthermore, a computer program has to be developed to classify patients automatically into
severity categories. At this stage of the research this has not been performed. It is believed
that the validity of the severity classification(s) should be assessed first by means of a multi-
centre survey.
Differences between the SIC-system and other disease-specific severity
systems.
In contrast to ordinal and unidimcnsional severity classifications like CSI, Apache II and
Mcdisgrps, the level of measurement of the Severity of Illness Classification (SIC) proposed
in this study is half nominal/half ordinal and it has a multidimensional character. We think
that the SIC classification will provide certain advantages. First of all, the classification will
give a clinical typology of patients according to their severity characteristics. Other severity
classifications are not intended as case type classifications. They classify patients into
severity categories ranging from level 1 to level 4 without referring to a clinical typology of
patients within each category. Secondly, the SIC-classification is based on empirically
observed combination of scores on severity indicators. Other severity systems have a
tendency to use linear weights to accomplish a unidimcnsional scale in the measurement of
severity of illness. In almost all cases a justification of these weights is not given. There arc
also differences in the methodology used to find relevant criteria for costs differences. The
SIC-LOS classification is based on criteria derived from a interactive combination of results
obtained from empirical cost analysis and professional judgement. Other systems arc
generally only based on consensus judgment of panels of clinicians and arc originally not
developed for economic purposes. At this stage of the research it is not possible to compare
the systems using criteria such as content validity of measurement and prcditivc validity.
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Costs of medical care.
Costs of medical care for AMI patients have been specified into specific types of costs, and
data analysis has been performed for each type separately. No data analysis has been done
involving the total costs of medical care seen as an aggregated dependent variable. In our
opinion overall cost analysis tends to conceal explanations for specific medical care costs.
Overall cost analysis will place greater weight on those subcosts that are relatively high. As
was found in this study, a specific type of costs can only be explained by a characteristic set
of predictors. One unique set of predictors explaining total costs of medical care could not
be established. Also, sets of predictors could not be interchanged in the explanation of
specific types of costs. Such an exchange will eventually harm the predictive validity of the
classification itself, because it will uses criteria not confirmed in empirical data analysis.
Costs of medical care have been determined for each patient by multiplying the number of
services registered by the billing system with a scrvicc-relatcd-cosl-price. Normally these
data arc collected for reimbursement purposes. The investigated costs of medical care are
therefore limited to chargeable services as specified by the billing system. Costs include
only product-related material and personnel costs based on studies performed within the
hospital under survey. These cost components can only be used for short term applications.
For long term applications, capacity and overhead costs also need to be incorporated.
Strictly speaking, no generalizations can be made with regard to other hospitals in which
costs may be different for the same service.
Unexplained variance.
The indices of severity of illness can, of course, not explain the total variance of the
dependent variables. The unexplained variance may have been caused by specific
department characteristics or by variations in the (quality of) medical care given to patients
by individual physicians. Unexplained variance will presumably also be caused by specific
illness conditions not captured by our severity indicators and other characteristics of
individual patients.
Recommendations.
It is clear that differences in costs of medical care between clinical patients can only be
partially explained by the DRG-classification. Other factors, such as (changes in) severity of
illness do contribute importantly to the explanation of costs in medical care. The DRG-
systcm is found to be an adequate tool to describe and analyse a total hospital population.
However in some DRG's a further specification according to a severity of illness is
necessary in order to reach a high predictive validity. A severity of illness classification may
thus only be relevant for those patient categories which show large variations in length of
stay and costs of medical care. Generally speaking one can state that the DRG-classification
proves to be satisfactory in explaining costs of surgical patients, this in contrast to patient
categories of non-surgical patients. We think that some adjacent DRG's with non-surgical
patients must be complemented with a severity of illness classification based on clinical
indicators, for this will certainly increase both the medical meaningfullness as well as the
predictive validity. For instance, the DRG's involving non-surgical oncology patients or
patients having chronic illnesses like renal failure (DRG 316 and DRG 317), medical back
problems (DRG 234) and chronic obstructive pulmonary diseases (DRG 88) are examples of
patient categories which, in general, show large variations in costs of medical care. Taking
into consideration the complexity and the time-consuming activities necessary to measure
and apply a severity of illness classification, it is recommended that further research must be
concentrated on such specific heterogeneous patient categories within the DRG-system.
Cbnc/usioos am/ (fccitwion 777
The DRG-system is normally used as an instrument for prospective reimbursement of
hospitals; specific reimbursement rates have been established for each DRG separately. The
reimbursement rates do rely for a large part on the ability of the DRG-system to predict the
length of stay. Costs of medical care are supposed to be related to the length of stay.
However, for AMI patients the predictive validity in explaining overall costs as well as
specific costs of care by the DRG-classification is rather low. If the goal of prospective
reimbursement is to finance hospitals in a reliable and fair way. the application of a patient
classification system such as the DRG-system for this goal must be critically evaluated and
handled. In our opinion further research is certainly necessary in order to achieve a valid
patient classification system for this specific purpose. We believe that the DRG-system will
show its value for purposes of general hospital administration. The DRG-informalion will
enable hospital managers to get global information on the hospital patient population, their
resource use, costs and needs in medical care. But additional information about the patient's
severity of illness will be necessary to understand and control clinical and financial
processes in a more valid way.
Furthermore, we believe that in the context of costs analysis of clinical patients, costs of care
need to be specified into various types of costs in order to evaluate and compare patient
populations within and between hospital settings. Only then a thorough understanding of the
relation between illness characteristics and costs of medical care will be made possible.
Further research should concentrate on building, expanding and empirically testing disease-
specific models which define the complex interplay between a patient's severity of illness
and the medical care provided. Doing research from this perspective will give valuable
insight into the complicated medical care processes within hospitals.
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Summary.
An important premise underlying this study is the assumption that patient classification
systems are used for managing medical care in hospitals (chapter I).
There are two important prerequisites for setting up such patient classification systems.
Firstly, patients classified in the same category must from a recognizable group from the
medical perspective of the health care providers. At the same time patients must he
classified into the same category from an economic point of view if they make comparable
use of hospital resources. A number of patient classification systems developed in the
United States are described and compared with respect to. amongst others, the criteria of
medical and economic mcaningfulncss. One of the most well known systems is the
Diagnosis Related Groups (DRG) system which classifies patients on the basis of discharge
data such as diagnosis and surgical procedures plus the patient's age and discharge status. A
study of the literature has revealed that a number of DRG's leave much to be desired in
terms of economic homogeneity and moreover, that the clinical validity of these DRG's can
be improved (chapter 2).
This thesis intends to determine the factors that provide an explanation of differences in
costs of medical care for patients categorized according to the DRG system. The research
population has been restricted to patients who arc classified under the DRG's 'Acute
Myocardial Infarction' (AMI). The research population comprises a total of 464 non-
surgical AMI patients who were admitted to and discharged from the department of
Cardiology at the University Hospital Maastricht between January 1, 1987 and April 30,
1988.
It is hypothesized that the patient's severity of illness is the most important factor influencing
differences in costs. In addition, individual background characteristics, conlra-indications for
treatment, participation in a research protocol (clinical trials) and admission and discharge
criteria are also believed to be important in predicting differences in costs. Because of the
dynamic interaction that can be expected to exist between the patient's medical condition
and his/her treatment, the hospital stay has been divided into several periods (chapter 3).
For the research population, data were retrospectively collected from discharge abstracts,
ancillary service records and medical records (chapter 4).
The assessment of the costs of medical care given to a patient can be realized by linking a
cost-price per service to the empirically determined number of services. The procedure by
which the costs of ancillary departments (such as the clinical chemistry laboratory, the heart
function laboratory etc. are specified per service (such as blood tests, ECG's etc.) is
described in chapter 5. This chapter also deals with the way in which the severity of several
cardiac and cardiovascular deficiencies relevant to AMI patients is opcrationali/.cd. In
severity of illness three interrelated dimensions arc distinguished: the intensity, the extent,
and the location-related vulnerability of a deficiency.
In chapter 6 both, the empirically determined costs of medical care and the severity of
illness of the research population are described. The costs of medical care arc .specified as
diagnostic costs (heart catheterization, laboratory tests, ECG's, echocardiography and
exercise tests), treatment costs (thrombolytic therapy, PTCA and medication) and nursing
costs (CCU and length of stay). The severity of various cardiac and cardiovascular
deficiencies is measured by linking results from diagnostic tests (laboratory results,
catheterization results, ECG data, echocardiography and exercise tests), physical
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examination and medical history to severity weights for each deficiency a patient may have
during a specific period of hospitalization. The way these periodic severity scores are
combined, resulting in the measurement of a patient's medical deficiency over the entire
hospital stay, is also explained in chapter 6.
In the data analysis (chapter 7) a distinction is made between costs closely related to the
acute phase of hospitalization and costs related to the entire hospital stay.
During the acute phase of hospitalization, the decision to administer thrombolytic therapy is
made. Analysis has shown that the location of myocardial necrosis (anteroseptal or non-
antcroscptal). the extent of the myocardial ischemia and the presence of ischemic pain on
admission will influence the decision to administer thrombolytic therapy. Furthermore,
specific contraindications (ischemic pain for more than six hours, an age over 75 and being
in coma) arc also found to be important factors.
The costs of a(n) (acute) heart cathctcrization arc only partly explained by the severity of
illness on admission. In addition to the extent of myocardial ischemia, the administration of
thrombolytic therapy appears to be the most important factor influencing these costs:
severely ill patients arc more likely to need thrombolytic therapy and as a consequence of
this a cathclcrization is more likely to be performed.
During heart cathctcrization a PTCA (Dotter procedure) can be performed. For patients with
coronary stenosis in one coronary artery, the administration of thrombolytic therapy
decreases the likelihood of incurring costs for a PTCA. Conversely, the intensity of stenosis
and the location of myocardial necrosis increase the likelihood of getting a PTCA. These
effects, however, arc not found in patients with stenosis in two or three coronary artcnes.
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From the beginning of hospitalization, all AMI patients receive intensive nursing care in the
coronary care unit (CCU); following a CCU stay which may vary in length, patients arc
placed in a regular nursing ward. Differences in CCU stay (and thus costs) are largely
explained by the severity of several deficiencies. Factors such as anteroseptal ischemia in
the myocardium, extremely high enzyme release (CPK-rclcasc), abnormal wall motion in
the anteroseptal myocardium, specific rhythm and conduction disorders, heart failure and
pericarditis each significantly increase CCU costs.
Differences in the total length of stay of AMI patients arc explained by some of the same
severity indicators mentioned above: anteroseptal ischemia in the myocardium, specific
rhythm disorders, heart failure and pericarditis arc found to influence length of stay. In
addition to this, length of slay is substantially increased as a result of continuous ischemic
pain after three days, having a prc-collapsc during hospitalization and specific complications
such as mitral insufficiency and CVA/TIA.
Other costs of medical care arc largely related to length of stay. The severity of specific
cardiac and cardiovascular deficiencies hardly increases the costs for laboratory services,
ECG's and medication in a direct way.
The costs of exercise tests appear not to be influenced by severity of illness. These tests are
normally applied to all patients, with the exception of a few patients who have contra-
indications.
Next to severity of illness, background characteristics of patients (such as age and gender)
appear to have very little additional value for predicting costs. Older patients, for example,
score relatively high on several severity indicators, which accounts for their higher costs.
The death of a patient during the hospital stay, however, docs affect costs. In case of death, a
distinction must be made between patients who die acutely and patients who die after a
prolonged stay.
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The results of this study have been used to develop a severity of illness classification system
for patients with AMI. On the one hand, this system will guarantee medical validity and on
the other hand will group patients with a similar length of stay. On the basis of empirically
found severity indicators which influence the length of stay. 17 categories of patients have
been distinguished. This severity of illness classification (SIC) proves to offer a considerably
better explanation for differences in length of hospital stay in comparison to the DRG
classification of the same patients, even when corrections arc made for the number of
categories that arc used (chapter 8).
Finally, the most important conclusions of this study arc presented in more detail in chapter
9. These conclusions arc followed by a discussion of the results in the light of a number of
methodological issues that arc universally applicable to patient classification systems.
Insight into the complex relations between severity of illness and costs of medical care is an
essential prerequisite for the management of medical care within hospitals. Therefore
improved patient classification systems can be a vital management instrument.
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Samenvatting.
Uitgangspunt van dit onderzoek is het gebruik van paliëni-classificaticsystcmen (er
besturing en beheersing van medische zorgverlening in ziekenhuizen (hoofdstuk 1).
Een belangrijk vereiste bij de op/et van zulke paticnt-classificaiicsysicmcn is dal patiënten
vanuil medisch oogpunt herkenbaar blijven voor zorgverleners. Daarnaast dienen patiënten
uit eenzelfde categorie vanuit een economisch perspectief een vergelijkbaar middclcnbcslag
te hebben. Een aantal beslaande patiënt-classificatiesystemen, alle ontwikkeld in de
Verenigde Staten, wordt besproken en vergeleken aan de hand van deze beide criteria. Een
van de meest bekende systemen is het zogenaamde Diagnosis Related Groups (DRG)-
systcem dat klinische patiënten classificeert op basis van ontslaggcgcvcns zoals de
diagnoses, aard van operaties, leeftijd en wijze van ontslag. Uil een literatuurstudie blijkt dal
niet alleen de economische homogeniteit van een aantal DRG's te wensen overlaat, maar dal
eveneens de klinische herkenbaarheid of validiteit van deze DRG's verbeterd kun worden
(hoofdstuk 2).
In dit proefschrift wordt nagegaan welke factoren een verklaring geven voor de verschillen
in de kosten van de klinische zorgverlening lussen de patiënten, ingedeeld volgens de DRG-
systcmatick. De onderzoekspopulatie is beperkt tol patiënten die zijn ingedeeld in de DRG's
'Acuut Myocard Infarct" (AMI). Het betreft in totaal 464 nicl-opcralicvc AMI-patiëntcn, die
opgenomen en ontslagen zijn bij de afdeling Cardiologie van het Academisch Ziekenhuis
Maastricht tussen 1 januari 1987 en 30 april 1988.
De belangrijkste factor voor kostenverschillen lussen patiënten is volgens menigeen hel
verschil in de ernst van hun aandoening. Daarnaast wordt verondersteld dat individuele
achtergrondkenmerken van de patiënt, contra-indicaties voor behandeling, deelname aan
bepaalde wetenschappelijk onderzoeken (medische 'trials') en opname- en ontslag-
kenmerken van belang kunnen zijn voor verschillen in kosten. Vanwege de te verwachten
dynamische interactie tussen de klinische toestand van de patiënt en zijn/haar behandeling is
het ziekenhuisverblijf van deze patiënten opgedeeld in diverse perioden (hoofdstuk 3).
Voor de onderzoekspopulatie zijn retrospectief ontslaggcgcvcns, vcrrichtingcngcgcvcns en
gegevens uit het medisch dossier verzameld (hoofdstuk 4).
Door een kostprijs per verrichting te combineren met het empirisch gevonden aantal
verrichtingen is het mogelijk de totale kosten voor de medische zorg aan een patiënt in beeld
te brengen. De procedure volgens welke de kosten van de ondersteunende afdelingen (zoals
laboratoria, hartfunctie afdeling, etc.) zijn verbijzonderd naar de diverse verrichtingen (zoals
bloedonderzoek, ECG, etc.) wordt in hoofdstuk 5 uiteengezet. In ditzelfde hoofdstuk wordt
ook ingegaan op welke wijze de ernst van de diverse hart- en vaataandocningen, die relevant
zijn voor AMI patiënten, wordt geoperationaliseerd. De ernst van elke aandoening wordt
onderscheiden naar drie dimensies: de intensiteit, de uitgebreidheid en de locatie-gebonden
kwetsbaarheid van de aandoening.
In hoofdstuk 6, passeren de empirische kosten voor de medische zorgverlening en de ernst
van de aandoening van de onderzoekspopulatie de revue. De kosten van de medische
zorgverlening zijn gespecificeerd naar kosten voor diagnostiek (hartcalhcterisatic,
laboratoriumtesten. ECG, echocardiografie en inspanningsonderzock), kosten voor
behandeling (thrombolytica, PTCA en medicatie) en kosten voor verpleging (CCU- en
verplecgduur). Daarnaast wordt de ernst van de diverse hart- en vaataandocningen gemeten
door resultaten van de diagnostiek (laboratoriumtesten, cathctcrisaticvcrslagcn, ECG-data,
cchocardiografic en inspanningsonderzuck), lichamelijk onderzoek en anamnesc te relateren
aan crnst-gcwichtcn. De emst-scores zijn gemeten gedurende diverse opname-perioden en
vervolgens samengevoegd tot de ernst van de aandoening over de gehele opname.
In de data-analysc (hoofdstuk 7) is een onderscheid gemaakt tussen kosten die samenhangen
met de acute periode van de opname en kosten die betrekking hebben op het totale
zickcnhuisverblijf
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In de acute periode van een opname wordt besloten of een patiënt in aanmerking komt voor
het krijgen van een thrombolylicum (stolscl-oplosscnd middel). Uit de data-analyse blijkt
dat de locatie van necrose in het myocard (antcroscptaal of niet), de mate van uitgebreidheid
van ischemie in het myocard en de aanwezigheid van ischcmischc hartpijn bij opname een
grote invloed hebben op het toedienen van thrombolytica. Daarnaast blijkt dat specifieke
contra-indicaties eveneens van belang zijn (langer dan zes uur ischcmischc pijn, het ouder
zijn dan 75 jaar en het feit of patiënten in coma zijn).
De kosten van een (acute) hartcalhclcrisatic worden deels verklaard door de uitgebreidheid
van de ischemie in het myocard. Het toedienen van thrombolytica blijkt de belangrijkste
factor te zijn voor deze kostenverschillen: ernstig zieke patiënten hebben een hogere kans op
thrombolytica en als gevolg hiervan zal bij hen eerder een cathctcrisatic plaatsvinden.
Tijdens zo'n hartcalhctcrisatic kan een PTCA ('Dotter' procedure) worden toegepast. Bij
patiënten met een kransslagadcrvcrnauwing in één coronaire arterie verkleint het toedienen
van thrombolytica de kans op kosten voor een PTCA. De mate van stcnose en de locatie van
necrose in het myocard daarentegen verhogen de kans op kosten voor een PTCA. Bij
patiënten met een vernauwing m twee of drie coronaire artericn kunnen deze efïecien echter
niet worden aangetoond.
Vanaf het begin van het zickcnhuisvcrblijf vindt voor alle AMI patiënten een intensieve
verpleging plaats in de Coronary Care Unit (CCU); na kortere of langere tijd worden de
patiënten daarna verpleegd op de 'normale' vcrplccgafdcling. Verschillen in CCU-duur (en
dus kosten) worden grotendeels verklaard door de ernst van diverse aandoeningen. Factoren
zoals anteroscptalc ischemie in het myt>card, extreem hoge enzym-waarden ('CPK-release'),
abnormale wandbewcging in het anteroscptalc myocard, specifieke ritme- en geleidings-
stoornissen, pompfuncticstoornissen en pericarditis blijken elk een significant verhogend
effect te hebben op de CCU-kostcn.
De verschillen in totale vcrplccgduur bij AMI patiënten worden deels door dezelfde ernst-
indicatoren verklaard: anteroscptalc ischemie in het myocard, specifieke ritme-stoornissen,
pompfuncticstoornissen en pericarditis blijken eveneens van invloed te zijn op de
opnameduur. Daarnaast blijkt dat aanhoudende ischemische hartpijn na drie opnamedagen,
het hebben van een (prc)collaps gedurende de opname en specifieke complicaties zoals
miiraalinsufficicntic en CVA/TIA de vcrplccgduur substantieel verlengen.
De overige kosten voor medische zorgverlening blijken grotendeels geassocieerd met de
vcrplccgduur. De ernst van bepaalde hart- en vaataandocningen heeft nauwelijks een direct
verhogend effect op kosten voor laboratorium-onderzoek, ECG en medicatie.
De kosten voor inspanningsonderzock blijken eveneens nauwelijks beïnvloed te worden
door de ernst van de aandoening. Met uitzondering van enkele patiënten (met contra-
indicaties) blijkt dit onderzoek standaard bij elke patiënt plaats te vinden.
Naast de ernst van de aandoening, blijken achtergrondgegevens van de patiënt (zoals leeftijd
en geslacht) nauwelijks of geen voorspellende waarde te hebben voor kosten. Oudere
patiënten bijvoorbeeld scoren relatief gezien hoger op diverse cmst-indicatoren en vandaar
dat de leeftijd van de patiënt geen extra verklaring voor verschillen in kosten voor
zorgverlening verschaft.
Van wezenlijk belang voor de kosten is echter wel het overlijden van een patiënt in het
ziekenhuis waarbij cen onderscheid gemaakt moet worden tussen patiënten die acuut bij
opname overlijden en patiënten die overlijden na een ruim verblijf in het ziekenhuis.
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De onderzocksresullaten zijn gebruikt om cen emst-classificaticsystccm voor AMI patiënten
te ontwikkelen dat enerzijds de klinische herkenbaarheid zoveel mogelijk waarborgt en
anderzijds zo goed mogelijk de paticntcn classificeert die cen gelijke vcrplccgduur hebben
(hoofdstuk 8). Gebaseerd op de empirisch gevonden ernst-indicatoren die van invloed zijn
op de vcrplccgduur, worden 17 categorieën van patiënten onderscheiden. Deze ernst-
indcling (SIC) blijkt cen aanzienlijk betere verklaring te geven voor verschillen in
vcrplccgduur vergeleken met de DRG-indcling voor dezelfde patiënten, ook als gecorrigeerd
wordt voor het aantal categorieën dat gehanteerd wordt.
Tenslotte worden in hoofdstuk 9 de belangrijkste conclusies uit het onderzoek gedetailleerd
weergegeven. Tevens worden de resultaten van dit onderzoek ter discussie gesteld aan de
hand van enkele methodologische criteria die algemeen gelden bij patiënt-classificutic
systemen.
Inzicht in de complexe relaties tussen de ernst van de ziekte en kosten wordt verondersteld
een belangrijke voorwaarde te zijn bij de besturing en beheersing van medische zorg-
verlening in ziekenhuizen. Intrinsiek verbeterde palicnt-classificaticsystcmcn kunnen hierbij
een belangrijk hulpmiddel zijn.
/so G/asjary
Glossary.
TO Time period 0 (six hours after admission)
Tl Time period 1 (six hours-lhree days after admission)
T2 Time period 2 (three-ten days after admission)
T3 Time period 3 (ten days after admission-discharge)
AMI Acute Myocardial Infarction
SIC Severity of Illness Classification
DRG Diagnosis Related Group
MDC Major Diagnostic Category
APACHE Acute Physiology and Chronic Health Evaluation
MEDISGRPS Medical Illness Grouping System
PMC Patient Management Category
CSI Computerized Severity of Illness
LMR Landelijke Medische Registatic
PTCA Percutaneous Transluminal Coronary Angioplasty
EC'G Electrocardiogram
ECHO Echocardiography
CCU Coronary Care Unit
ICU Intensive Care Unit
CTIIROM Costs of Thrombolytic therapy
CC ATH Costs of Heart Cathctcri/ation
CPTCA Costs of PTCA
LOS Length of Stay
CCCU Costs of CCU
CLAB Costs of Laboratory services
CECG Costs of ECG 's
CR ADIO Costs of Radiology
CHOLTER Costs of Holler ECG tests
CECHO Costs of Echocardiography
CBRUCE Costs of Bruce ECG tests
CTHAL Costs of Thallium tests
CEXER Costs of Exercise tests
CDRUGS Cost of Drugs
COTI1ER Costs of other interventions besides thrombolytic therapy, drugs
and PTCA
CPHYS Costs of Physical therapy
STENINT Coronary stenosis intensity (or degree)
STENEXT Coronary stenosis extent
STENLOC Coronary stenosis location
ISEXT Ischemia extent according to ECG at rest
1SLOC Ischemia location according to ECG at rest
BR1NT Ischemia intensity according to Bruce-ECG
BREXT Ischemia extent according to Brucc-ECG
BRLOC Ischemia location according to Brucc-ECG
BREXP Ischemia expansion; additional ischemia according to Bruce-ECG
Gfouorv
ISTHEXT Ischemia extent according to thallium test
1STHLOC Ischemia location according to thallium test
SGOT Scrum Glutamic Oxalacctic Transaminasc
CPK Crcatinc Phospho-Kinasc
LDH Serum Lactic Dehydrogcnase
SGPT Scrum Glutamic Pyruvatic Transaminasc
NETHEXT Necrosis extent according to thallium test
NETHLOC Necrosis location according to thallium lest
ISPAIN Ischcmic pain
CWMINT Intensity (or degree) of cardiac wall motion abnormalities
CWMEXT Extent of cardiac wall motion abnormalities
CWMLOC Location of cardiac wall motion abnormalities
LVEF Left Ventricular Ejection Fraction
LVEDD Left Ventricular End Diastolic Dimension
VCI Collapse Vena Cave Inferior
ISCRV Ischemia right ventricle
CWMRV Cardiac wall motion abnormalities in right ventricle
PALP Palpitations
DYSPN Dyspnea
PRECOL (Prc)-collapsc
SYCOL Syncope/collapse
HBLPRES High blood pressure
LBLPRES Low blood pressure
AP Angina pectoris
LEDEMA Lung edema
BEDEMA Body edema
HEPTO Hepatomegaly
PERIC Pericarditis
MITINS Mitral insufficiency
CSHOCK Cardiac shock
CVA/TIA Cerebral vascular accident/ transient ischcmic attack
FTHROM Former thrombolytic therapy
FCOR Former coronary insufficiency
FAMI Former acute myocardial infarction
FHYP Former hypertension
AF/F Atria! fluUer/-fibrillations
VF/F Ventricular fluUer/-fibrillations
RBBB Right bundle branch block
ADINT Admission internal
ADEXT Admission external
DEATH Deceased during hospital stay
HOME Discharge to home
TRANS Transferred during hospital stay
PRJMI PRO-urokinase In Myocardial Infarction (clinical trial)
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Appendix 9 Descriptive Statistics of Costs of Thallium Tests per Time Period and for the Total
Hospital Stay.
7bfa/o/ Tow/ M/m/wr o/ Va/ia" M?an 5ral
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Appendix 10 Descriptive Statistics of Costs of Thrombolytic Therapy per Time Period and for
the Total Hospital Stay.
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Appendix 11 Descriptive Statistics of Custs of Drugs (except thmmbolytic therapy) per Time
Period and for the Total Hospital Stay.
7ïme Period TO
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Appendix 12 Descriptive Statistics of Costs of PTCA per Time Period and for the Total
Hospital Stay.
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Appendix 13 Descriptive Statistics of Costs of Other Medical Interventions per Time Period
and for the Total Hospital Stay.
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Appendix 14 Descriptive Statistics of Costs of Intensive Care per Time Period and for the
Total Hospital Stay.
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iVu/noe r o/ Va/id
«9
/7J
464
CofK
7J9.67
4S7.78
67J.J2
7J92.O2
5/d.
D<-v.
22J.67
68J.97
/5J5.O0
/577.4O
Appendix 15 Descriptive Statistics of Costs of Physical Therapy per Time Period and for the
Total Hospital Stay.
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Appendix 16 Severity Dummy variables.
»rn'/y o/Cownnry jf<
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RVTE/V7.0O
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2
' 4 vrr.vi« no j/£.
5 vrrsu.5 no s/'g.
y / V«TJJ« no JI^'.
y 2 irrjiw no ii' .^
5TEA/EAT aif«•#«/>• J vrrj«5 no jy».
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vrr5«5 no 5i^.
tvjfcjjorv' 2 vrr.viis no ,w#.
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c rc.vf »rrii« no
20/
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fl/?l/C7Af7" category 2 vrrsus no isc/temw
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B/?L/C/ATT category 5 \rrjuj no i'sWtemia
fl/Jt/C£XT category / irrjtu no «cnrmia
fl/?£/C£YT category 2 vrrsui no isc/temia
fl/J(/C£XT category J vrwiu no «
B/?(/C£Xr category ^ vrwas no uc
B/?l/C£XT category 5 vrrinj no
B/?t/CLOC category 7 vrrsi« no «c/»rmia
B/?t/CLOC category 2 vrrens no Mc/trmid
B/?t/C£XP category / vrrsi« no üc/icmiii
B/?fC£X/' ca/«"gory 2 vrrsuj no i«7tem/a
B/fL/C£Y/* category i vrrjiu no «c/tenw'a
B/?t/C£XP category < vrrsuj no /.sc/icmia
no f/w///Mm tejf i r n u j no rrt'. r/uj//i'um c/wngM
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DCPATi
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D5CO7"
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CPAf category 2 vrrsui no (TK r/wnj[M
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CP^f carfgory 5 versus no
no SGOT-area mraiure W<TS«J /W 5GO7" c/wngf j ;
5GO7" category 7 V<T5«J no SGO7" c/ia/ige5
5GO7" category 2 verms no 5GO7"c/ia;igei
5GO7" category J v m i « no SGO7"c/wnge5
5GOT category 4 Vfrms no SGOrc/wnges
5GO7" category 5 versus no 5GO7 c/ia/iges
5GO7 category 6 versus no SG07" c/w/iges
no ZZW measure versus no LD// c/ia/iges
Zi)/¥ cafpgory / vers/ts no LDW c/wnges
/-ƒ)/¥ category 2 versus no £ƒ)/ƒ c/wnges
iDA/ category J versus no LD/Z c/ia/iges
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A^£CT//£XT category / versus no irreu »Aa///'«m cnangM
yV£CTA/£XT ca/egory 2 versus no irrev. f/ia///«m c/wnges
/V£CT//Z/)C category / versus no /rrev. r/uiZ/ium cnanges
5ever/fy o//sc/iem/c Pa/n
: m/'ssing rfa/a versus no £$c/iem/c pa/n
; /5/M//V category / versus no isc7/em/c
D/Sfl4//V2 ; /5PA/A/ ca/egory 2 versus no /sc//e/n/c pa/'n
Severiiy o/ Carrf/ac Wa// Mof ion aonorma/ir/es
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C 0 W ^ [ / C cafegory ƒ v<rms no conrfi/cfion dworders fa)
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rr#u/<ir (/isc/uirye in 77 versus deceased in FJ
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20J
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Appendix 17 Correlation matrix concerning severity of illness on admission, background
characteristics and costs of thrombolytic therapy (I.is twist deletion of missing cases, n=254).
ISEXTO
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SEX
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.J l*
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•06
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- 1 2 '
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08
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Appendix 18 Correlation matrix of severity of illness on admission, medical treatment,
background characteristics and costs of heart catheterization during period TO (Listwise
deletion of missing cases, n=374).
ISEXTO
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•09
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-.07
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•p< .03
Appendix 19 Correlation matrix of severity of illness on admission, medical treatment and
costs of PTCA for all cathelerized AMI patients (Listwise deletion of missing cases, n=127).
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•24*
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• 0 8
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.(1*
69^
-.14"
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.27'
STENEXO
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»6'
-.18'
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STENLOO
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-.01
.59*
.49*
NECLOO
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-.11*
.05
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.50»
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•p<jO5
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Appendix 20 Correlation matrix of severity of illness indicators, background variables and
length of stay (List wise deletion of missing cases, n=451>.
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Appendix 21 Correlation matrix of severity of illness indicators, background variables, length
of stay and costs of CCU (Listwise deletion of missing cases, n=454).
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ry Dcscnprion
no i5cn/7ni<: pain
iK/irmir pain in TO or 7"/
üc/i^mic pain f afro J in 72 or 7J
in severity categories representing Lschemic
A/ran
J8.9J
60.67
/O5.7S
17./J
&£*!-. F,
5J.7V
42..J6
7J.67
2J.00
pain.
54
92
6
Appendix 23 Mean costs of drugs of patients in severity categories representing the extent of
Cardiac Wall Motion Abnormalities.
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Appendix 241 Mean cost of drugs of patients in severity categories representing type
of appearance of cardiac rhythm disorders.
Ca/e#ory
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recurrent /tF/F
acuff VF/F comMn^a' w/f/i <4F/F or
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Appendix 25 Mean costs of drugs of patients in severity categories representing the Left
Ventricular Ejection Fraction.
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Appendix 26 Correlation matrix of severity of illness indicators, background variables, length
of stay and costs of drugs (Listwise deletion of missing cases, n=446).
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Appendix 27 Results from regression analysis: dependent variable is total costs of drugs in
AMI-patients (Listwise deletion of missing cases, n = 456).
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Appendix 28 Mean costs of laboratory services of patients in severity categories representing
myocardial necrosis estimated by total CPK release.
Description
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Appendix 29 Mean costs of laboratory services of patients in severity categories representing
ischemic pain.
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Appendix 30 Mean costs of laboratory services of patients in severity categories representing
the extent of in Cardiac Wall Motion abnormalities.
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Appendix 31 Mean costs of laboratory services of patients in severity categories representing
type and time of appearance of cardiac rhythm disorders.
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Appendix 32 Correlation matrix of severity of illness indicators, background variables, length
of stay and enrollment in PR1M1 protocol and costs of laborator)- services (l.istwise driftion of
missing cases, n=456).
8
8 8
8 M
8 8 8 8 ^
8 S S 8 S ö 2
8 S S S S 8 8 S S
8 n - » - r N ^ ^ v i —r * O O O O O O O f i
8
8
38
*
 
1
8
13
*
 
1
22
*
r*
3
.91
s
.11
s
o
.60
s
o
02
o
8
S
•80
$
3
14
*
o
07
o
8
8
g
10
*
S
o
•61
§
.80
o
18
*
10
*
Appendix 33 Results from regression analysis:
services (Listwise deletion of missing cases, n =
~ " "
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96.92
-76J8
47./5
4i. i6
75.2i
70.75
5.25
i.4i
77.45
.47
i6.09
97.92
/ 76.62
-72.9i
2i.77
-7.99
78.7i
-7.49
46.2/
-.45
6/44
74/. 2 i
i02.i7
i.5/
-57.Oi
-77.99
7.75
-9.Ü
4i.67
/8.02
-/52.85
-796.52
95. i 8
-/76.26
-76.50
49.47
-27.57
/04./5
.72
dependent variable
458).
7.69
i4.85
i4.76
i4.72
i4J8
i5.i6
i5.50
46.60
76.82
78.90
7/.J4
27.87
2i.92
22.94
79.89
47.22
78.70
i7.27
i4.27
28.46
Z6.44
29.97
i/.75
2i.22
48./5
/O.57
77.07
40.6i
7i.55
.66
25.67
44.05
i5.96
55.67
i&85
77.62
60.70
57.i7
97.i2
i6.96
27.85
27.76
i8.55
45.48
is total costs
.75
-.75
.75
.78
.77
. / i
.20
-.05
./2
.77
.04
.07
.00
.00
.0i
.00
.06
.08
.75
-.07
.04
.00
.08
.00
-.0i
.00
./O
.72
.6i
.27
-.06
-.07
.00
.00
0 i
.06
-.08
-.72
Oi
-./O
.Oi
.05
-.02
of laboratory
.000
/VS
TVS
.029
A'S
/VS
.007
A'S
.0/5
.022
A'S
TVS
TVS
/VS
/VS
/VS
TVS
.009
.000
ATS
A»
TVS
.0/4
/VS
/VS
A'S
.000
.007
.000
.000
.027
/VS
ATS
A'S
/VS
A'S
.077
.007
TVS
.002
A'S
A'S
A'S
.02i
2/5
no s«'g. CPAf c/io/ig«
Appendix 34 Mean costs of ECG of patients in severity categories representing myocardial
necrosis estimated by total CPK release.
Category
0
7
2 70000 - 20000
i 2«X» - 40000
4 40000-60000
5 >60000
24.0J
J5.W
4S./4
49.98
48.47
64.5/
42.7J
27.50
2JJ2
2&4O
29.09
J4.09
4J.74
57.76
9
85
72
/fltf
58
56
7/
£fa':. 7 9 (p<. 00/j
Appendix 35 Mean costs of ECG of patients in severity categories representing ischemic pain.
Category 7)«cripfion
0 no iic/temic pain
7 iic/i^mic pain in TO or 77
2 iic/if/nic pain faiso,) in 72 or 73
29.92
44.25
68.2 3
75.90
23.69
33.43
46.33
23.77
54
305
92
6
Appendix 36 Mean costs of ECG of patients in severity categories representing the extent of
Cardiac Wall Motion Abnormalities.
Category
0
7
2
J
4
5
£,a ' . ,73(
Description
no »va// mofion awnorm«/;7ie.y
wa// mo/ion awn. in 7 or 2 »•«ƒ/ .sfgmpnf.s
wa// mo/ion awn. in 3 HY/// jfgmentt
wa// mo/ion aftn. in 4 wa// .segm^ntt
wa// mofion aftn. in 5 wa// segméws
wa// mofion awn. in 6 or 7 wa// .jpgmpnf.s
miijing
p <.007)
A/ean
37.87
47.60
57.82
57.95
99.45
39.28
37.67
S,,/.aW
73.67
25.76
37.49
38.73
76.84
42.56
27.73
22
726
88
36
22
/7
746
2/6
Appendix 37 Mean costs of FCG of patients in severity categories representing type and time
of appearance of cardiac rhythm disorders.
/w r/ryf/i/n dV
a*
j/'/iM.v/ac/iycaraïa or /lon-jutfa/nn/ v^  n/ncu/ar
rfcurrrm j/nitffac/iycaraïa or non-jusfa/nc </
v^nfricutir wc/rycar<//'a
AF/F comM/ifd vW//i i/niu/ac/i^carrfm or
n-.tu.j/a/'/K'rf v«"nrrictt/«r tac/rycflrrfi'a m
vW//i VF/F or .tu.vfa//i«'a' vcnrncu/ar fac/rycaraVa
VF/F
J2(/x.0fl/)
/ F/Mf/<-
cu/ar F/«/fir/-Fi7>ri//af/o/u
Afea/i
J6.22
50.88
J8.9/
62./9
6JJ5
7/.2J
75.09
64.66
2/.6Z
27/5
26.68
JJ./9
i7.06
J9.27
JJ.47
55.4/
J9.9/
220
2/
/7
/8
25
5
i/
6
/6S./9
0.00
82.99
Appendix 38 Mean costs of RCG of patients in severity categories representing Left
Ventricular Ejection Fraction.
Mean
nonna/ fLVEF >
< Z.VEF < 40 %)
Z.V£F < iO %)
vrry jf vrrr impnranil fLV£F < 20 %)
44J5
67.65
72.45
5i.7/
29.79
20.57
49.90
4J.62
97.76
25.50
/ 8 i
80
46
9
/J9
Efa'.-./Of/x.OO/j
2/7
Appendix 39 Correlation matrix of severity of illness indicators, background variables,
length of stay and costs of ECG (Listwise deletion of missing cases, n=451).
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Appendix 40 Results fmm
deletion uf missing cases, n
D/?/Y)T/M/2
/.)/?// JT//MJ
/.)/?//K7YM/4
/;/?//KT//W5
/;/?7/>7///W6
/;/f// lT//M7
/J/?//KT//W«
/.>#//JT///W9
LOS
M/MA7W
/MA>£X7/
7M/;£X72
/M/)£XTJ
/•>//OM£7
/J//OWEJ
/jr/?y47V5/
7Jr/M/VS2
/J7"7JA/VSJ
A)/)E/t 77/0
/)/)E47Y//
/)/)£/t77/2
/WE47Y/.?
/X-OTVSW/vT
£.V/>/«//I<Y/ Vr/nV;;icT (/?' i :
regression analysis:
= 457).
.42
7.79
-.70
7.58
5.40
7.89
-.J8
8.74
79.4J
5.22
-79.76
.05
6.05
8J8
-4.78
-./7
-67./J
-/69.52
-/6.52
/.79
-J54
-9.66
7.06
-8.66
. .9
dependent variable
/.59
J.04
JJ7
J.24
2.9/
6.00
2.7/
5.58
5.J6
.77
J.78
5.5J
4.7i
7.85
5.52
/.8i
9.29
/0.«7
/J.28
4J9
JJ /
i.8i
5.84
7.67
is costs of ECG
.00
.07
.00
.04
.0i
.02
.00
.0i
.07
.9i
-.09
.00
.02
.02
-.02
-.00
-.72
-JO
-.02
.00
-.02
-.05
.00
(List wise
TVS
TVS
TVS
.020
A'S
ATS
A'S
ATS
.OOi
.000
.000
ATS
A'S
A'S
A'S
A'S
.000
.000
A'S
A'S
A'S
.072
/VS
.000
Appendix 41 Mean costs of etfiocardiography of patients in severity categories representing
myocardial necrosis estimated by total CPK release.
0
7
2
i
4
5
£w';
«o .ïi#. <
< /(XM
/OfXX) -
2 M M •
•MM) -
> 6MM
««WIJ
"P/fr/
)
20000
40000
.070><.OO7)
i/.72
J5.86
J9.82
48.7i
44.90
59.95
J/.78
J2.59
28J8
2J.0/
J/.67
J/.//
9
85
74
/06
60
56
J7J9 44.60 74
2/9
Appendix 42 Mean costs of echocardiography
type and time of appearance of cardiac rhythm
a
c
ƒ
g
A
,•
•y D«cn/J/ion
no r/ivf/tm aYsonfrr
acufr 5inu5/ir/rya]nrta
aruf«'arrw//7«n«'r/-/i/)n7/o/io/u
aruf** vrnfricu/ar/7u/frrA/i/>n7/<»iof
ji/iiwMcnyca/rfia or non-.$u.vf<H>tf<y i
Mc/ivcflM/ia in/o/Zon-upp/wir
rfcurrp/ir iinitsrac/tycan/ia or non-j
vfn/ricuZar fac/iycani/a
n/)n-i«jrai'rt«'a' vrnm'cu/«r fat/wfl/r
/o//oH--up p/iajc
recMrrcn/AF/F
acure VF/F comM/i^d H-I/A AF/F or
of patients
disorders.
w
'i>cflft/i<i or
/in in
5i'/m5/ac//V'
in severity
M«*a/i
J6.7J
40JO
40.7«
47.5S
49.6i
60.57
56.0J
62.69
52.6J
categories
5frf.rfr\'.
27.7i
26.52
2S.7O
.»5.O7
22.65
J7J6
J4.6J
42.59
4J 99
representing
A *
222
/05
2/
/»
/«
26
6
.?/
7
w »n/O//OH'-U/) ƒ>/«
arufr 5tniurac/ivain/M ory4F/From/>;;i^rfH'i//i /W.50 57.79
VF/F or 5tu/(i/;ic(/ vcn(ht'u/«ir («ic/iycan/ta I/I
aoo o.oo
AF/F = A/ria/ F/MHer/-Fi7;n7/afio/u
KF/F=
220
Appendix 43 Correlation matrix of severity of illness indicators, backgmund variables, length
of stay and costs of echocardiography (Listwise deletion of missing cases, n=446).
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Appendix 44 Results from regression analysis: dependent >ariable is costs of echocardiography
(I.istwise deletion of missing cases, n = 461).
f VurujMc; B S£ fl firM 5i> 7"
/»£J?/C
A/CCI;
LOS
/M/JEJOV
D77JAAS2
5.58
//.9/
/.9ó
J4
-7.08
-8.29
-5./8
2.87
J5.29
.50
/O.-/O
4/J0
59/9
/J.96
2J./9
/0J7
/4.85
/.94
¥.67
.J0
.20
7.58
//.5Ü
9.9/
/ft.JO
//.57
J.4/
/6.^ 8
/ft/8
28.02
/0.78
ft. 99
7.97
/ / . / 8
. / i
.//
JJ
./O
>.0¥
-.fli
-.02
.00
-./2
.00
-.Oi
-J2
.08
-.05
-./¥
.05
-.06
.OIM
.0//
.000
A/S
A'S
NS
A/S
A'S
.«J2
/VS
A/S
.0//
.(W5
A/S
.00/
A/S
29.26 2.4/
* J: .52
222
Appendix 45 Mean costs of exercise tests of patients in severity categories representing by type
and time appearance of cardiac rhythm disorders.
no r/;yf/wn d «
acuff afria//7MM<T/-/i/;ri7/afi0/u
toc/iycaraïa in/"o//ow-
venrriru&jr Mt'/rytYi/r/ia
acttf** M/7F com/wic^ w/'f/i .wViu.vf«t7i>'<;an/iVi or
r«'t'Mr/"«'n/ AF/F
VF/F comW/iw/ wi'//i MF/F or
in/o//ow-u/> /j/w.
VF/F or vu.vM/>iC(/ vr/i/n'cu/ar Mc/ryca/r/ia m
/O//OH'-M/>/)/W.V^
mw.ving
.05;
AF/F = /I/mi/ F/i<ffff/-Fi7;n7/«f/o«i
4S.26
0.00
5J.56
0.00
50.8i
6«.06
45.5/
5J.4i
4/4/
55J4
2/.2Z
J5.48
52.80
76.7i
59.58
Ó/.47
4J./J
44./5
74.92
J6.68
78./4
222
/04
2/
/8
/8
26
6
JO
7
Appendix 46 Mean costs of exercise tests of patients in severity categories representing the I/eft
Ventricular Ejection Fraction.
Freo.
0
/
2
J
«om,;/ (Z.VEF > 40 %)
i7i\'/»f/y im/xiirmc/ir (JO 9f- < LVfF < 40 %i
51-vrrf im/wirnw-nf (20 % < LVEF < JO %J
vrrv .\rvrrc im/wirnwif (LV£F < 20 %)
59.98
72.28
J6.60
2/.J7
J6.0J
55.05
78.67
5J.87
JJ.88
49.60
/8J
79
49
9
/ 4 /
Appendix 47 Correlation matrix of severity of illness indicators, background variables, length
of stay and costs of exercise tests (l.istwise deletion of missing cases, n=453).
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Appendix 48 Results from regression analysis: dependent variable is costs of exercise ECG
(Lislwise deletion of missing cases, n = 460).
/J/Ü//K77/M6
/•W//K77/M9
«£/J
TV/4
M/V/V7W
//.42
-2J2
-6.24
-/0.07
-y/./5
2.56
-2J.47
-/0.J5
-/0.«7
-/* .6/
-42.60
-/.07
.02
/2.7O
-5./6
4/.25
-2 7. «7
-59.77
2J.44
-7.79
6.79
42.59
4/76
-J7.64
/a «5
Z/6.5/
6.00
7/65
72.49
72./«
7O.6«
20.9S
/0./9
79.*4
79.Oi
&8/
2/.0J
.22
J5
7J.62
20.99
77.65
2«.96
20.64
5.W
47.45
JO. 75
76.J7
72.J4
74.40
2Z.96
7i.S7
.09
.00
-.02
-.04
-.05
.00
-.70
-.02
-0J
-.09
-.//
-2J
.00
.04
-.0/
-./O
-,rw
-./2
.2/
.00
.0/
-.//
-./5
-.70
.02
.058 (A'S)
7V5
/VS
A»
/VS
/VS
.022
Atf
/V5
.0J5
04J
.000
/VS
/VS
/VS
.020
AS
.004
.000
/VS
/VS
.009
.00/
.029
/VS
.000
.25
22J
Appendix 49 Pattern-analysis
(• = adjacent pattern)
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Appendix 50 Means, standard deviations and numbers of the SICI.OS for AMI-patients by
age and sex.
SICLOS
category
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Subtotal
Unclassif.
Total
Outliers
Grand total
Mean
age
59.8
55.6
60.4
60.0
66.0
57.3
60.2
57.6
58.7
58.4
643
596
63.8
70.5
62.3
68.7
807
603
64.2
604
61.3
60.5
Male
Sl.dev
11.4
8.9
7.7
10.5
95.5
11.1
8.5
10.6
11.9
9.2
3.2
8.7
5.7
11.5
13.1
13.1
4.2
11.0
15.3
11.2
8.6
112
N
86
45
11
41
6
10
11
27
3
11
4
8
8
4
7
27
3
312
10
322
3
325
27.6
14.4
3.5
13.1
1.9
3.2
35
8.7
1.0
3.5
1.3
2.6
2.6
13
2.3
87
10
100*
Mean
age
61.9
63.6
85.0
66.1
69.3
80.0
72.0
648
70.7
58.0
76.7
75.0
68.7
71.0
71.1
80.5
67.8
704
67.9
72.3
68 1
Female
Sldev.
11.0
9.3
11.9
9.5
9.1
11.7
5.9
17.3
10.0
.
12.7
9.2
8.4
58
11.4
6.6
111
7.6
11.0
N
22
13
1
22
7
5
1
11
6
4
6
0
1
3
4
16
4
126
9
135
4
139
%
175
10.3
.8
17.5
5.6
4.0
.8
8.7
4 8
3.2
4 8
.8
2.4
3.2
127
3.2
100%
Mean
age
60.1
57.4
62.4
62 1
67.8
64.9
61.2
59.7
66.7
583
71.7
59.6
65.0
69.7
65.5
69 6
80.6
62.5
67.2
622
67.6
62.7
Sl.dev
11.3
9.6
10.2
11.3
9.2
15.0
8.8
11.3
9.6
11.2
10.0
8.7
6.5
11.0
12.1
116
4 8
10.9
12.1
12.1
9.4
11.6
ToUl
N
108
58
12
63
13
15
12
38
9
15
10
8
9
7
11
43
7
438
19
19
7
464
%
24.7
13.2
2.7
14.4
3.0
3.4
2.7
87
2.1
3.4
2.3
1.8
2.1
1.6
2.5
9 8
1.6
100%

Curricu/um Vïfcir 229
Curriculum Vitae.
Gemma Voss was born in Sustcrcn on the 12th of november 1961. In 1980 she finished her
high-school at the Bisschoppelijk College in Sittard. After graduating from the Faculty of
Health Sciences at the University of Limburg in 1984, she has attended an one-year course
in research methodology at the same university. During that year, 1985. she joined the
University Hospital Maastricht where she is in charge of the development and implementation
of the DRG patient classification system. During 1986 she visited various hospitals and
universities in the USA to learn from the experience with patient classification systems. On
a number of occasions she was a temporary advisor for the World Health Organization. She has
published articles and has given several lectures on the subject of patient classification
systems. In 1987 she started her doctoral research.
DATAWYSE I Universitaire Pers Maastricht
ISBN 90 5278 054 4
NUGI 742 / 689
